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SUMMARY
The aim of this study was to investigate the role 
of human cytomegalovirus (HCMV) in transformation and 
its possible involvement in the development of cervical 
intraepithélial neoplasia (CIN).
Although cell transformation by HCMV is well 
documented in the literature, the mode of 
transformation has not yet been elucidated. Nelson ^  
al. ( 1982) identified a DNA sequence within the Hindlll 
E fragment of the HCMV AD169 genome which when 
transfected into NIH 3T3 cells, can initiate colony 
formation in methylcellulose and tumourigenicity in 
nude mice. It was intended to extend these experiments 
to investigate the molecular basis for HCMV cell 
transformation. Repeated attempts to transform 3T3, 
human embryo lung (Helu) and rat embryo (RE) cells with 
the HCMV AD169 Hindlll E fragment were unsuccessful. 
However, transformation of RE cells was repeatedly 
observed after infection of the cells with 
UV-irradiated HCMV AD169 virus. Southern blot analysis 
could not detect HCMV DNA in HCMV transformed cell and 
derived tumour cell lines. This suggested that the 
retention of viral DNA in the transformed cells may be 
transient and only necessary to initiate the 
transformation event. One mechanism by which HCMV DNA 
could initiate transformation is by activating a 
cellular proto-oncogene. Experiments were carried out
in collaboration with Ms. L. Clark and Dr. J.C.M.
Macnab to see if the DNA from a rat tumour induced 
after inoculation with HCMV transformed cells contained 
a transforming gene. The rat tumour DNA was found to 
contain a transforming gene that could be transfected 
into 3T3 cells and could initiate tumourigenesis when 
the transfected cells were injected into nude mice. As 
viral DNA could not be detected in the original HCMV 
transformed cells, the transforming gene must have been 
of cellular origin. Preliminary experiments suggested 
that HCMV may have activated a ras oncogene in the 
transformed cells.
Past seroepidemiological studies have implicated 
HCMV as an oncogenic agent in the development of CIN 
and cervical carcinoma. The second aim of this study 
was to provide molecular evidence for an association 
between HCMV and CIN. The DNA from biopsies of 4 3 CIN 
patients in the West of Scotland was examined for the 
presence of HCMV DNA sequences by Southern blot 
analysis. Two biopsies, C2 and C17 were found to 
contain DNA sequences that hybridized to the HCMV AD169 
Hindlll E fragment. In Cl7 the hybridizable DNA 
sequences were only present at about 0.1 copy/cell and 
therefore in an amount too low to permit detailed 
sequence analysis. The hybridizable DNA sequences in 
C2 were present at about 20 copies/cell and were found 
to contain BamHI restriction fragments that comigrated 
with the BamHI P, W, c and e fragments of HCMV AD169.
The hybridizable CIN DNA sequences may represent HCMV 
sequences that were retained in the tissue after HCMV 
infection and may have instigated the development of 
CIN, Two other BamHI fragments of C2 DNA were detected 
using the HCMV AD169 Hindlll E fragment as a probe and 
these may represent rearranged sequences in the 
retained HCMV DNA. Rearrangements could have occurred 
when the viral DNA became integrated into the cellular 
DNA of this patient. As only a small amount of DNA was 
available from the C2 biopsy, further analysis of the 
viral sequences retained and the nature of the 
rearrangements was only possible if the relevant 
sequences could be cloned. A A library of the C 2 D N A  
was constructed using the vector EMBL3 and three clones 
were isolated that contained C2 sequences that 
hybridized to the cloned HCMV AD169 Hindlll E fragment. 
One of the clones was found to contain C2 sequences 
that hybridized to pAT vector sequences present in the 
probe. The other two clones contained C2 sequences 
that hybridized specifically to the HCMV AD169 Hindlll 
E fragment but were unfortunately lost during the 
purification procedure after only 2 or 3 rounds of 
replication.
Since HSV-2 and HPV have also been implicated in 
the development of CIN and cervical carcinoma, the same 
43 CIN biopsies were analysed for the presence of HSV-2 
and HPVll DNA sequences. Authentic HPVll DNA was 
detected in two CIN biopsies (C13 and Cl9) but no
conclusive evidence of HSV-2 specific DNA could be 
found, although sequences that hybridized to vector 
pBR322 were detected.
As herpesviruses are important pathogens of the 
cervix, biological studies were carried out to 
determine the response of cervical cells to infection 
in vitro by HCMV and HSV-2. Ectocervical cells were 
found to be fully permissive for HSV-2 replication but 
nonpermissive for HCMV infection. HCMV infection of 
ectocervical cells did not produce any morphological 
alteration of the cells and did not result in the 
production of infectious virus. Immunofluorescence 
revealed that only about 10% of the infected cells 
contained HCMV specific antigens. Because latent 
infection is an important factor in the pathogenesis of 
herpesviruses, an investigation of latent infection of 
ectocervical and Helu cells was also undertaken. By 
incubating infected cultures at 42^C it was possible to 
establish HSV-2 infections during which infectious 
virus could not be detected. Superinfection of 42^0 
treated HSV-2 infected Helu cultures with HCMV AD169 
and ^  mutants of HSV types 1 and 2 resulted in 
reactivation of the virus. Furthermore, the 
reactivated virus was found to be capable of efficient 
replication. Superinfection of 42^0 treated HSV-2 
infected ectocervical cell cultures with HCMV did not 
reactivate virus and superinfection of the cultures 
with HSV ts mutants resulted in cell death. The
possible role of hormones in reactivating virus was 
also investigated in Helu cells. Exposure of 420C 
treated HSV-2 infected Helu cells to IQ-'^M or 10“^M 
oestrogen, progesterone or dexamethasone did not result 
in virus reactivation. The reactivation of HSV-2 by 
HCMV from Helu but not from ectocervical cells may be 
related to the fact that ectocervical cells are 
epithelial cells and Helu cells are fibroblasts. Like 
the course of normal HCMV infection, the mechanism of 
reactivation may be different in the different cell 
types. These experiments illustrate that fibroblasts 
do not provide a suitable in vitro model system for 
studying the role of herpesviruses in the development 
of cervical neoplasia and emphasise the necessity for 
further studies on the response of cervical cells to 
herpesviruses.
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INTRODUCTION
GENERAL PROPERTIES OF HUMAN CYTOMEGALOVIRUS
Human cytomegalovirus (HCMV) is a member of the 
herpes virus group and is a very important pathogen 
responsible for a wide spectrum of diseases (Weller, 
1971). Viral infection can be fatal in the foetus, 
newborn and immunodeficient. HCMV is a serious cause of 
congenital birth defects. The frequency of congenital 
HCMV infection approaches 1.5% of all births. Congenital 
cytomegalic inclusion disease (CID) is usually fatal and 
surviving infants suffer from extensive mental and motor 
dysfunction. HCMV also causes a type of infectious 
mononucleosis and interstitial pneumonia which can be 
fatal in organ and bone transplant patients^. The virus 
is present in most body fluids and excretions including 
blood, saliva, urine and semen and transmission can occur 
congenitally, natally, venereally and through blood 
transfusions and organ and bone marrow transplants. 
Disease can also result from reactivation of latent 
virus, particularly in immunodeficient hosts. In 
addition, the virus has oncogenic potential and has been 
associated with a number of human neoplasias, including 
Kaposi's sarcoma, cervical carcinoma, prostatic carcinoma 
and adenocarcinoma of the colon. This thesis describes 
studies undertaken to investigate the oncogenic potential 
of HCMV and its possible involvement in the development 
of cervical intraepithélial neoplasia (CIN), the
precursor stage to cervical carcinoma.
Morphology
Cytomegalovirions are composed of a spherical core 
about 60nm in diameter, surrounded by a 90-1lOnm 
icosahedral capsid of 162 capsomeres (Smith and 
Rasmussen, 1963; Montplaisir et al., 1972). The virions 
are enveloped by 2 discrete membranes, an inner membrane 
derived from the nuclear membrane and an outer 
loose-fitting membrane derived from the cytoplasmic 
membrane of infected cells. The outer membrane is mainly 
composed of glycoproteins. A variable number of 
glycoproteins have been described ranging from 4 (Fiala 
et al., 1976; Gibson, 1983) 5 (Farrar and Oram, 1984) 7 
(Kim et al., 1976; Nowak et al., 1984b) to 8 (Stinski, 
1976). Antisera to the glycoproteins contain antibodies 
that neutralize viral infectivity and react with antigens 
in HCMV infected cells (Stinski, 1976). In addition to 
mature virions, dense bodies are observed in HCMV 
infected cells. These are spherical particles which vary 
in size but are usually about twice the diameter of 
mature enveloped virions. They are formed concurrently 
with cytomegalovirions by the envelopment of electron 
dense material by budding into cytoplasmic vacuoles in 
the golgi region of infected cells. The envelope is very 
similar, if not identical, to the outer membrane of the 
mature virion. Both membranes share common antigens as
determined by immune microscopy (Craighead et al., 1972) 
and both attach and fuse to the membrane of host cells. 
The electron dense material is thought to be composed of 
virion structural proteins. Nothing is known of the 
biological significance of dense bodies. They contain 
very little or no viral DNA and may represent the end 
products of aberrant assembly of HCMV structural envelope 
and tegument proteins.
Between 20 and 35 structural virus-specific 
polypeptides have been described in HCMV virions and 
dense bodies ranging in molecular weight (MW) from 11,000 
to 290,000 daltons (Sarov and Abady, 1975; Fiala et al., 
1976; Kim et al., 1976; Gupta et al., 1977; Stinski,
1976, 1977). A few polypeptides are present exclusively 
in either mature virions or dense bodies but the majority 
are shared by both. The major capsid protein is a 
protein of 150,000 daltons and the major matrix protein a
68,000 dalton protein (Stinski, 1977). These proteins 
are present in both virions and dense bodies.
Irmiere and Gibson (1983) have described a third 
type of virus particle produced in lesser amounts in HCMV 
infected cells. These have been called non-infectious 
enveloped particles (NIEP's). They are morphologically 
distinguished from virions only by their core structure. 
The NIEP capsid has a diameter 10-15% smaller than that 
of the virion and has a much less densely stained centre. 
It is enveloped, does not contain viral DNA, and is
consequently non infectious. The protein composition of 
NIEP's is very similar to that of the virion. It differs 
only in that NIEP's contain significantly less of the
74,000 and 69,000 dalton matrix proteins and seem to 
contain an additional 35,000 dalton protein not present 
in virions (Irmiere and Gibson, 1983;1985). The 35,000 
dalton protein is the most abundant NIEP protein species 
and has properties in common with the 37,000 dalton 
B-capsid protein of Colburn CMV, a simian-like human CMV 
isolate (Gibson 1981a) and the 38,000-40,000 dalton 
B-capsid protein of herpes simplex virus (HSV) (Gibson 
and Roizman, 1972, 1974) suggesting that a protein of 
this nature may play a common role in the assembly 
pathway of herpesviruses. It has been proposed that this 
protein functions to mediate DNA packaging and/or 
nucleocapsid envelopment and in the normal course of 
events is modified and/or removed from the particle 
(Gibson and Roizman, 1972; Gibson 1981a). NIEP's are 
produced by all human CMV strains but not by Old World 
Monkey CMV infected cells or HSV. NIEP's are generally 
present in much lower amounts than virions. However, 
strain AD169 overproduces NIEP's by ten-fold and the 
additional NIEP protein of this strain has an apparently 
larger size (36,000 daltons) than the corresponding 
protein of other strains.
Genomic structure
The HCMV genome is one of the largest among DNA 
viruses consisting of a linear double stranded DNA 
molecule of approximately 225kb. Reports vary as to the 
MW of HCMV DNA. Huang et al. (1973) estimated the MW to 
be lOOxloG daltons by cosedimentation with HSV DNA and 
Sarov and Friedman (1976) used length measurements to 
arrive at a MW of 107^2.7x10^ daltons. Geelen et al. 
(1978) reported a MW of 147±6.2xlO& daltons. Kilpatrick 
and Huang (1977), DeMarchi et al. (1978) and Stinski e^ 
al. (1979) all calculate the MW to be about 150x10^ 
daltons and this is now generally accepted as the correct 
value for full length HCMV DNA. Stinski et al. (1979) 
investigated size heterogeneity of HCMV DNA and concluded 
that serial high-multiplicity passage results in the 
production of defective cytomegalovirions which contain 
shorter DNA molecules of 100x10^ and 60x10^ daltons.
This may explain some of the earlier observations. 
Alterations in the restriction enzyme profile eg 
defective-specific fragments of defective HCMV DNA 
suggests that deletions, substitutions or duplications 
may all be mechanisms by which defective DNA may be 
generated. The development of defective virions is 
associated with a decrease in infectivity but an increase 
in the particle/pfu ratio. Although defective virions 
have been identified for HSV, defectiveness in HSV is not 
associated with a decrease in the size of the virion DNA
(Frenkel et al., 1975, 1976). This suggests that the 
generation of HCMV DNA defective molecules is different 
from that of HSV.
HCMV DNA has a buoyant density of 1.7T6gcm3 which 
corresponds to a G+C content of about 57%. Melting curve 
analysis reveals a bisigmoidal curve with 2 
distinguishable melting transition points at 86°C and 
94^C corresponding to a G+C content of 43% and 60% 
respectively (Kilpatrick and Huang, 1977).
The HCMV genome consists of a long unique (U^) and 
short unique (Ug) region, each bound by inverted repeat 
sequences (IR^/TR^ and IRg/TRg) (LaFemina and Hayward, 
1980; Westrate et al., 1980). During virus replication 
the long and short unique regions become inverted with 
respect to each other resulting in HCMV DNA preparations 
of 4 genomic arrangements present in equimolar amounts 
(Figure 1). Restriction endonuclease digestion studies 
confirm this and demonstrate that all 4 forms are found 
in virus isolates and are capable of replication 
(Westrate et al., 1980; DeMarchi, 1981). The sequence 
arrangement in HCMV DNA is of the same general plan as in 
HSV DNA (Sheldrick and Berthelot, 1974; Hayward et al., 
1975; Delius and Clements, 1976) but with regions of 
different relative and absolute size.
In HSV, intrastrain heterogeneity of viral DNA has 
been observed in the terminal and joint fragments (Wagner 
and Summers, 1978; Locker and Frenkel, 1979; Post et al.,
s
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FIGURE 1 Structure of the HCMV Genome
Schematic representation of the DNA sequence 
arrangement of the HCMV ADI69 genome. Short (S) and 
long (L) segments are each framed by a pair of inverted 
repeats (IRg/TRg and IR^/TR^). Unique sequences of 
short and long segments (Ug and Uj^ ) may be arranged in 
either orientation, resulting in four isomeric 
conformations.
(Figure from FTeckenstein et al., 1982)
1980). These sequences have been designated the "a" 
sequences and are thought to play an important role in 
the isomerization of the viral genome (Mocarski et al., 
1980; Smiley et al., 1981; Mocarski and Roizman, 1982). 
HCMV DNA presumably has a similar "a" sequence 
arrangement since Geelen and Westrate (1982) were able to 
find unit length circular DNA molecules after brief 
exonuclease III treatment followed by dénaturation and 
reannealing of full length HCMV DNA. Preliminary data 
for the Towne strain of HCMV has revealed a 7 50bp 
sequence within the terminal and joint fragments that may 
be analogous to the HSV "a" sequence (LaFemina and 
Hayward, 1980, 1983). Similarly, Spector et al. (1982) 
have observed sequence heterogeneity in the terminal 
fragments bounding the L and S regions and in the repeats 
bounding the L region of strain AD169. This sequence 
variability may result from insertions and/or deletions 
of sequences within the repeated regions, as has been 
reported for HSV (Wagner and Summers, 1978).
The origin of replication and packaging signals have 
been localized for HSV (Stow, 1982) but have not yet been 
determined for HCMV.
Physical maps of HCMV strain AD169 (Westrate et al., 
1980; Oram et al., 1982; Fleckenstein et al., 1982; 
Greenaway et al., 1982; Spector et al., 1982), Towne 
(LaFemina and Hayward, 1980) and Davis (DeMarchi, 1981) 
have been constructed after restriction by several
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8different endonucleases. Physical maps for the digestion 
products of Hindlll, BamHI EcoRI, PstI, Bglll and Xbal of 
HCMV strain AD169 are given in Figure 2.
DNA 'restriction endonuclease analysis of different 
isolates of HCMV shows that there are a large number of 
comigrating fragments, suggesting extensive conservation 
of DNA sequence order among the various strains. There 
are a few unique DNA fragments present in
epidemiologically unrelated isolates (Huang et al., 1976; 
Kilpatrick et al., 1976; Doerr et al., 1979; Westrate e;t 
al., 1983). Restriction endonuclease analysis of various 
HCMV isolates can yield information on the epidemiology 
of the virus. For example restriction -enzyme profiles of 
HCMV isolates from sexual partners have been found to be 
identical suggesting that HCMV can be sexually 
transmitted (Chandler et al., 1984; Handsfield et al., 
1985). HCMV isolates from mother and baby have also been 
found to be identical (Chandler et al., 1984) suggesting 
that HCMV can be congenitally or natally transmitted. 
Huang et al. (1976) demonstrated that 10 
epidemiologically unrelated HCMV isolates shared 80% 
homology with the AD169 prototype strain by DNA-DNA 
reassociation kinetics. HCMV strains Towne and AD169 
share about 90% DNA sequence homology (Pritchett, 1980). 
This is a striking contrast to the degree of homology 
that exists between the herpes simplex viruses. HSV-1 
and HSV-2 share about 48% nucleic acid homology (Kieff e_t
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FIGURE 2 Restriction endonuclease cleavage maps
of HCMV DNA strain AD169
Map of the HCMV genome strain ADI69 for the 
enzymes Hindlll, BamHI, EcoRI, PstI, Bglll and Xbal. 
Only the prototype orientation is shown. Repeated 
sequences are indicated by thick horizontal lines, the 
join between the long and short internally repeated 
sequences is indicated by the dotted line.
(Figure from Greenaway et al., 1982).
An unbound copy of this Figure can be found at the back 
of this thesis.
al. , 1972). Most of the genetic variability and 
heterogeneity between CMV isolates exists within the 
repeat sequences (LaFemina and Hayward, 1980; Westrate e;t 
^ . ,  1983).
The HCMV genome shares less than 5% nucleic acid 
homology with the DNAs of HSV-1, #SV-2, EBV or simian and 
murine CMV (Huang and Pagano, 1974). Recently, D'Aquila 
and Summers (1985) have reported homology between the 
HCMV Towne BamHI E fragment and the DNA polymerase loci 
of HSV-1 and EBV. Peden et al. (1982) and Rüger et al. 
(1984, 1985) have shown that AD169 DNA has sequence 
homologies to cellular DNAs of various origins. The 
homologous sequences have been localized to 4 regions of 
the long unique segment (EcoRI fragments R, 1 and b and 
Hindlll fragment S) and one region in the terminal 
inverted repeats (EcoRI fragments 0 and H) and are not 
related to human Alu repeats or to cloned human c-myc 
sequences.
Productive infection
HCMV is highly species specific, consequently the 
interaction between HCMV and the infected cell differs 
between permissive and nonpermissive hosts. HCMV 
nonproductive infection and latency will be discussed 
later.
HCMV has a lengthy growth cycle. Viral DNA 
synthesis does not occur until approximately 24 hr post
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infection (DeMarchi and Kaplan, 1976; Huang et al., 1973) 
and progeny virus may not appear until 72 hr post 
infection (Michelson-Fiske et al., 1977; St. Jeor and 
Rapp, 1973a). The replicative cycle is often even longer 
in cells infected with primary isolates of CMV. 
Furthermore, the cellular response to infection depends 
upon the physiological state of the cells (DeMarchi and 
Kaplan, 1977a) HCMV replication is enhanced by a number 
of chemicals including 5-iodo--2 '-deoxyur idine (St. Jeor 
and Rapp, 1973b), dexamethasone (Tanaka et al., 1984a, 
1984b), and cortisol (Koment, 1985).
Virus penetration occurs rapidly and virus capsids 
can be detected in close association with nuclear pores 
by 5 min after the initiation of penetration (Smith and 
DeHarven, 1974) . Virus induced antigens can be detected 
early in infection. Geder (1976) detected HCMV induced 
nuclear antigens that resembled Epstein Barr virus 
nuclear antigen by anticomplement immunofluorescence 
(ACIF) within 3 hr post infection. Immediate early 
antigens have been detected in the nucleus within the 
first hour of infection by indirect immunofluorescence 
and ACIF (Michelson-Fiske et al., 1977; Reynolds, 1978).
The infected cell undergoes drastic changes during 
the early phase of HCMV infection. Alterations in 
chromatin conformation are detectable at the end of a 1 
hour virus adsorption period (Kamata et al., 1978). This 
requires virus coded functions expressed immediately
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after infection. By 18 hr post infection a novel 
chromatin pattern can be observed by electron microscopy 
(Kierszenbaum and Huang, 1978). In the first 24 hr of 
infection, HCMV stimulates host cell DNA, RNA, protein 
synthesis and the production of enzymes particularly 
those associated with the S phase of the cell cycle.
These effects will be discussed in detail in a later 
section. Virus specific cytopathic effect (cpe) ie cell 
rounding, can be observed in infected cells by 6 hr post 
infection (Stinski, 1977).
Gene expression
Like other herpesviruses, HCMV has regulated phases 
of transcription (DeMarchi et al., 1980; Stinski et al., 
1981; Wathen et al., 1981; McDonough and Spector, 1983) 
and translation (Stinski, 1977, 1978; Stinski et al., 
1980; Wathen et al., 1981). In general viral 
transcription and translation can be divided into 3 
phases; immediate early (IE), early and late.
IE transcription occurs in the absence of de novo 
protein synthesis and transcripts can be detected 2-4 hr 
post infection (DeMarchi et al., 1980). Major immediate 
early transcription of HCMV originates from the long 
unique region (DeMarchi, 1981; Wathen and Stinski, 1982; 
Stinski et al., 1983; McDonough and Spector, 1983; Jahn 
et al., 1984; Wilkinson et al., 1984). This differs from 
HSV and pseudorabies virus in which the major IE
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transcripts originate from the long and short repeat 
sequences (Clements et al., 1977; Jones et al., 1977; 
Clements et al., 1979; Feldman et al., 1979; Costa et 
al., 1980). In HCMV strain AD169, IE transcription 
occurs predominantly from the Hindlll E region (McDonough 
and Spector, 1983; Jahn et al., 1984; Wilkinson et al., 
1984). The most abundant IE mRNA is a 1.95 kb transcript 
transcribed from left to right between map units (mu) 
0.0764 to 0.0865 on the prototype molecule of AD169. The 
most abundant IE mRNA in cells infected with HCMV Towne 
(1.95 kb; Wathen and Stinski, 1982; Stinksi et al., 1983) 
and Davis (2.2 kb; DeMarchi 1981, 1983) maps in the same 
relative position of the long unique region as the 1.95 
kb IE mRNA of strain AD169. Wilkinson et al. (1984) 
demonstrated by hybrid-selected translation that the 
abundant 1.95 kb mRNA encoded the major IE polypeptide 
with a MW of 7 5,000 daltons. The major IE polypeptides 
of strain Davis, Towne and AD169 each have slightly 
different M W ’s. (Cameron and Preston, 1981; Gibson, 
1981b) but cross react immunologically (Goldstein et al., 
1982). Transcription of two middle abundant 
polyadenylated mRNAs of 1.7 and 2.15 kb is initiated 
immediately downstream and in the same orientation as the 
IE 1.95 gene. These mRNAs differ in both size and 
orientation of transcription from those observed in IE 
coding region 2 immediately downstream of the major IE 
gene (coding region 1) of HCMV strain Towne (Stinski et
13
al., 1983). Other mRNAs are transcribed from the Hindlll 
E region and these are summarized in Figure 3.
A second IE transcriptionally active area of the 
HCMV AD169 genome has been identified at 0.593-0.619 mu. 
1.75, 3.8 and 4.8 kb mRNAs are transcribed from this 
region (Wilkinson et al., 1984). Additional minor IE 
transcription has also been observed from other regions 
of the HCMV genome and the data is presented in Figure 3.
Jahn et al. (1984) also identified a 5 kb IE 
transcript of HCMV AD169 of which only a small part is 
polyadenylated. This may correspond to the 5.2 kb IE 
mRNA identified by Wilkinson et al. (1984). The DNA 
coding for the 5 kb IE mRNA is transcribed in high 
quantities during the late phase of virus replication, 
unlike the other IE genes. This may represent an 
exception from the general rule of temporal regulation of 
herpesvirus transcription. It is noteworthy that the 
transforming region identified by Nelson et al. (1982) is 
included within the DNA coding region for this 
5 kb transcript.
The major IE gene of HCMV AD169 has been sequenced 
(Akrigg et al., 1985) and appears to be structurally very 
similar to that of strain Towne (Stenberg et al., 1984). 
The gene encodes a spliced molecule of 1736 nucleotides 
made up of 4 exon sequences. A single open reading frame 
starting in the second exon extends for 491 amino acids 
corresponding to a protein of MW 64,000 daltons. This is
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of considerably lower MW than that estimated by SDS PAGE. 
This may be due to the high proline content which may 
disrupt part of the protein's helical structure leading 
to anomalous mobility on SDS PAGE. There were only 2 
amino acid differences between the major IE proteins of 
AD169 and Towne which is surprising in view of the 
significant differences in their electrophoretic 
mobilities by SDS PAGE (Cameron and Preston, 1981;
Gibson, 1981b). There is a putative promoter regulatory 
region extending 509 nucleotides upstream from the 
transcriptional start site (Akrigg et al., 1985). It 
contains typical TATA and CAAT boxes and several short 
direct and inverted repeat sequences of 16, 18, 19 and 21 
nucleotides which may also influence the regulation of 
transcription. A promoter regulatory region 465 
nucleotides upstream of the cap site for transcriptional 
initiation has also been described for HCMV strain Towne 
(Thomsen et al., 1984; Stinski et al., 1983). The Towne 
major IE gene is activated by cis-acting (enhancer) 
elements in the promoter-regulatory sequence and by 
virus-specific trans-acting components (Stinski and 
Roehr, 1985). There is evidence for the presence of 
enhancers and trans-act ing components in the AD169 
genome. Akrigg et al. (1985) have identified potential 
enhancer core sequences in the complementary strand of 
the IE promoter at -98 to -93, -157 to -161 and -412 to 
-417. Boshart et al. (1985) have recently identified
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strong enhancer sequences located upstream of the 
transcription initiation site of the major IE gene 
between nucleotides -118 and -524. The enhancer is 3-5 
fold more active than the SV40 enhancer. Galloway and 
Hill (1985) have also reported a transcriptional enhancer 
within the transforming region identified by Nelson ^  
al. (1982) downstream of the major IE gene. In addition, 
Everett and Dunlop (1984) have reported trans-activation 
of the HSV-1 glycoprotein D and rabbit yS globin promoters 
by HCMV AD169 which suggests that the AD169 genome also 
contains trans-activating elements.
Early transcription occurs in the absence of viral 
DNA synthesis between 4 and 24 hr post infection 
(DeMarchi et al., 1980). At early times, abundant 
transcription is shifted from the long unique to the long 
repeat and adjacent sequences in strains, Davis, Towne, 
and AD169 (DeMarchi, 1981; Wathen and Stinski, 1982; 
McDonough and Spector, 1983) and continues late into 
infection. Since early viral gene products are 
presumably involved in viral DNA replication, the 
continuous expression of the gene products from the long 
repeat sequences could be related to the extended phase 
of viral DNA replication which does not reach its peak 
until 72-96 hr post infection. Ten to 16 early 
polypeptides have been detected within the first 6 hr of 
infection (Stinski, 1978; Blanton and Tevethia, 1981).
One of the early proteins has been identified as a 68,000
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dalton phospboprotein with protein kinase activity 
(Michelson et al., 1984; Mar et al., 1985). The protein 
can be detected by immunoprécipitation from 3 to 120 hr 
after infection and is induced by AD169, Towne and Davis 
strains but not by simian CMV's. The 68,000 dalton 
protein is of particular interest as it may be involved 
in transformation since some transformation-related gene 
products of both RNA (Collett and Erikson 1978) and DNA 
viruses (Griffin et al., 1979; Smith et al., 1979) 
described so far appear to be protein kinases.
Late transcription occurs after viral DNA synthesis 
from most regions of the HCMV genome. The proteins coded 
for by the late mRNA are structural proteins and at least 
35 have been described (Sarov and Abady, 1975; Fiala e^ 
al. , 1976; Kim et al., 1976; Gupta et al., 1977; Stinski 
1976, 1977, 1978). Few late transcripts and their 
corresponding proteins have been studied to date. Davis 
et al. (1984) have mapped a major virion phosphorylated 
tegument protein of 67,000 daltons to an mRNA coded for 
by the long unique region between mu 0.37 and 0.39. The 
nucleotide sequence of this protein has been determined 
(Davis et al., 1985). The authors suggest that the 
protein may have important functions, such as protein 
kinase activity, DNA binding and possible transcriptional 
activation of IE genes. Nowak et al. (1984a) have
identified the DNA sequences coding for a virion 
phospboprotein of 71,000 daltons. An mRNA of the same
17
size, map coordinates and orientation is translated into 
the 65,000 dalton polypeptide. Other structural proteins 
have been analysed but not yet mapped (Farrar and Oram, 
1984; Clark et al., 1984).
Genetics
Genetic analysis of temperature sensitive (ts) 
mutants of HSV has generated a wealth of information 
about the locations and functions of essential genes in 
the HSV lytic cycle. Recombination analysis has produced 
genetic linkage maps for HSV genomes (Brown et al., 1973; 
Subak-Sharpe, 1973; Timbury and Calder, 1976; Preston, 
1981) and many polypeptides have been mapped by analysis 
of intertypic HSV-1 and HSV-2 recombination and by marker 
rescue (Marsden et al., 1978; Preston et al., 1978). 
Unfortunately, this approach to gene mapping and analysis 
of gene functions has met with little success when 
applied to HCMV. After mutagenesis by UV light, Ihara et 
al. (1978) isolated 15 ^  mutants of HCMV which were 
unable to form plaques at 39°c but formed plaques at 
34OC. Five mutants defective in viral DNA synthesis at 
39^C were classified into 2 complementation groups 
according to whether they were normal or defective in 
inducing viral DNA polymerase. Yamanishi and Rapp 
(1979a) used DNA-negative HCMV mutants to induce host 
DNA synthesis and DNA polymerase in permissive and 
nonpermissive cells. They concluded that 4, and possibly
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more, cistrons control the synthesis of HCMV DNA and that 
HCMV DNA is not required for the induction of host cell 
DNA synthesis. The mutants of HCMV are, however, 
unstable as they revert to wild type on recovery from the 
freezer (Ihara, personal communication). Further studies 
have not, therefore, been possible with ^  mutants. 
Attempts to produce HCMV ^  mutants in this Institute 
also proved to be unsuccessful (J. Cameron, personal 
communication).
Genetic mapping of the HCMV genome is more likely to 
be accomplished by sequencing. This approach has been 
successful with VZV (Davison, 1985). Most of the HCMV 
AD169 Hindlll E fragment containing the transforming 
region identified by Nelson et al. (1982) and the major 
immediate early gene has already been sequenced 
(Kouzarides et al., 1983; Nelson et al., 1984; Akrigg et 
al., 1985) and the group in Cambridge are currently 
sequencing the entire HCMV AD169 genome (Kouzarides et 
^. ,  1985).
Nonproductive infection
During nonproductive infection, virus adsorption and 
penetration occur but there is no viral DNA synthesis. 
Viral cpe can sometimes be observed. For example, 
Fioretti et al. (1973) observed cpe when guinea pig cells 
were infected at high multiplicity. Some, but not all, 
early functions of HCMV are expressed in nonpermissive
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cells. IE and early antigens have been detected in the 
nucleus and cytoplasm of HCMV infected nonpermissive 
cells (Fioretti et al., 1973; Michelson-Fiske et al.,
1977) and also in HCMV-transformed nonpermissive cells 
(Albrecht and Rapp, 1973) by immunofluorescence. IE and 
early proteins, but not late proteins can also be 
detected in infected nonpermissive cells by SDS PAGE 
(Stinski, 1978). The viral genome can persist in 
nonpermissive cells for a long period of time and be 
recovered by fusion with permissive human cells (Boldogh 
et al., 1977). Stimulation of host cell macromolecule 
synthesis, thought to require early HCMV gene products, 
also occurs in HCMV infected nonpermissive cells (St.
Jeor et al., 1974; Furukawa et al., 1975). DeMarchi 
(1985) observed that in nonpermissively infected rabbit 
kidney cells, only the earliest of the early transcripts 
are synthesised and progression of transcription into the 
later part of the early phase does not occur. The lack 
of expression of some early functions in these 
nonpermissively infected cells results, therefore, from a 
lack of transcription of some early virus genes. 
Transcription could be prevented by cellular events such 
as cell proteins binding to DNA and preventing further 
transcription.
Stinski et al. (1981) have proposed that the
nonpermissive cell may favour persistence or latency of 
the viral genome. Latency occurs in the nonpermissive
20
cell when the genome does not proceed to replication. 
Physiological changes and the eventual expression of a 
required early viral gene may convert the nonpermissive 
cell to a permissive cell. As a consequence of this, the 
viral genome could move from the latent state to 
productive infection. This hypothesis is supported by 
the work of St. Jeor and Rapp (1973) which showed that it 
is possible to induce the replication of HCMV in 
nonpermissive cells pretreated with
5-iodo-2'-deoxyuridine. Possibly 5-iodo-2'-deoxyuridine 
interferes with the production of a cellular product 
inhibitory for HCMV replication or alternatively induces 
a cell product, not normally present, which aids or 
permits virus replication.
Latent and persistent infections
Most HCMV infection is subclinical (Weller, 1971). 
Primary infection is followed by persistent infection, 
during which virus continues to be shed sometimes for 
long periods of time. Even after virus shedding has 
ceased, the virus persists in a 'silent' state, probably 
for life. This latter condition is referred to as 
'latency'. During latent infection, no infectious virus 
or late antigens can be detected.
The majority of the adult population is believed to 
harbour HCMV.in a latent state. This is supported by the 
isolation from infected individuals of cell lines that
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contain HCMV DNA but are free of detectable infectious 
virus or late antigens (Rapp et al., 1975; Joncas et al.,
1975). Reactivation of latent virus can occur in 
response to an imbalance in the immunological integrity 
of the host. Clinical situations which allow for the 
reactivation of HCMV include pregnancy (Montgomery e^ 
al., 1972) organ and bone marrow transplants (Gadler et 
al., 1982; Craighead, 1969; Rinaldo et al., 1976) blood 
transfusions (Diosi et al., 1969; Perham et al., 1971) 
and immunosuppressive chemotherapy (Dowling et al.,
1970). All these situations share two common features, a 
change in the immune system and the presence of foreign 
antigen.
The cell type in which HCMV persists or remains 
latent is unknown. There is evidence to suggest that 
lymphocytes (Pagano, 1975; St. Jeor and Weisser, 1977) or 
leukocytes (Fiala et al., 1975) may be involved. Joncas 
et al. (1975) have reported the presence of an 
unexpressed HCMV genome in an EBV-transformed human 
lymphoblastoid line. Other possible sites of HCMV 
latency include human skin fibroblasts (Williams et al., 
1980) and human kidney epithelial cells (Pagano, 1975). 
HSV has been shown to be latent in the trigeminal ganglia 
(Bastian et al., 1972; Baringer and Swoveland, 1973; 
Warren et al., 1977). There is no evidence to suggest 
that HCMV is latent in ganglia. It would seem that HCMV 
may become latent in a variety of cell types.
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Very little evidence is known about the state of the 
viral genome during latency. Gadler and Wahren (1983) 
presented evidence to suggest that HCMV DNA integrates 
into, or associates with a subset of cell DNA relatively 
rich in A-T content. They assume complete viral genomes 
persist in the cells but do not know whether they are 
fragmented or present as a continuous sequence.
A number of in vitro model systems for studying HCMV
latency have been developed. Some groups have utilized
inhibitors of viral replication such as
cytosine-arabinoside (Gônczôl and Vaczi, 1973), 
no
phospho^formic acid (Gadler and Wahren, 1983) and human 
leucocyte interferon and acyclovir (Bucher et al., 1983) 
to establish latency in cells normally permissive for 
HCMV. The value of acyclovir in the model system used by 
Bucher et al. (1983) is questionable, since acyclovir is 
not inhibitory to HCMV replication. Li and Albrecht 
(1982) established nonproductive persistent HCMV 
infections in human embryo lung (Helu) cells by using 
supra-optimal temperatures to restrict HCMV replication. 
Mocarski and Stinksi (1979) established persistent HCMV 
infections in human fibroblasts by high multiplicity 
infection and long term tissue culture.
Murine cytomegalovirus (MCMV) has also been used in 
model systems for studying latency. MCMV is latent in 
spleen cells (Mayo et al., 1978; Wise et al., 1979;
Hudson et al., 1979; Mercer and Spector, 1985), salivary
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gland tissues (Cheung and Lang, 1977; Cheung et al.,
1980) and prostate gland tissue (Cheung and Lang, 1977). 
Like HCMV, latent MCMV can be reactivated by 
immunosuppression, (Jordan et al., 1977; Mayo et al.,
1978) and during pregnancy (Gould and Mims, 1980) . No 
MCMV specific antigens or virus particles can be detected 
in latently infected cells but nucleic acid hybridization 
studies indicate the presence of viral DNA. Cheung e^ 
al. (1980) were able to detect 45 copies per cell of MCMV 
specific DNA in cultures of salivary gland cells and 0.2 
copies per cell in prostate gland cells.
It is hoped that using the model systems described 
will help to determine how CMV exists during its latent 
state and define more precisely the stimuli involved in 
reactivation.
ALTERATIONS IN HOST MACROMOLECULAR SYNTHESIS AFTER 
INFECTION BY HCMV
Stimulation of host cell nucleic acid synthesis
HCMV is able to induce cellular DNA synthesis in 
both permissive Helu cells and nonpermissive Vero cells 
(St. Jeor et al., 1974). AD169, Davis and Colburn (C-87)
strains have been found to stimulate host cell DNA 
synthesis which suggests that this stimulation may be 
characteristic of the cytomegalovirus group. The DNA 
synthesis induced by HCMV infection appears to represent
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normal semiconservative replication as opposed to repair 
synthesis (St. Jeor et al., 1974; DeMarchi and Kaplan, 
1976). It has been suggested that HCMV replication and 
synthesis of new virus is dependent upon cell DNA 
synthesis (St. Jeor and Hutt, 1977). It appears that 
viral DNA synthesis is not required for the stimulation 
of host cell DNA synthesis as maximum stimulation occurs 
before the onset of viral DNA replication (St. Jeor e^ 
al., 1974). Certain HCMV ^  mutants defective in viral 
DNA synthesis retain their ability to induce cellular DNA 
synthesis at both the permissive and nonpermissive 
temperatures in both permissive and nonpermissive cells. 
(Ihara et al., 1977; Yamanishi and Rapp, 1979a). This 
suggests that an early gene product of HCMV may be 
responsible for stimulation.
The ability of infectious virions to induce the 
synthesis of cellular DNA increases if the virions are 
irradiated with low doses of UV (DeMarchi and Kaplan 
1977; Boldogh et al., 1978). After high doses of UV no 
stimulation is observed (St. Jeor et al., 1974; Furukawa 
et al., 1975) .
DeMarchi and Kaplan (1977b) have found that 
defective virions play an important role in the 
stimulation of host cell DNA synthesis. More recently, 
defective virions have been found to induce a 
cytomegalovirus growth factor that enhances DNA synthesis 
and mitotic activity in target cells (Gbnczôl and
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Plotkin, 1984) .
Furukawa et al. (1976) reported that much of the- 
stimulation of cellular DNA synthesis is due to an 
increased rate of mitochondrial DNA synthesis. HCMV 
stimulation of mitochondrial DNA synthesis is not 
mediated through a stimulation of nuclear DNA synthesis 
as in polyoma and SV40 infection (Levine, 1971; Vesco and 
Basilico, 1971; Radsak and Albring, 1974).
In addition to stimulating host cell DNA synthesis, 
HCMV infection also stimulates host cell RNA synthesis in 
permissive and nonpermissive cells (Tanaka et al., 1975; 
Furukawa et al., 1975). Stimulation of RNA synthesis in 
infected cells precedes the synthesis of viral DNA and 
progeny virus by approximately 24 hr and the RNA species 
synthesised include ribosomal 288 and 188, and 48 
transfer RNA. The stimulation of host cell ribosomal RNA 
seems to be a characteristic feature of HCMV infections. 
Oncogenic viruses like polyoma and 8V40 have been shown 
to enhance host cell RNA species but not host cell 
ribosomal and transfer RNA synthesis (Oda and Dulbecco,
1968). Herpesviruses inhibit the synthesis of cellular 
RNA and polysomes early in infection (Flanagan, 1967; Hay 
et al., 1966; Tamara et al., 19721 Wagner and Roizman,
1969). Recently, H8V has been shown to stimulate certain 
cellular RNA species (D. Latchman, personal 
communication). Tanaka et al. (1975) suggest that HCMV 
induction of host cell RNA synthesis is dependent upon a
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protein(s) that is synthesised during the early stages of 
infection.
Stimulation of host cell protein synthesis
HCMV stimulates host cell protein synthesis on 
infection. During the early phase of HCMV infection, 
70-90% of the total proteins synthesised are host 
specific (Stinksi, 1977). Although host protein 
synthesis decreases at the onset of viral DNA synthesis, 
it still accounts for 40-50% of the total proteins 
synthesised during the late phase of infection. This 
distinguishes HCMV from HSV which only induces a small 
number of cellular proteins on infection (LaThangue e^ 
al., 1984 and personal communication) and subsequently 
specializes in viral protein synthesis. Selective 
suppression of host cell protein synthesis by the 
hypertonic conditions indicates that HCMV-induced 
proteins are synthesised in a cyclic manner (Gupta and 
Rapp, 1978). It is not known how HCMV stimulates host 
cell protein synthesis but as stimulation can occur 
before the onset of viral DNA replication it is possible 
that an early virus coded protein may be responsible.
The cellular proteins induced by HCMV infection have 
been poorly studied. Weder and Radsak (1983) described 
the induction of a host specific chromatin-associated 
glycopolypeptide which possibly mediates the stimulation 
of host cell DNA synthesis. More recently, Radsak et al.
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(1985) described three host derived glycopolypeptides one 
of which exhibits immunological relatedness to 
fibronectin.
Stimulation of host cell enzyme synthesis
In HCMV infected cells the stimulation of host cell 
nucleic acid synthesis is usually preceded by enhanced 
enzyme activities. These include thymidine kinases, DNA 
polymerases, DNA-dependent RNA polymerases, exonuclease 
and topoisomerases, ornithine decarboxylase and 
plasminogen activator. Enhanced enzyme activity occurs 
after the derepression of host cell chromatin. HCMV 
induces at least two chromatin associated factors 
immediately after infection which activate template 
activity of chromatin (Kamata et al., 1978).
HCMV infection stimulates the production of cellular 
thymidine kinases within 12 hr after infection. In HCMV 
infected fibroblasts there is rapid high level 
stimulation of cytoplasmic cellular thymidine kinase 
activity (Zavada et al., 1976) and mitochondrial 
thymidine kinase activity (Estes and Huang, 1977). 
Characterization of these enzymes with respect to 
phosphate donor specificity, optimal pH, thermostability, 
salt inhibition and electromobility shows that the 
postulated virus stimulated thymidine kinase activities 
in HCMV-infected cells are actually all of cellular 
origin. HCMV does not code for its own thymidine kinase.
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a feature that distinguishes it from HSV and also 
accounts for the fact that antiviral drugs, such as 
acyclovir, that act by inhibiting the production of viral 
thymidine kinases are not effective against HCMV. HCMV 
infection also stimulates host cell synthesis of and p 
DNA polymerases (Hirai, et al., 1976; Hirai and Watanabe,
1976) . These enzymes may be associated with the 
stimulation of host cell DNA synthesis. It is not known 
whether they are also involved in the initiation or 
elongation of viral DNA synthesis or act as core enzyme 
for the formation of viral-specific holoenzyme for viral
Q yS repticoxe
DNA synthesis^ In addition, HCMV induces a novel 
virus-specific DNA polymerase in infected cells that can 
be distinguished from the cellular DNA polymerases by its 
distinct chromatographic behaviour, template primer 
specificity, sedimentation property and salt requirement 
for maximal activity (Huang 1975; Hirai et al., 1976; 
Nishiyama et al., 1983). Tanaka et al. (1978) also found 
that HCMV infection induces three major classes of 
DNA-dependent RNA polymerases in human diploid cells. 
There is also evidence that the levels of topoisomerases 
are greatly enhanced upon infection with HCMV (Huang et 
al., 1984). These enzymes reduce the helical turn 
numbers of supercoiled DNA molecules which could 
facilitate DNA mutagenesis by an oncogenic virus. Isom 
(1979) found that HCMV markedly stimulated the activity 
of ornithine decarboxylase (ODC) and that the increase in
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activity is apparent 12 hr post infection. ODC is the 
first enzyme and rate-limiting step in the biosynthesis 
of polyamines and increases in ODC activity are found to 
accompany and precede rises in DNA synthesis. Levels of 
the enzyme are low in quiescent cells but high in tumour 
tissue and transformed cells and also increase after 
infection with tumour viruses. The ability of HCMV to 
stimulate ODC activity is dependent upon the multiplicity 
of infection (moi). Stimulation is not inhibited by the 
addition of polyamine although it is reversibly inhibited 
by the addition of phosphonoacetic acid.
HCMV infection has also been found to stimulate the 
production of plasminogen activator in both permissive 
and nonpermissive cells (Yamanishi and Rapp, 1979b). 
Plasminogen activator is another enzyme closely 
associated with malignant transformation (Unkeless et 
al., 1973; Ossowski et al., 1974). It is a protease that 
converts a serum plasminogen to plasmin which in turn 
hydrolyses fibrin. HCMV stimulation of plasminogen 
activator is apparent 24 hr post infection. It does not 
require viral DNA replication suggesting that the 
stimulation of plasminogen activator is controlled by an 
early gene function of HCMV.
Stimulation of Glucose uptake
It has been known for sometime that enhanced glucose 
uptake is associated with malignant transformation
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(Hatanaka, 1974) . HCMV infection causes a two-fold 
increase in the uptake of glucose by infected cells 20 hr 
post infection and an even greater increase later in the 
viral replication cycle (Landini, 1984). The selective 
increase in glucose uptake in HCMV infected cells could 
be the result of virus-induced stimulation in cellular 
macromolecule synthesis producing a demand for energy 
yielding reactions. This could lead to a rapid depletion 
of glucose from the medium and an increase in the number 
of glucose receptors on the plasma membrane. However, 
the stimulation of glucose uptake appears to depend upon
early transcription of the HCMV genome and de novo
s
protein syntheis, events not required for HCMV 
stimulation of host cellular macromolecule synthesis. 
Furthermore, at least part of the enhanced glucose uptake 
seems to be independent of the sugar level in the medium. 
This would suggest that there may be a specific 
virus-induced modification of the infected cell plasma 
membrane.
ONCOGENIC TRANSFORMATION OF CELLS BY HCMV
HCMV can transform both permissive and nonpermissive 
cells in vitro and these transformed cells are 
tumourigenic when introduced into experimental animals. 
Furthermore, the oncogenicity of the cells is 
dramatically increased after animal passage and the
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tumours frequently metastasize.
Oncogenic transformation was first demonstrated by 
Albrecht and Rapp (1973) in hamster embryo fibroblasts 
(HEF) after exposure to UV-irradiated HCMV. The 
HCMV-transformed HEF cells are tumourigenic in weanling 
hamsters and express HCMV-induced cytoplasmic and 
membrane antigens. No infectious virus can be isolated 
or virions detected in the cells. Isom et al. (1983) 
have shown that UV-irradiated HCMV will also transform 
guinea pig fibroblasts and that the transformed cells 
produce tumours when inoculated into athymic nude mice.
In this laboratory we have successfully transformed rat 
embryo (RE) cells using UV-irradiated HCMV AD169 and 
these transformed cells are again tumourigenic in Hooded 
Lister rats. They express antigens apparently induced by 
HCMV infection but lack of detectable HCMV virus DNA 
sequences (Fletcher, this thesis) suggests that such 
antigens are not HCMV-specific but probably of cellular 
origin.
HCMV has also been shown to transform human cells in 
vitro. Rapp et al. (1975) isolated a strain of HCMV 
(designated Mj) from human cells of prostatic origin. 
After continuous passaging these cells demonstrated 
non-contact-inhibited growth which suggests that the 
cells are either chronically infected or have been 
transformed in vitro by HCMV. Geder et al. (1976) 
further investigated the latter possibility by
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establishing persistent infections in Helu cells using 
the HCMV Mj strain. After a crisis period, foci of 
transformed cells appeared and two transformed cell lines 
were subsequently established. These transformed cells 
are tumourigenic in athymic nude mice (Geder et al.,
1976, 1977) and have detectable HCMV-induced membrane and 
nuclear antigens (Geder et al., 1976; 1977; Geder and 
Rapp, 1977). Microcytotoxicity tests reveal that the 
transformed cells share a common membrane antigen with 
HCMV-transformed HEF cells. Lack of published evidence 
for the retention.of HCMV DNA sequences and our own 
experience, cast doubt on the presence of HCMV coded 
antigens and suggest that the antigens recognised in 
HCMV-transformed cells are cellular in origin and may 
result from polypeptides switched on by HCMV infection 
perhaps by transactivation and subsequently upregulated 
continuously. The studies do, however, provide further 
evidence for the possible oncogenic potential of HCMV in 
its natural host.
More recently, transformation studies using 
restriction endonuclease fragments of the HCMV genome 
have led to the identification of the DNA sequences 
involved in initiating transformation. Nelson et al.
(1982) transfected NIH 3T3 cells with restriction DNA 
fragments of HCMV AD169 and obtained transformation with 
the Hindlll E and Xbal N fragments. The transformed 
cells exhibit anchorage-independent growth in
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methylcellulose and tumourigenicity in Balb/c nude mice. 
No viral DNA has been detected in the transformed cells 
at a sensitivity of 0.5 copies per cell. However, 
Buonaguro et al. (1985) have generated transformants 
which retain viral DNA by cotransfecting the transforming 
fragment with a dominant marker (pSV2-neo). 
Characterisation of the retained viral sequence is in 
progress. The frequency of transformation is lower than 
that of transformation by avian sarcoma and leukosis 
viruses but comparable to that obtained with adenovirus 
or with HSV-2 DNA fragments. Nelson has revealed the 
transforming region to be a 2.9kb sequence located within 
the Hindlll E fragment between mu 0.123 and 0.14 (Nelson 
et al., 1982). Later experiments have shown that this 
fragment can be reduced to about 558 bp and still 
initiate transformation (Nelson et al., 1983).
The transforming region of AD169 has been sequenced 
(Nelson et al., 1983; Kouzarides et al., 1983). The 
possibility of the sequence coding for a protein that 
could be involved in transformation has been considered. 
The sequence contains no open reading frames of 
significant size that could code for such a protein and 
further investigations have ruled out the possibility of 
RNA splicing (Nelson et al., 1983). The transforming 
activity is sensitive to EcoRI digestion suggesting that 
the nucleotide sequence at the EcoRI site must be 
essential for transformation. Kouzarides et al. (1983)
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noted that the EcoRl site falls within an 8 bp inverted 
complementary repeat that could be part of a promoter 
sequence. This suggestion is also supported by the fact 
that the transforming region is A-T rich, a feature 
characteristic of promoter sequences. The sequence is 
bounded by suitable transformation signals and could 
encode a polypeptide of 80 amino acids if a single donor 
and acceptor splice site were used. Galloway and Hill 
(1985) have since presented evidence to suggest that the 
transforming region is a transcriptional activator that 
could initiate transformation by altering cellular gene 
expression.
Spector and Vacquier (1983) and Gelmann et al.
(1983) detected DNA sequences homologous to v-myc in the 
AD169 Hindlll E fragment by Southern analysis. However, 
Rasmussen et al. (1985) have reported that homologous 
regions between the HCMV genome and v-myc are limited to 
short G+C rich regions in each genome and that the HCMV 
genome shares little or no homology with the human c-myc 
gene. Kouzarides et al. (1983) could find no evidence of 
homology with viral oncogenes within the transforming 
region itself.
Analysis of the transforming sequence has revealed
one interesting feature. There is a stem-loop structure
an
located near the Hindlll site with EcoRI site in the stemA
of the molecule. This is homologous with a stem-loop 
structure found in the Bglll N transforming fragment of
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HSV-2 (Galloway et al., 1984).
Clanton et al. (1983) have described a second 
transforming region of the HCMV genome. This Towne Xbal 
E fragment is homologous to the HSV-2 Bglll C fragment 
previously described to be capable of transforming normal 
diploid HEF cells (Jariwalla et al., 1980). It is also 
homologous to a sequence located odjacent fo the AD169 
transforming region described by Nelson et al. (1982).
The Xbal E fragment of Towne transforms normal HEF cells 
in the continuous passage assay and NIH 3T3 cells in the 
focal transformation assay. The transformed cells are 
tumourigenic in athymic nude mice. El-Beik et al. (1984) 
localized the transforming activity within the two 
terminal Xbal/Bam HI subfragments EJ (7.6 kb) and EM (3.0 
kb). Razzaque et al. (1985) reported the presence of EM 
sequences in cell lines transformed with EM alone and the 
lack of EJ sequences in cell lines transformed with EJ 
alone. Jariwalla et al. (1985) have shown that 
metastasis in rats is mediated by the co-transfer of EM 
and EJ DNA fragments. Southern analysis of genomic DNA 
from EJ + EM -induced rat tumours revealed the presence 
of EM but not EJ sequences. Northern analysis of total 
RNA from the same tumours exhibited complete shut-off in 
the synthesis of cytoskeletal alpha-actin, a 
transformation-sensitive marker in rat fibroblasts.
Gelmann et al. (1983) have identified myc homologous 
sequences located in the 2 Bam HI subfragments of the
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Towne Xbal E fragment. However, since homology is 
restricted to the 5' half of myc it is unlikely that the 
homologous sequences in HCMV represent specific 
functional genes.
A comparison between transformation by HCMV and 
HSV-2 reveals several features common to both. Both 
viruses have more than one location of sequences involved 
in transformation and viral DNA is not retained in the 
transformed cells in most cases. One transforming 
sequence of HCMV DNA is similar to one of HSV-2 in 
possessing a stem-loop structure. Despite these 
similarities, it is unlikely that both viruses have a 
similar mode of transformation. Recent evidence suggests 
that HSV-2 induces mutations of cellular genes (Brandt e^ 
al., 1985) HCMV has not been shown to have similar 
mutagenic capacity. The possible modes of HCMV 
transformation are discussed more fully later in this 
thesis.
In addition to the human cytomegaloviruses, equine 
cytomegalovirus (ECMV) has oncogenic potential and can 
transform cells in vitro (Staczek et al., 1984). High 
multiplicity infection of primary LSH hamster embryo 
cells with ECMV results in the coestablishment of 
persistent infection and oncogenic transformation. 
ECMV-transformed cells are tumourigenic in LSH hamsters,• 
resistant to ECMV and equine herpesvirus type 1 (EHV-1) 
superinfection and express ECMV-specific proteins.
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Transformed cells have also been found to contain small 
amounts of a limited portion (<0.05%) of the ECMV genome 
However, no evidence exists that ECMV's are associated 
with neoplastic disease in the horse - an uncommon state
THE ASSOCIATION OF HCMV WITH VARIOUS HUMAN NEOPLASIAS
It is very difficult to prove that viruses are 
involved in the development of human cancers. Causal 
associations have to be deduced from sero or molecular 
epidemiological surveys and the results of such surveys 
must be interpreted with caution. HCMV is a ubiquitous 
pathogen and exhibits a complex epidemiology. 
Seroepidemiological studies are complicated by the 
naturally high level of antibodies to HCMV in the 
population. The overall frequency of antibodies to HCMV 
in a normal population for all ages is thought to be 
approximately 54% (Stern and Elek, 1965) but is higher 
among the newborn and older members of the population 
(Embil et al., 1969). Fluctuations of antibody levels 
occur in individuals due to blood transfusion, 
immunosuppression (particularly as a result of 
chemotherapy) and pregnancy. Although molecular 
epidemiological studies may reveal the presence of virus 
or viral information in tumour tissue, it is not 
conclusive of a causal relationship. As HCMV can infect 
a wide range of cells and tissues and be present in
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almost all body fluids, the presence of virus in tumour 
tissue could be fortuitous. Cancer patients are 
immunosuppressed and ideal targets for HCMV infection. 
Lartent virus could reactivate or secondary infection 
occur during malignancy.
These problems should be borne in mind when 
evaluating the evidence presented here for a causal 
association between HCMV and various human neoplasias.
Cervical carcinoma
Several epidemiological studies (Rawls et al., 1968; 
Nahmias et al., 1970) and molecular studies (Eglin ^  
al., 1981; Galloway and McDougall, 1983; Park et al., 
1983; Macnab et al., 1985) have linked cervical 
neoplastic disease to infection by HSV-2. However, in 
some geographical areas such an association is not 
observed and not all women with cervical carcinoma have 
serologic evidence of past HSV-2 infection (Vonka et al.,
1984). These factors indicate a possible multi factorial 
etiology of cervical carcinoma and it has been suggested 
that HSV-2 may interact with other agents that infect the 
cervix (Zur Hausen, 1982). Human papillomaviruses (HPV) 
have been strongly implicated in cervical carcinoma. 
Koilocytes and antigens characteristic of HPV infection 
can be detected in neoplastic tissue (Meisels et al., 
1979; Shah et al., 1980). DNA from HPV6 and 11 has been 
detected in GIN tissue (Gissmann et al., 1983; McCance et
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al., 1983) and DNA from HPV16 and 18 has been detected in 
carcinoma tissue (Dürst et al., 1983; 1985; Boshart e;t 
al., 1984). Evidence is presented in this thesis for 
considering HCMV as a possible oncogenic agent in the 
development of cervical cancer.
HCMV has been isolated from semen, prostate, uterus 
and cervix and can be sexually transmitted. It can 
persist for many months in asymptomatic carriers and has 
been associated with other sexually transmitted diseases. 
In a study by Jordan et al. (1973), HCMV was more 
frequently isolated from the cervices of women with 
suspected venereal disease than HSV-2. HCMV has also 
been isolated from the genital tract and urine of sexual 
partners (Chretien et al., 1977; Chandler et al., 1984; 
Handsfield et al., 1985). In addition, HCMV has been 
identified as a common cause of cervicitis and urethritis 
following venereal transmission (Evans, 1976).
It is now generally accepted that cervical carcinoma 
is a progressive disease. The first signs of the disease 
are characterised by the presence of abnormal epithelial 
cells in the cervix and are most often graded as 
dysplasia or CIN. Severe dysplasia is usually referred 
to as carcinoma in situ (CIS). When the disease has 
progressed to the stage where neoplastic cells breach the 
basement membrane it is termed invasive carcinoma.
There have been relatively few seroepidemiological 
studies investigating an association between HCMV and
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cervical carcinoma. All stages of the disease have been 
investigated but the studies so far have yielded 
controversial results. Fucillo et al. (1971) found that 
indirect haemaglutination (IHA) antibody titres to HCMV 
were not significantly elevated among patients prior to 
the development of CIS or during the period that CIS was 
present when compared to matched controls. 
Sprecher-Goldberger et al. (1971) looked at complement 
fixing (CF) antibodies to adenovirus associated virus, 
adenoviruses, HCMV and HSV in patients with various types 
of cancer and in control individuals but found no 
association between elevated HCMV antibodies and cervical 
carcinoma. Kumar et al. (1980) studied the humoral and 
cellular immune responses in patients with cervical 
carcinoma and healthy controls. They found no 
significant differences between CF and IHA antibodies to 
HCMV and lymphocyte stimulation in patients with cervical 
carcinoma and healthy controls. Similarly Hart et al. 
(1982b) found no correlation between antibody titres to 
HCMV tested by ELISA, ACIF and neutralization methods and 
either cervical dysplasia or CIS. Best et al. (1983) 
found no significant difference in the prevalence or 
titres to HCMV IgG and IgA antibodies in patients with 
cervical dysplasia or carcinoma and in matched controls 
from England, Sri Lanka, Malawi and Sudan.
By contrast, some studies have correlated elevated 
antibody levels to HCMV with cervical dysplasia and
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carcinoma. Vestergaard et al. (1972) reported a 
significantly higher level of CF antibodies to HCMV in 
patients with cervical carcinoma when compared with 
matched controls. There appeared to be no correlation 
between the incidence of antibodies and clinical stage of 
the disease. Pacsa et al. (1975) detected CF antibodies 
to HCMV more frequently in the sera of women with 
cervical atypia than in the sera of women with cervical 
disorders other than atypia or healthy controls. Stoian 
et al. (1982) looked at the prevalence of HCMV antibodies 
in patients with various cancers and reported a higher 
incidence of CF antibodies to HCMV in patients with 
breast cancer, uterine cervical carcinoma and ovarian 
neoplasms. This study, however, was not suitably 
controlled. More recently there has been a 
seroepidemiological study of patients attending a 
colposcopy clinic at the Western Infirmary, Glasgow 
(Walkinshaw, Roberts, and Cordiner, in preparation).
This study was carried out between 1982 and 1984 and 
included both patients with CIN and patients with no 
evidence of dysplasia. Exposure to HCMV and HSV-2 was 
determined by the presence of CF antibodies to the 
viruses and HPV infection was diagnosed by histological 
examination of colposcopy specimens. Initially the data 
showed no significant difference between CIN patients and 
controls for previous infection with a single agent 
(HCMV, HSV-2, HPV or Chlamydia) suggesting that single
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agent infection is not a significant risk factor.
However, significantly more patients with CIN had 
evidence of prior HCMV and HSV-2 or HCMV, HSV-2 and HPV 
combined infections when compared with the controls.
This may represent evidence for interaction between these 
viruses or the presence in the study population of a 
small group exposed to multiple infectious agents.
Further evidence for an association comes from a 
study by Melnick et al. (1978). They isolated HCMV from 
cell cultures derived from 2 out of 10 cervical cancer 
biopsies from patients in an advanced state of the 
disease. The patients demonstrated CF antibodies to HCMV 
and 6 out of 8 patients tested also had HSV-2 antibodies. 
Huang et al. (1983) performed a molecular epidemiological 
survey of HCMV and HSV-2 DNA in the normal cervix and 
cervical carcinomas from various geographic regions by 
DNA-DNA reassociation kinetic analysis. They found no 
significant difference between the frequency of HCMV DNA 
in African patients with normal cervices compared with 
those with carcinoma of the cervix, but among patients 
from Taiwan HCMV DNA was detected more frequently in 
cervical carcinoma specimens than in normal cervices.
The HCMV DNA positive rate was found to be significantly 
lower in cervical carcinoma specimens from Finland and 
the USA. From my own work described in this thesis I 
have detected HCMV DNA in 2 of 43 CIN biopsy specimens 
from patients in the West of Scotland. These patients
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were also included in the epidemiological study by 
Walkinshaw, Roberts and Cordiner mentioned previously.
It is very difficult to postulate a causal 
association between cervical carcinoma and HCMV alone.
It is far more likely that more than one virus and 
probably other environmental factors are involved in the 
etiology of this disease. These possibilités are 
discussed later in this thesis.
Prostatic carcinoma
HCMV has been considered as a possible oncogenic 
agent in the development of this disease for several 
reasons. HCMV can be sexually transmitted and the 
prostate appears to be a repository for HCMV (Lang and 
Kummer, 1972; Lang et al., 1975). As mentioned 
previously, Rapp et al. (1975) isolated a strain of HCMV, 
CMV-Mj, from normal prostatic tissue. Furthermore, this 
strain has been shown to be oncogenic. The prostatic 
cells infected in vivo by CMV-Mj grew to passage levels 
higher than those routinely attained by normal cells and 
exhibited properties characteristic of transformed cells. 
Geder et al. (1976) transformed Helu cells in vitro with 
CMV-Mj and established a transformed cell line designated 
CMV-Mj-HEL-2. When these cells were injected into 
athymic nude mice, tumours were produced from which 
another cell line, CMV-Mj-HEL-2, T— 1, was established. 
Some of the evidence for an association of HCMV with
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prostatic carcinoma comes from immunological data 
involving these transformed cells.
Patients with prostatic carcinoma show a significant 
humoral immune response to HCMV. Antibody titres against 
CMV-Mj-HEL-2, T-1 have been detected in patients sera by 
indirect immunofluorescence (Sanford et al., 1977b; 
Sandford et al., 1978). Studies have also indicated that 
patients with prostatic carcinoma demonstrate a cellular 
immune response to HCMV. Lymphocyte microcytotoxicity 
assays using CMV-Mj-HEL-2 and CMV-Mj-HEL-2, T-1 have 
revealed that a high percentage of patients with 
prostatic carcinoma show significant cytotoxicity to both 
these transformed cell lines (Sandford et al., 1977a; 
Sandford et al., 1978; Dagen et al., 1978). Control 
patients with benign prostatic hyperplasia and other 
urinary tract tumours showed significant lymphocyte 
cytotoxicity to CMV-Mj-HEL-2, T-1 but not CMV-Mj-HEL-2 
transformed cells. The high degree of in vitro 
cytotoxicity to CMV-Mj-HEL-2, T-1, may reflect the 
ubiquity of HCMV infection in the general population.
The fact that significantly more patients with prostatic 
carcinoma show cytotoxicity to CMV-Mj-HEL-2 suggests the 
presence of multiple antigens on the target cell 
membrane. Patients with prostatic carcinoma may 
recognise a tumour specific antigen as well as a viral 
specific antigen induced by HCMV. However, it must be 
stressed that the assays used in the studies mentioned
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are not specific for HCMV, so there is a strong 
possibility that the antigens recognised are cellular in 
origin either casting doubt on the involvement of HCMV in 
prostatic cancer or suggesting that the mechanism of 
involvement may be obtuse.
HCMV antigens have also been detected in cultures 
derived from prostatic cancer cells. Geder et al. (1977) 
found 2 out of 34 prostatic cancer cell lines reacted 
with HCMV-specific human convalescent sera in indirect 
immunofluorescence tests.
More recently, Boldogh et al. (1983) have analysed 
normal prostate, benign prostate hypertrophy and 
prostatic adenocarcinoma biopsy specimens for HCMV and 
HSV-2 specific nucleic acids. They detected HCMV DNA in 
all 3 tissue groups and HCMV RNA in benign prostate 
hypertrophy and prostatic adenocarcinomas but not in 
normal prostate. It is possible that normal prostatic 
tissue is a site of latent HCMV infection and that the 
virus is reactivated during conversion of cells to 
malignancy. HSV-2 DNA was detected at a much lower 
frequency and HSV-2 RNA was only detected in one 
specimen. HCMV-induced antigens were demonstrated in 
benign prostate hypertrophy and prostatic adenocarcinoma 
sections by ACIF.
In conclusion, the studies so far indicate a very 
tenuous link between prostatic carcinoma and HCMV 
infection.
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Adenocarcinoma of the colon
Little is known about the etiology of this disease, 
although epidemiological studies have implied that 
environmental and genetic factors may be involved.
Another possibility is that there may be a viral 
association with the disease. HCMV has been found in the 
gastrointestinal tract of patients with ulcerative 
colitis (UC), a disease which predisposes to later 
malignancy (Powell et al., 1961) Levine et al., 1964; 
Henson, 1972; Farmer et al., 1973) and also in cell 
cultures derived from biopsy samples of patients with 
adenocarcinoma of the colon (ACC) (Hashiro et al., 1979). 
However, Avni et al. (1981) looked at antibody pattern to 
HCMV in patients with ACC using immunoperoxidase antibody 
to membrane antigen and CF techniques. They found 
significantly elevated antibody titres to HCMV in the 
sera of ACC patients undergoing chemotherapy but not in 
the sera of untreated ACC patients. A more recent study 
by Hart et al. (1982a) failed to detect HCMV in frozen
sections of ACC gut mucosa using amplified direct 
immunofluorescence.
A number of studies have been undertaken to 
determine the presence of HCMV DNA in UC and ACC 
patients. These again have yielded controversial 
results. Using cRNA-DNA membrane hybridization which can 
detect 2 or more genome equivalents of HCMV DNA per cell,
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Roche and Huang (1977) could only detect HCMV DNA in 1 
out of 9 cases of UC and in no cases of Crohn's disease. 
In a later study they detected HCMV DNA in 4 out of 7 
specimens of ACC, 1 out of 2 patients with familial 
polyposis and 1 out of 3 patients with UC. The 
techniques of DNA-DNA hybridization and reassociation 
kinetics are more sensitive and can detect 0.1 genome 
equivalents of HCMV per cell. Using a reassociation 
kinetics test Brichacek et al. (1980) failed to detect 
HCMV DNA in ACC biopsies. Roche et al. (1981) detected 
HCMV DNA in the majority of patients with ACC but also in 
histologically normal and diseased but non-neoplastic 
tissue. They, therefore, concluded that the HCMV 
detected was not specifically cancer associated. Hart e^ 
al. (1982a) also failed to detect HCMV mRNA in frozen 
tissue sections from patients with ACC by in situ 
hybridization. In considering the results of the studies 
to date it seems unlikely that HCMV plays a direct 
causative role in ACC unless as an initiation of some 
event in which retention of the HCMV genome is not 
required.
Kaposi's sarcoma
This is a multiple pigmented haemangiosarcoma 
occurring on the skin, common in equatorial Africa with a 
distribution strongly reminiscent of Burkitt's lymphoma. 
In Europe, it has been reported to occur with greater
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frequency in Eastern countries and in certain parts of 
Italy, and is common among Asll^kenazic Jews and 
homosexuals. Giraldo et al. (1972a) were the first to 
observe herpesviruses in cell cultures derived from 
biopsies taken from patients with Kaposi's sarcoma (KS). 
Immunological studies demonstrated a common precipitating 
soluble antigen in cell extracts of these virus-carrier 
lines tested against HCMV and EBV sera. A herpesvirus 
was subsequently isolated from one of these cell lines 
(Giraldo et al., 1972b) which was later confirmed to be a 
strain of HCMV by Glaser et al. (1977).
Seroepidemiological studies have shown that European 
KS patients (mainly regressors ie patients in which KS 
regresses rather than proceeds to malignancy) have 
elevated antibody titres to HCMV with a significant 
increase in the geometric mean over melanoma patients and 
healthy matched controls (Giraldo et al., 1975). No 
significant serologic association was observed with EBV, 
HSV-1 or HSV-2. African KS patients (mainly progressors) 
showed no serological relationship with any of these 
viruses. These studies were extended to larger groups of 
patients and a specific serological association of HCMV 
with American but not African KS patients was found 
(Giraldo et al., 1978).
Molecular epidemiological studies have identified 
HCMV-specific nucleic acids in KS biopsies and cell 
cultures (Giraldo et al., 1980; Boldogh et al., 1981;
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Drew et al., 1982; Fenoglio et al., 1982; Spector et al., 
1983). CMV-specific antigens have also been demonstrated 
to varying degrees.
Kaposi's sarcoma is frequently associated with 
acquired immunedeficiency syndrome (AIDS). Downing ^  
al. (1984) reported that African KS patients have 
immunological and virological profiles similar to those 
seen in American patients with AIDS. Individuals within 
the high risk groups for KS and AIDS generally have 
evidence of prior or current HCMV infection. However, 
they also show evidence of previous infection with other 
viruses including EBV, HBV and HTLV. This makes it very 
difficult to determine whether HCMV plays any role in the 
etiology of this disease. Possibly the factors that 
predispose these individuals to virus infection also 
predispose them to KS. KS in AIDS patients never 
regresses and the multifocal lesions are metastatic. The 
disease results in eventual death.
Nasopharyngeal carcinoma
Desgranges et al. (1983) isolated HCMV from cell 
cultures derived from 2 out of 11 EBV-associated 
nasopharyngeal carcinoma biopsy specimens from N African 
patients. The authors believe that the cultures were 
persistently infected with HCMV and propose that an 
interaction between EBV and HCMV could favour 
co-carcinogenesis. HCMV could facilitate fusion between
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epithelial cells and infiltrating EBV genome carrying B 
lymphocytes, thus promoting the transfer of the EBV
genome to nasopharyngeal epithelial cells.
More recently, however, EBV has been found to infect 
differentiating epithelial cells (Sixbey et , 1983).
Neuroblastoma and Wilm's Tumour
Neuroblastomas and probably Wilm's tumours arise 
from cells derived from the neural crest. As 
herpesviruses preferentially infect and persist in 
nervous tissue, Wertheim and Voute (1976) undertook a 
study to investigate whether herpesviruses may be 
associated with these tumours. They found a significant 
proportion of children with these tumours to have CF 
antibodies to HCMV. They propose that the children may 
have been infected transplacentally and that the virus 
persisted in the neural crest derivatives, eventually 
transforming the cells and giving rise to the tumour 
after a latent period. However, these studies do not 
seem to have been followed up and more recently these 
tumours have been linked with chromosomal aberrations, 
specifically a deletion of band pl3 of chromosome 11 
(Solomon, 1984) .
Chromosome aberrations have, however, been
associated with Burkitt lymphomas. Translocations
between the c-myc gene on chromosome 8 and the
immunogioboha beov^ cbci»n genes on cb/'omo5orr\e T&ub - , \^%Z^y
"ike k Ig b l cKaiA on ohromosonna Z y •*^S3) gr H*îc ^
genes oo chromosocne. ZZ (_ Lcnoi*' eFq1 ■. »4Sl') cKoroctefisbc
lymphormos. E .6V
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is thought to be responsible for these translocations and 
we cannot preclude a similar mechanism for HCMV in Wilm's 
tumours.
ONCOGENES
Several mechanisms of oncogenesis have been 
identified; transformation by virus-encoded oncogenes 
(reviewed by Tooze, 1981; Weiss et al., 1982; Bishop,
1985) and activation of cellular proto-oncogenes 
(reviewed by Bishop, 1983; Klein, 1983; Land et al., 
1983).
Viral Oncogenes
The oncogenicity of several small DNA tumour viruses 
has been found to involve the coordinated expression of 
more than one viral oncogene eg adenoviruses,
bui-rvao
papovaviruses. Human adenoviruses were the first^viruses 
found to be capable of transforming cells in culture, 
although neither adenovirus DNAnor gene products have 
been associated with naturally occurring tumours. Only 
the members of the subgenera A and B (eg Adl2 and Ad7, 
respectively) can cause tumours in rodents but all human 
adenoviruses studied so far are capable of transforming 
cells in vitro (Gallimore et al., 1977). Varying amounts 
of adenovirus DNA sequences are integrated randomly into 
cellular DNA but a region encompassing the left hand end
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of the adenovirus genome is common to all adenovirus 
transformed cell lines (Gallimore et al., 1974; Sambrook 
et al., 1974). In Ad 12 transformed cells the entire 
genome is often present. The left hand 11% of the 
adenovirus genome corresponds to early region 1 (El) 
which consists of two transcriptional units Ela and Elb. 
In transformed cells, Ela codes for two coterminal RNAs 
(12S and 13S) that differ only in the amount of RNA 
removed internally by splicing. The RNAs code for two 
polypeptides (26,000 and 32,000 daltons) that are 
structurally related. Region Elb codes for one major RNA 
species of 22S which specifies two unrelated polypeptides 
of 20,000 and 55,000 daltons.
Rat cells transformed by El of Ad5 or Adl2 are 
indistinguishable from cells transformed by intact DNA or 
virions, indicating that all transforming functions are 
located in El. DNA fragments comprising certain parts of 
El may still contain transforming activity, although the 
resulting transformed cells show abnormal phenotypes.
The Ela region of Ad2 and Ad5 is responsible for 
immortalizing cells. Cells transformed by Ela and the 
adjoining 50% of Elb of Ad2 and Ad5 appear completely 
transformed although they are not tumourigenic in nude 
mice (Jochemsen et al., 1982). Both Ela products seem to 
be required for the fully transformed phenotype. The
26,000 dalton protein appears to be the most important 
for anchorage independent growth. The 32,000 dalton
53
protein may stimulate transcription of cellular genes 
perhaps by binding to and altering the properties of host 
cell RNA polymerase. The Ela products of Adl2 inhibit 
expression of class 1 MHC antigens by transformed cells 
(Tanaka et al., 1985). In this Way Ad12 transformed 
cells inoculated into animals may manage to evade the 
host immune system and establish tumours with high 
frequency.
The Elb region cannot transform cells in the absence 
of Ela products but nevertheless is required for the 
conversion of cells to the fully transformed phenotype. 
Introduction of a mutation in one of the Ad12 Elb 
products results in loss of oncogenicity (Jochemsen et 
al./ 1982) and transplantation studies using cells 
transformed by Ad5/Adl2 hybrid El regions consisting of 
Ela of nononcogenic Ad5 and Elb of oncogenic Adi2 (and 
vice versa) have shown that the high oncogenic potential 
of Ad12 transformed cells in nude mice is determined by 
the 55,000 dalton Elb protein (Bernards et al., 1983).
The 55,000 dalton Elb protein can form a complex with the 
p53 cellular tumour antigen (Sarnow et al., 1982) and 
this complex might be important for the transforming 
function of this Elb protein.
Transformation by polyoma virus requires the 
coordination of three distinct oncogenes which become 
integrated into cellular DNA and are continually 
expressed in virus-transformed and tumour cells (reviewed
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by Ito, 1980; Cuzin et al., 1984). The products of these 
viral oncogenes constitute the viral T antigens that are 
immunoprecipitated by antibodies present in the serum of 
tumour-bearing animals and are known as large T (MW
105,000 daltons) middle T (56,000) and small T (22,000). 
During the lytic cycle of the virus in permissive cells, 
large T is a nuclear protein required for the initiation 
of viral DNA synthesis, middle T is a membrane protein 
associated with tyrosine kinase activity which is likely 
to correspond to the c-src gene product artd small T is 
found in the cytosol, and plays some role in the 
maintenance of the cell cytoskeleton. During 
tumourigenesis, large T is responsible for immortalizing 
cells and for reduced serum requirement and middle T is 
responsible for the remainder of the transformed 
phenotype. Small T may cause disruption of actin cables 
and reduce the tightness of cell adhesion to substratum. 
All three T antigens are required to produce the fully 
transformed state. The functions of the polyoma large 
and middle T antigens are combined in the large T antigen 
of simian virus 40 (SV40) which transforms primary cells 
(Kriegler et al., 1984). SV40 small T antigen may be 
required exclusively to initiate transformation of 
resting cells and. has a structure reminiscent of, and 
might mimic the action of certain growth factors (Martin, 
1981). Like the adenovirus Elb protein, SV40 large T 
antigen forms a complex with the cellular p53 protein
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(Sarnow et al., 1982) which suggests some common features 
in the mode of action of these viral proteins.
Papillomaviruses can transform cells in vitro but no 
connection has yet been made between this property and 
tumourigenesis in the natural host. Transforming domains 
have so far been mapped only in the genome of bovine 
papillomaviruses (BPV) (Yang et al.,- 1985). Two have 
been found, one that carries four complete open reading 
frames and another that carries only one. The products 
of these domains and the mechanisms by which they act are 
not known. Each domain can independently transform cells 
in culture and when the two domains are used together 
their effects are additive.
Among the herpesviruses, EHV-1 may have a mode of 
transformation similar to that of adenoviruses and 
papovaviruses in that a small amount of DNA (about 6% of 
the total genome length lying between map units 0.32 and 
0.38) appears to be retained and integrated into the 
cellular DNA of transformed hamster cells (O'Callaghan e^ 
al., 1983). In cells transformed by most other 
herpesviruses, integration of specific DNA regions cannot 
be detected.
Herpesvirus saimiri (HVS) will transform T cells in 
culture and produce tumours in primate hosts. HVS DNA 
appears to be present in transformed and tumour cells in 
multiple copies existing as non integrated circular 
molecules. Studies using non oncogenic deletion mutants
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have identified a 2kb region of the genome that is 
required for transformation and oncogenicity (Desrosiers 
et al., 1985) .
Epstein Barr Virus (EBV) is another herpesvirus 
capable of transforming lymphocyte cells in vitro. The 
presence of antibodies to EBV in patients with Burkitt's 
lymphoma and nasopharyngeal carcinoma has suggested that 
the virus is also associated with these tumours. The 
viral genome is maintained in transformed and tumour 
cells mainly as a circular episome present usually in 
high copy number. All lymphoblastoid cell lines examined 
this far that contain EBV DNA express a nuclear antigen 
termed EBNA which can be detected with antibody from the 
serum of patients recovering from infectious 
mononucleosis. The size of the EBNA component varies 
between different strains of EBV. To date three EBNA 
proteins have been described; EBNAl, EBNA2 and EBNA 3 of 
MW's 65,000 (Strnad et al., 1981) 82,000 (Hennessy and 
Kieff, 1983) and 140,000 daltons (Hennessy et al., 1985) 
respectively. MW's vary according to the gel systems 
used. Hearing and Levine (1985) have demonstrated that 
the EBV Bam HI K fragment encodes an 88,000 MW EBNA 
protein. An EBNA protein has been found to be associated 
with the cellular p53 protein in cells transformed by EBV 
(Crawford et al., 1981).
Transfection studies using restriction fragments of 
DNA have identified specific viral transforming genes in
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the human herpesviruses HSV-1, HSV-2 and HCMV. In HSV-1 
the transforming region occurs within the Bgl II i 
fragment and in HSV-2 in the Bgl II n and c fragments. 
There is no evidence that these sequences are retained 
and integrated into cellular DNA in transformed and 
tumour cells.
A large number of viral oncogenes have been 
identified among the 'acute' transforming retroviruses 
(Bishop and Varmus, 1982). These RNA viruses replicate 
by way of a DNA provirus inserted into cellular DNA 
(Figure 4). They are assumed to have evolved by 
recombination between the genome of a non-transforming 
virus and transduced cellular proto-oncogenes. The genes 
exert their oncogenic effect when recombined into the 
viral genome where they become governed by a strong 
promoter in the long terminal repeat region of the 
proviral genome. At first it was thought that 
transformation by retroviral oncogenes was 
self-sufficient but now it appears that transformation 
may be assisted by other factors. For example, 
tumourigenesis by v-abl may be assisted by cellular genes 
(Ohno et al., 1984); v-src encodes a second small protein 
that could make its own independent contribution to 
tumourigenesis (Mardon and Varmus, 1983) and several 
retroviruses may act in concert to produce tumours (Graf 
and Beug, 1983; Kan et al., 1984). The human T cell 
leukaemia viruses, HTLV-1 and HTLV-11 are unique among
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FIGURE 4 Replication of retroviruses
Schematic representation of the replication of 
retroviral genomes. The viral RNA genome is diploid 
and composed of two single-stranded, identical subunits 
of about 5-lOkb. The RNA is reverse transcribed in the 
cytoplasm of infected cells into a linear duplex 
molecule by an enzyme encoded by the retroviral pol 
gene. Some of the linear DNA migrates to the host cell 
nucleus where a fraction of it is converted to a closed 
circular species, the function of which is unknown.
The viral DNA is then integrated into the host genome 
and the viral genes transcribed and translated. The 
pol gene encodes the DNA polymerase, the gag gene 
encodes the core proteins and the env gene encodes the 
envelope glycoproteins.
Symbols ;
ijfc
Retroviruses that have incorporated cellular genes into 
their genomes by a recombination event are defective and 
require helper viruses in order to replicate. No such 
helper viruses have, however, been identified in humans.
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the transforming retroviruses in that they do not have a 
viral oncogene with a normal cellular homologue, nor do 
they integrate at any preferential site in tumours or 
transformed cells. These viruses are closely associated 
with specific human T cell leukaemias and lymphomas and 
can transform normal T lymphocytes in vitro. In addition 
to the characteristic retroviral gag, pol and env genes, 
they have an extra region of the genome designated X or 
LOR. The region has no definite assigned function but is 
believed to participate in HTLV-induced cellular 
transformation. The region has been shown to contain a 
gene encoding a protein of 40,000 in HTLV-1 and 37,000 
daltons in HTLV-11 (designated p40%"l and p37^“^^ 
respectively) (Slamon et al., 1984). It is possible that 
these proteins may function in a manner analogous to the 
papovavirus T antigens or the adenovirus Ela proteins.
Cellular oncogenes
Cellular proto-oncogenes are normal cellular genes 
potentially capable of inducing oncogenic transformation. 
More than 20 such genes have been identified by homology 
to the transforming genes of retroviruses and by the 
biological activity of cellular DNAs in transfection 
assays (reviewed by Cooper, 1982). Proto-oncogenes have 
been highly conserved throughout evolution and appear to 
represent single-copy sequences in cellular DNA, with the 
exception of the ras genes which constitute a multigene
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family. The^function of the proto-oncogenes is unknown, 
although it has been assumed that they participate in the 
regulation of cell proliferation. Oncogenes have been 
identified in a large number of human and animal tumour 
cells and it is presumed but not proven that each 
oncogene was instrumental in generating the tumour from 
which it was isolated.
Proto-oncogenes can be activated to become oncogenes 
in a number of ways. A proto-oncogene may undergo 
mutation, so that the protein encoded by the mutant 
oncogene is structurally different from the corresponding 
normal protein. Alternatively, oncogenesis may involve a 
"dosage-effect", and mutation could produce a tandem 
duplication of a proto-oncogene. Gene amplification 
could then occur by successive unequal sister chromatid 
exchanges in different cell cycles until sufficient 
protein is produced to transform the cell (Pall, 1981). 
Proto-oncogene activation can also occur by promoter 
insertion (Hayward et al., 1981) or enhancer insertion 
(Weber and Schaffner, 1985). In either case the 
expression of the proto-oncogene is upregulated resulting 
in over-production of the gene product. Chromosomal 
aberrations such as translocations and deletions can also 
result in activation of proto-oncogenes (reviewed by 
Rowley, 1983). For example, in some Burkitt's lymphomas 
the c-myc proto-oncogene has been translocated into the 
immunoglobulin heavy chain locus (Taub et al., 1982)
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where its expression is upregulated by enhancer elements 
present in the heavy chain locus (Boss, 1983). Evidence 
is also accumulating for the involvement of multiple 
cooperating independently-activated oncogenes in 
transformation eg Ela and ras (Land et al., 1983; Ruley, 
1983) providing confirmation at the molecular level that 
carcinogenesis is a multistep process.
Whatever the mechanism of activation, an oncogene 
must finally have its effect by way of the protein it 
encodes. The oncogenic protein almost invariably has a 
function similar to that of its cellular counterpart.
The oncogenic proteins studied so far have varied 
functions and are characterised in.Table 1.
Many of the oncogenic proteins studied so far have 
been found to be, or to be associated with, protein 
kinases. The protein products of the src, yes, fgr, abl, 
fps, fes and ros oncogenes are all tyrosine-specific 
protein kinases. Since tyrosine phosphorylation may be 
intimately involved in the complex regulatory systems 
that maintain cellular shape and control the growth of 
cells, subtle alterations in these systems could give 
rise to the cancerous state. Potential target proteins 
for these protein kinases in the normal cell and the 
possible effects of tyrosine phosphorylation are given in 
Table 2. The nucleotide sequences of the tyrosine-kinase 
associated oncogenes as well as proto-oncogenes are all 
related. The homology is strongest in the parts of the
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TABLE 2 Potential target proteins for tyrosine-
specific protein kinases in the normal cell 
and the possible effects of tyrosine 
phosphorylation
TARGET
PROTEIN
CELLULAR
LOCATION
NORMAL
FUNCTION
POSSIBLE EFFECT 
OF TYROSINE 
PHOSPHORYLATION
Vinculin Adhesion
plaques
Links actin 
to a hypothetical 
anchor protein 
in cell membrane
Disruption of 
the vinculin 
link causing 
disorganization 
of actin 
bundles
p36 Inner face 
of plasma 
membrane 
of some 
cell types
Structural 
functions eg in 
intestinal 
columnar cells, 
anchors actin 
filaments to the 
terminal web of 
microvilli
Cytoskeletal
changes
Enolase Mitochondria
Phosphogl-
ycerate
mutase
Lactate
dehydrogenase
Enzymes in 
glycolytic 
pathway
Increase in 
glycolysis(?)
The cellular proteins listed have been found to contain 
phosphotyrosine in transformed cells, and could therefore be 
potential target proteins for tyrosine-specific 
phosphokinases. Less than 0.1% of the protein-bound 
phosphate is attached to tyrosine in a normal cell.
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genes that are believed to code for the kinase domains of 
the protein products, ie the 3' end for src, yes, fes, 
fps and fgr and the 5' end for abl. In this part of the 
molecules, homologies have been found also to the 
oncogenes mos, rel, raf, mil, fms and erbB. We surmise 
that the products of these oncogenes have functions 
similar in some sense to protein kinases.
Some oncogenes may code for the production of a 
growth factor (reviewed by Heldin and Westermark, 1984). 
For example, the predicted sequence of the transforming 
protein p2ASis simian sarcoma virus is almost 
identical to that of platelet-derived-growth factor 
(PDGF; Waterfield et al., 1983; Doolittle et al., 1983). 
It is assumed that the p28£i£ product functions by 
stimulating cell replication by interacting with the PDGF 
receptor.
Oncogenic proteins may also function by switching on 
the production of a cellular growth factor (reviewed by 
Heldin and Westermark, 1984). The oncogenic products of 
Moloney murine sarcoma virus (p37E££) and Kirsten murine 
sarcoma virus (p21kras) directly or indirectly regulate 
the synthesis of a transforming growth factor (TGF) which 
probably functions by blocking EOF receptors.
There are structural and functional homologies 
between growth factor receptors and tyrosine-specific 
protein kinases. Recently, the EGF receptor has been 
shown to have strong homology with gp65ËEËÊ, the
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transforming protein of avian erythroblastosis virus 
(Downward et al., 1984). The EGF receptor has an 
extracellular domain that binds EGF and a 
tyrosine-specific protein kinase domain inside the cell. 
The binding of an EGF molecule presumably changes the 
receptor's conformation so that the intracellular domain 
catalyses the phosphorylation of a cellular substrate 
protein. gpASerbB may correspond to a truncated EGF 
receptor. The absence of the EGF binding domain might 
remove the control by EGF molecules binding and the 
result could be the continuous generation of a signal 
equivalent to that produced by EGF causing cells to 
proliferate rapidly.
The most frequently isolated tumour oncogenes are 
the cellular homologues of the retroviral oncogenes ras 
and myc. The p2lJE5Ë proteins encoded by the ras oncogene 
are localized in the plasma membrane. They are 
GTP-binding proteins that may act as coupling factors in 
cell reactions and transmit a continuous signal rather 
than a regulatory one. The proteins encoded by the myc, 
myb and fos oncogenes are localised in the nucleus and 
are probably DNA binding proteins. The presence of large 
amounts of these proteins may establish the transition of 
a normal cell to one with infinite growth potential.
To summarise, the products of proto-oncogenes from 
which oncogenes are derived seem to have roles that must 
be crucial in the control of cell growth and
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differentiation and in embryonic development. 
Transforming proteins may have their profound effects on 
cells because they perturb these fundamental cellular 
processes. As our knowledge of the functions of the 
various transforming proteins increases, we become 
progressively nearer to understanding at least some 
stages in the multistep process of carcinogenesis.
MATERIALS
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1. VIRUSES
The following viruses were used in this study
(a) Human cytomegalovirus strain AD169 (HCMV AD169)
(Rowe et al., 1956). Plaque-purified virus was 
supplied by Dr. J.D. Oram.
(b) Herpes simplex virus type 2 strain HG52 (HSV-2 
HG52)
(Timbury, 1971) provided by Mrs. M. Murphy.
(c) Temperature-sensitive (^) mutants of HSV-2 HG52
(Timbury, 1971) and of herpes simplex virus type 1
strain 17 syn+ (Brown et al., 1973; Crombie, 1975) 
were used for virus reactivation studies and were 
also supplied by Mrs. M. Murphy.
2. TISSUE CULTURE CELLS
(a) Cell lines
Helu, a continuous cell line established from human 
embryo lung cells was purchased from Flow
Laboratories, Irvine, Ayrshire, Scotland. Helu
cells were used to prepare HCMV AD169 virus stocks,
to titrate virus and for virus reactivation studies
where stated. Human embryo cells were also 
established from abortis material.
BHK21/C13, a continuous cell line established from 
baby hamster kidney cells by Macpherson and
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Stoker(1962) maintained in this Institute. BHK21 
cells were used to titrate HSV-2 HG52 and HSV ^  
mutants.
3T3, a continuous cell line established from mouse 
fibroblasts. 3T3 cells were provided by M.
Freshney (Beaston Institute, Glasgow), G. van de 
Woode (National Cancer Institute, Bethesda), G.M. 
Cooper (Harvard University, Boston) and C. Marshall 
(Chester Beatty Institute, England) and were used 
for transformation studies.
(b) primary cells
Rat embryo (RE) cells were prepared from a single 
litter of approximately 20 day old embryos from an 
inbred Hooded Lister rat colony maintained in this 
Institute.
Cervical cells were prepared from the cervices of 
routine hysterectomy specimens of patients with no 
history of, or colposcopic evidence of CIN or 
carcinoma.
(c) HCMV transformed and tumour cell lines 
Primary RE cells were transformed using 
UV-irradiated HCMV AD169 by A. Bunce in this 
Institute. Tumour cell lines were derived from 
tumours induced in Hooded Lister rats by the 
inoculation of HCMV transformed cells. All HCMV
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transformed and tumour cell lines were obtained 
from Dr. J.C.M. Macnab.
3. TISSUE CULTURE MEDIA AND SOLUTIONS
Helu, BHK21, RE and HCMV transformed and tumour 
cell lines were grown in BHK21 Glasgow modification of 
Eagle's medium (Gibco Laboratories, Paisley, Scotland) 
supplemented with 2mM L-glutamine, lOOug/ml 
streptomycin and lOOu/ml penicillin. The following 
tissue culture media have been used:- 
ECX Eagle's medium containing X% calf serum
ETCX Eagle's medium containing X% calf serum and 10%
(v/v) Difco tryptose phosphate broth (T.P.)
EFX Eagle's medium containing X% foetal calf serum
EHu2 Eagle's medium containing 2% pooled human sera
Ec2-Pi Phosphate-free Eagles medium containing 2% 
calf serum.
3T3 cells were grown in Dulbecco's modified Eagle's 
medium (D) (Flow Laboratories, Irvine, Ayrshire, 
Scotland) supplemented with 2mM L-glutamine, lOOug/ml 
streptomycin, lOOu/ml penicillin and X% foetal calf 
serum.
Cervical cells were grown in Dulbecco's modified 
Eagle's medium supplemented with the following;- 
2mM L-glutamine 
lOOu/ml penicillin
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lOOug/ml streptomycin
10% (v/v) foetal calf serum
PQ-l^H cholera toxin
0.5ug/ml hydrocortisone acetate
lOng/ml epidermal growth factor (EGF)
This medium has been abbreviated CM in the text. 
Versene solution consisted of 0.006M EDTA in PBS 
containing 0.0015% (w/v) phenol red.
Trypsin was prepared as a 0.25% solution 
supplemented with 0.0015% (w/v) phenol red.
Agar medium
Agar overlay medium for HCMV AD169 titrations was 
prepared at 45°C to a final concentration of 0.3% 
SeaKem hE agarose and IxEagle’s medium with the sodium 
bicarbonate content increased to 8mM and supplemented 
with 2% foetal calf serum.
Noble agar (Difco Bacto) was used for plating 
cells in soft agar to assay for anchorage independent 
growth- A 3.2% stock of Moble agar was prepared in 
distilled water then sterilized. 4ml of agar underlay 
was added to 50mm petri dishes and the cell suspension 
added in a 2ml overlay medium.
Agar underlay: prepared at 45°'C to a final 
concentration of:
0.6% agar
lxEagle“s medium containing lOOu/ml of penicillin 
and lOOug/ml of streptomycin
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10% foetal calf serum 
10% TP
overlay; prepared at" 45°C to a final concentration of:- 
0.3% agar 
IxEagle's medium 
10% foetal calf serum 
10% TP
4. BACTERIA AND BACTERIOPHAGE CULTURE MEDIA 
AND SOLUTIONS
Liquid media
Bacteria were propagated in L-Broth (LB) which 
consisted of 1% (w/v) Bacto-tryptone (Difco), 0.5%
(w/v) yeast extract (Difco) and 0.17M NaCl with the pH 
adjusted to 7.5.
Bacteriophage were stored and diluted in SM buffer 
which was prepared from lOmM NaCl, lOmM MgSO,^. 78^0, 
lOmM Tris-HCl (pH7.5) and 0.01% (w/v) gelatin.
Media containing agar or agarose
Agar plates were prepared from LB containing 1.5% 
(w/v) Bacto-agar and sterilized by autoclaving.
Top agarose for plating bacteriophage was prepared 
by adding 0.7% (w/v) agarose (type-1, low EEC) to LB 
medium and sterilized by autoclaving.
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5. CLONED VIRAL DNA AND PLASMID VECTORS
The Hind III DNA fragments of HCMV AD169 were
cloned into plasmid vector pAT153 at the single Hind 
III site and propagated in E . coli HBlOl or C292 (Oram 
et al./ 1982). The Hind IIl/Bam HI subclone (EHB3) was 
cloned into the Bam HI site of pAT153. All cloned HCMV 
DNA fragments were provided by Dr. J.D. Oram (Public 
Health Laboratory, Porton Down, Salisbury, England).
The Bam HI t fragment of HSV-2 HG52 was cloned
into the Bam HI site of plasmid vector pAT153 and was
supplied by Dr. J.C.M. Macnab.
HPV 11 DNA was cloned into phage X 47 and subcloned 
in pBR322 together with 69% of the BPV-1 genome 
(Gissmann et al., 1982, 1983). Recombinant plasmid was 
propagated in C292 cells and was provided by Dr. J.C.M. 
Macnab.
6. CLONING VECTOR AND HOST BACTERIA
Bacteriophage vector EMBL3 (Frischauf et al.,
1983) was used to construct a genomic library of CIN 
DNA. Bacterial host strains Q358 and Q359 (Karn e^ 
al., 1980) were used. Both recombinant and 
non-recombinant phage will grow on Q358 but only 
recombinant phage will grow on Q359. EMBL3 arms, host 
strains and packaging extract were purchased from
This plasmid was kindly provided by Zur Hausen. A 
plasmid containing HPVll DNA but no BPV DNA was not 
available at the time this work was commenced.
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Vector -Cloning Systems, 3770 Tansy St., San Diego, C.A. 
92121, USA,
Host bacteria were propagated in LB supplemented 
with lOmM MgSO^ and 0.2% maltose. Host strain K803 
(Wood, 1966) was provided by Dr. I. Kennedy and was 
used for propagating recombinant bacteriophage for DNA 
extraction.
7. STANDARD BUFFER SOLUTIONS
PBS 170mM NaCl, 3.4mM KCl, ImM Na2HP04, 2mM KH2PQ4,
pH7.2
HBS (Hepes buffered saline) 140mM NaCl, 0.75mM
Na2HP04, 25mM Hepes(N-2-hydroxyethylpiperazine 
N-2 ethane sulphonic acid) pH7.1 
TE ImM EDTA, lOmM Tris-HCl
TNE 5mM EDTA, 50mM Tris-HCl (pH7.4), 150mM NaCl
SSC 150mM NaCl, 15mM Tri-sodium citrate, pH7.4 -
SSPE 180mM NaCl, lOmM NaH2P04 (pH7.4) ImM EDTA
(pH7.4)
IxE 30mM NaH2P04, ImM EDTA, 36mM Tris-HCl (pH7.8)
IxTBE 89mM Tris-borate, 89mM boric acid
Dye Ficoll 150mM Na2 HPO4, lOmM EDTA, 180mM Tris (pH7.8) 
10% (w/v) Ficoll, 0.05% (w/v) bromophenol blue 
Cell lysis 50mM Tris-HCl, lOmM EDTA, lOOmM NaCl, 0.4% SDS, 
buffer pH8.0.
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Triton
lysis
buffer
NTB
Denhardt's 
solution
DNase
dilution
buffer
Ligation
buffer
62.5mM EDTA, 50mM Tris-HCl (pHS.O) 2% Triton 
-X-100
Nick translation buffer, 50mM Tris-HCl (pH7.S), 
5mM MgCl2/ ImM dithiofhreitoi (DTT)
0.02% (w/v) Ficoll, 0.02% (w/v) 
polyvinylpyrollidone, 0 .02% bovine serum 
albumin (BSA)
50% glycerol, lOmg/ml BSA, 5M NaCl, IM Tris-HCl 
(pH7.5), 250mM EDTA, IM DTT
SOmM Tris-HCl (pH7.8),. lOmM MgCl2, 20mM DTT 
ImM ATP, 50ug/ml BSA
8. CHEMICALS
Agarose, trizma base (tris 
hydroxymethylaminomethane) salmon sperm DNA, bovine 
serum albumin, polyvinylpyrollidone, Triton-X-100, 
cholera toxin (from Vibrio cholera), hydrocortisone 
acetate and epidermal growth factor were obtained from 
Sigma (London) Chemical Company Ltd., 
Kingston-Upon-Thames, London, UK.
Trichloroacetic acid (TCA), 2, 5-diphenyloxazole 
(POP) and caesium chloride were purchased from 
Koch-Light Laboratories Ltd, Colinbrook, Bucks, UK.
Ficoll (average molecular weight 400,000) and 
Sephadex G50 were purchased from Pharmacia Fine
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Chemicals, Uppsala, Sweden.
SeaKem LE agarose was obtained from FMC 
Corporation, Marine Colloids Division, Rockland, ME 
04841 USA.
Difco agar Noble, Difco bacto agar and Difco yeast 
extract were purchased from Difco Laboratories,
Detroit, Michigan, USA.
Ethanol (analytical grade) was purchased from 
James Burroughs Ltd, London, UK.
" All other chemicals were purchased from BDH 
Chemicals Ltd, Poole, Dorset, UK and were of analytical 
or reagent grade.
9. FLUORESCENCE REAGENTS
Goat anti-rat antibody conjugated with fluorescein 
isothiocyanate was obtained from Nordic, Maidenhead, 
Berks, UK.
Swine anti-human IgG antibody conjugated with 
fluorescein isothiocyanate was obtained from Wellcome 
Laboratories, Temple Hill, Dartford, Kent UK.
Hoe^cht 33258 stain was a gift of Hoechst.
RADIOCHEMICALS
All radiochemicals were obtained from the 
Radiochemical Centre, Amersham, Bucks, UK. The
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specific activities of the 5'-®^-32p deoxynucleoside 
triphosphates were 3,000 Ci/mmol. (32p) orthophosphate 
was carrier free.
ENZYMES
All restriction endonucleases and DNA polymerase 1 
were purchased from Bethesda Research Laboratories, 
Rockville, Maryland, USA.
Deoxyribonuclease (bovine pancreas) and 
ribonuclease A (bovine pancreas) were obtained from 
Sigma (London) Chemical Company Ltd., 
Kingston-Upon-Thames, London, UK.
Proteinase K and calf intestinal phosphatase were 
purchased from Boehringer Mannheim, GmbH, W. Germany.
Ligase was purchased from New England Biolabs Inc. 
(NEB) Beverly, MA, USA.
MISCELLANEOUS MATERIAL
Kodirex X-ray film, X-omat S film, Dx80 developer:- 
Kodak Ltd., London, UK 
Amfix:-
May and Baker Ltd., Dagenham, UK 
Dupont Cronex Lighting Plus intensifying screens;- 
Dupont, Newton, Connecticut, USA.
Plastic centrifuge tubes:-
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Falcon Incorporated, Oxhard, California, USA. 
Visking dialysis merabrane;-
Medical International Ltd., London, UK 
Millex filters 0.22 and 0.45 um:-
Millipore UK Ltd., Abbey Road, London, UK.
Whatman chromatography paper, 3mm sheets and 2.5cm 
circles :-
Whatman Ltd., Maidstone, England, UK 
Biodyne transfer membranes
Pall Ultrafine Filtration Corporation, Glen Cove, 
N.Y. 11542.
Gene Screen Plus Hybridization transfer membrane 
sheets NEF-976;-
New England Nuclear, Dupont UK Ltd. NEN Products 
Division, Stevenage, Herts, UK.
Nitrocellulose membrane filters 0.45um, 82mm diameter 
BA85/21:-
Schleicher and Schuell, D3354, Dassel, W. Germany 
Plastic tissue culture flasks and 35mm petri dishes:- 
Inter Med (Nunc) a /S Nunc, Kamstrupvej 90, 
Kamstrup, DK-4000, Roskilde, Denmark.
Plastic 90mm petri dishes and 50mm plastic tissue 
culture petri dishes:-
Sterilin Ltd., Teddington, Middlesex, England, UK,
METHODS
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1. CELL CULTURE
(a) Cell lines
BHK21/C13 cells v/ere cultured in rotating 80oz 
bottles seeded at 4x10^ cells in 200ml of ETCIO. 50mm 
diameter plastic petri dishes were seeded at a density 
of 2.5x10^ cells per dish in 4ml of ETC5.
Helu cells were cultured in 800ml plastic tissue 
culture flasks seeded at 2x10^ cells in 30ml of EF5 +
1% non essential amino acids. 35mm diameter petri 
dishes were seeded at a density of 4x10^ cells per dish 
in 2ml of EF5 + 1% non essential amino acids and 50mm 
diameter petri dishes at a density of 1x10^ cells per 
dish in 4ml of medium.
HCMV-transformed and tumour cell lines were 
propagated in EF5 seeded at a density of 2x10? cells 
per 800ml tissue culture flask. 3T3 cells were 
cultured in DFIO seeded at 1x10^ per 800ml tissue 
culture flask or 2x10^ cells per 50mm petri dish.
Cells were never allowed to become completely 
confluent.
All cells were harvested by washing twice with 
trypsin-versene, incubating at 370c for a few minutes 
and resuspending at the required concentration in the 
appropriate medium. Cells were grown in an atmosphere 
of 5% CO2 at 370c.
Helu cells were routinely checked for mycoplasma
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infection as follows. Cells were grown on glass 
coverslips for 48 hrs, washed in PBS, and then fixed in 
methanol: acetone (3:1) cooled to -20*^C for 4-5 min. 
After air drying the cells were stained with Hoechst 
stain (lOul of stain diluted to 0.05ug/ml) for 10 min 
at room temperature. The coverslips were then washed 
in 3 changes of PBS and mounted in 20% glycerol-PBS on 
glass slides. The cells were examined under the UV 
microscope for evidence of mycoplasma infection. Any 
mycoplasma present on the cell surface could be 
identified by fluorescence.
(b) Human embryo lung cells
Human embryo lung cells were prepared from a 15 wk 
old aborted foetus. The lungs were aseptically removed 
and left for 30 min in EF5 with a high concentration of 
antibiotics. The tissue was then washed six times in 
trypsin to remove red blood cells and finely minced 
with sterile scissors in about 5-lOml of trypsin. 
Fragments of tissue were dissociated by two separated 
trypsinization procedures at 31^ C in 0.25% trypsin each 
of 20 min duration. Single cells were pelleted at 1000 
rpm for 10 min at 4*^ C, counted in a haemocytometer and 
seeded at 2x10? cells per 800ml tissue culture flask in 
EF5. After 24 hr the medium plus any floating cells 
was removed and poured into a fresh flask and fresh 
medium was added to the cultures. The remaining
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fragments of tissue were seeded in EF5 in 50ml tissue 
culture flasks as explants and left for 2-3 days at 
37°C before changing the medium. Once confluency was 
attained, the cells were trypsinized and reseeded as 
previously described for Helu cells.
(c ) Primary rat embryo cells
Rat embryo cells were prepared from 20 day old 
embryos from an inbred Hooded Lister rat from the 
colony maintained in this Institute. The embryos were 
aseptically removed from the rat and washed in six 
changes of versene. After evisceration the embryos 
were finely minced and washed in PBS to remove red 
blood cells. The tissue fragments were dissociated by 
two separate trypsinization procedures as described 
above for human embryo lung cells. Single cells were 
pelleted, counted and 1x10® cells were seeded into 
rotating 80oz roller bottles in EFIO. For use in 
assays RE cells were treated as BHK21/C13 cells but 
seeded in EFIO.
(d) Cervical cells
Cervical cells were prepared from hysterectomy 
specimens from patients with no evidence of CIN or 
carcinoma. Cells prepared from the cervices of women 
who were in the first 14 days of the menstrual cycle 
usually grew more efficiently in cell culture. For
DISSECTION OF THE CERVIX TO SEPARATE ECTO- 
AND ENDOCERVICAL TISSUE
Excision of cervix from hysterectomy specimen
Uterus
cutCervix
os
Excision of ectocervix
Transformation 
zone ______
Ectocervix
—  cut
Excision of endocervix
Endocervix -----
(Cut down through 
os then remove 
stroma) cut
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this reason, premenopausal cervices were used wherever 
possible. The cervix was excised from the uterus and 
vagina and washed three times in PBS to remove red 
blood cells. The ecto - and endocervix were removed by 
cutting 2mm above and below the transformation zone 
(see diagram). Tissue from the transformation zone was 
discarded as it contains a mixture of both cell types. 
Ecto - and endocervical explants were prepared 
separately. Muscle and stroma were carefully removed 
using a sharp scalpel until a thin epithelium of cells 
remained. If the cervix had been stained blue by the 
surgeon (a technique used in surgery to identify the 
ectocervix and vaginal epithelium) the blue dye was 
gently scraped off in PBS. The epithelium was then 
finely minced using 3-4" curved iris scissors. A few 
drops of PBS were added to prevent the tissue from 
drying out. About 10-20 small tissue fragments were 
seeded per 35mm plastic tissue culture petri dish and 
just covered with a small volume of foetal calf serum. 
The explants were incubated at 37*^ 0 in an atmosphere of 
5% CO2, overnight, to allow them to anchor to the 
plates. Next morning 2ml of CM without EGF was added 
to each plate and the explants incubated for a further 
2-3 days without any disturbance. After this time, any 
floating explants were removed and fresh complete CM 
added to the plates. The medium was changed twice 
weekly. Ectocervical cells formed a confluent
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monolayer in 2-3 weeks. Endocervical cells would not 
form confluent monolayers and if the cells were 
cultured for more than three weeks, the cells tended to 
lift off the plates. For this reason, endocervical 
cells were used as soon as no further appreciable 
increase in size of the monolayer could be detected ie 
usually after 7-10 days in culture.
2. PRODUCTION OF ADI69 VIRUS STOCKS
HCMV AD169 virus stocks were prepared by infecting 
just subconfluent Helu cells in 800ml plastic tissue 
culture flasks at a moi of O.Olpfu/cell. The virus was 
absorbed for 90 min at 37°C and the cells overlaid with 
30ml of EF5. After 4 days, the medium was discarded 
and 10ml of fresh medium added. Infected cells were 
incubated at 37*^ C for a total of 10-11 days. Medium 
was collected daily and 10ml of fresh medium added from 
day 6 post infection. On day 10 or 11, any remaining 
cells were shaken into the medium before harvesting.
The collected medium from each day was divided into 1ml 
aliquots in sterile black capped vials and stored at 
-70*^ C. The virus was sonicated in a Cole-Palmer 
ultrasonic cleaning bath before use. Sterility checks 
were routinely performed by streak-plating virus stocks 
onto blood agar plates. Virus stocks were also checked 
for mycoplasma contamination by infecting Helu cells on
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glass coverslips and staining with Hoechst as 
previously described for the detection of mycoplasma in 
cell cultures.
3. TITRATION OF VIRUS
(a) HCMV ADI69
Virus stocks were plaqued by the method of 
Wentworth and French (1970). Serial ten-fold dilutions 
of virus were made in 2xEF2. lOOul inocula were added 
to almost confluent monolayers of Helu cells in 50mm 
plstic tissue culture petri dishes. After 90 min 
absorption at 37°C, 5ml of overlay agar medium was 
added to each plate and the monolayers incubated for 7 
days at 37*^ C in 5% CO2. After this period a second 
agar overlay of 5ml was added as a feeder layer and the 
monolayers incubated for a further 7 days. Monolayers 
were fixed by adding 2ml of 10% formalin to each plate. 
The agar overlays were discarded after 10 min at room 
temperature and the fixed monolayers washed with tap 
water and stained with Giemsa (10 min at room 
temperature). Plaques were counted using a dissecting 
microscope.
HCMV was also plaqued by a much quicker method 
that did not involve the use of agar overlays. Virus 
was diluted in EF2 and lOOul inocula added to 
monolayers of Helu cells as previously described.
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After virus adsorption, 4ml of EF2 were added and the 
infected monolayers incubated at 37^0 for 10 days. 
Monolayers were then stained with Giemsa and scored for 
plaques. Titres obtained using this method did not 
differ signficantly from those obtained using the 
method of Wentworth and French (1970). Since the 
method of Wentworth and French (1970) is quoted in the 
literature as being routinely used, this method was 
preferred for titrating virus stocks.
(b) HSV
Serial ten-fold dilutions of virus were made in 
PBS + 2% calf serum and lOOul inocula added to BHK/C13 
cell monolayers. The virus was absorbed for 45 min at 
37^C, after which time 4ml of EHu2 were added. Cells 
infected with wild type virus were incubated at 37°C 
for 2 days. mutants were titrated at both the
permissive (31°C) and nonpermissive temperature 
(38.50c) for 3 and 2 days respectively. Monolayers 
were stained for 10 min at room temperature with Giemsa 
and plaques counted using a dissecting microscope.
4. ESTABLISHMENT OF LATENTLY INFECTED CELL CULTURES
Latently infected cell cultures were established
at supra-optimal temperatures by the method described
a n d  R o rse il an>d Resh>rv ( ^ \ ^ î h )  
by E. Notarianni (submitted for publication). Cell
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monolayers were infected at a moi of 0.003 pfu/cell 
with HSV-2 HG52. After 1 hr absorption at 370c, the 
monolayers were overlaid with prewarmed medium and 
incubated at 42^0. After a period of 6 days the 
cultures were shifted down to 370c and incubated for a 
minimum of 3 days. During this time the cultures were 
carefully examined for any signs of virus reactivation. 
If no spontaneous reactivation was apparent, some of 
the latently infected cultures were superinfected with 
either HCMV AD169 or mutants of HSV as described 
below.
5. SUPERINFECTION OF LATENTLY INFECTED CELLS
Latently infected cells were superinfected with 5 
pfu/cell of a ^  mutant or between 0.5 and 5 pfu/cell 
of HCMV AD169. HCMV AD169 was absorbed for 1 hr at 
370c and the superinfected cultures incubated at 37°C 
for 3 days. Duplicate plates of latently infected 
cells were superinfected at both 37°C and 38.5®c with 
HSV mutants and incubated for 3 days at both 
temperatures. At the end of the incubation period, the 
cells were scraped off into the medium, sonicated and 
then titrated on monolayers of BHK C13 cells for 
reactivated virus. Those cultures superinfected with 
ts mutants were titrated at both the permissive (31*^ C) 
and nonpermissive temperature (38.5°C) for 3 and 2 days
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respectively. The yield of virus from each plate was 
calculated. _
6. IMMUNOFLUORESCENCE
Cells were grown on sterile coverslips in 50mm 
petri dishes and subconfluent monolayers were infected 
with virus. After the appropriate incubation period, 
the cells were washed 6 times in PBS and then fixed for 
4 min in methanol: acetone (3:1) at -20°C. After air 
drying the cells were dipped in PBS and incubated with 
lOOul of the appropriate primary antibody for 30 min at 
37^C in a humid atmosphere. The cells were then washed 
three times in PBS and incubated for 30 min at 37°C 
with lOOul of the secondary antibody (an antibody 
raised against the IgG of the primary antibody 
conjugated with fluoroscein isothiocyanate - FITC). 
Finally, the cells were washed three times in PBS and 
mounted on glass slides in glycerol.
The various antibodies used included the 
following:- 
Primary antibodies:
(a) Human antiserum to HCMV obtained from the serum of 
a patient submitted to the Diagnostic Unit for 
antibody analysis. The serum has an HCMV CF 
antibody titre of >1:512 but an HSV-2 CF antibody 
titre of <1:8 and was diluted 1:10 prior to use.
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(b) Rat antiserum to the IE polypeptides of HCMV 
prepared in Hooded Lister rats maintained in this 
Institute. Primary RE cells were infected with 
2.5 pfu/cell of HCMV AD169 for 11-12 hr in the 
presence of 50ug/ml of cycloheximide and released 
for 2-3 hr in lOug/ml of Actinomycin D. The cells 
were scraped off the plates and injected either 
subcutaneously or intradermally into rats with 
Freunds complete adjuvant. Rats were injected for 
three consecutive weeks, boosted 10-14 days later 
and finally bled after 10 days. The antiserum was 
checked for specificity against HCMV AD169 IE 
polypeptides by reacting the antibody with 
proteins extracted from HCMV AD169 infected RE 
cells in an immunoprécipitation assay. The 
antiserum was diluted 1:10 prior to use.
(c) Rat antiserum to the and ^6 IE polypeptides of
HSV-2 HG52 prepared in Hooded Lister rats.
Primary RE cells were infected with 10 pfu/cell of 
HSV-2 HG52 in the presence of 50ug/ml of
cycloheximide for 7 hr and released for 3 hr in
the presence of lOug/ml of Actinomycin D. Rats
were injected as described above and the
specificity of the antiserum checked by 
immunoprécipitation assay. The antiserum was 
diluted 1:10 prior to use.
Secondary antibodies:
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(a) Swine anti-human IgG FITC. This was used as the 
second antibody to human antiserum to HCMV and was 
diluted 1:20 before use.
(b) Goat anti-rat FITC. This was used as the second 
antibody to rat antisera to HCMV and HSV-2 and was 
diluted 1:20 before use.
8. TRANSFORMATION OF RE CELLS BY UV-IRRADIATED VIRUS
HCMV AD169 virus was irradiated using an Englehard
Hanovia Lamp model 16 with a 12" low pressure mercury
vapour discharge tube, operated at 15 watts and 30mA.
5Uip<ar»die-ci in P0S 
0.6-0.8ml of virus^was gently stirred in a 35mm petri
dish for 20 min under the UV lamp placed 27.5 cm above
the dish. At this height the emission of radiation
CMacnob^
from the lamp was 17 ergs/mm^/sec^ UV-irradiated virus
was stored at -70^C until required.
RE cells were seeded at 2x10^ cells per 50mm petri
dish and incubated from 16-24 hr at 37°c until just
subconfluent. The medium was removed and the cells
C'nitval ViWc )
infected with 1-2 pfu/cell^of UV-irradiated HCMV AD169. 
After 90 min absorption, the virus was removed, the 
cells washed three times in EFIO and then overlaid with 
4ml of medium. The medium was changed after 10 min and 
washing was continued if the cells were detaching from 
the plate (a cytotoxic effect in response to the high 
multiplicity of virus infection). 20ul of human
UV - irradiated virus was checked for infectivity before 
use. No plaques were produced when cells were infecte 
at 370c with l-2pfu/cell (initial titre) of 
UV-irradiated virus.
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antiserum to HCMV (see above) was added to each plate. 
The medium was changed 4 or 8 hr post infection and 
after 2 days the cells were trypsinized and split 1:3. 
Once confluent, the monolayers were maintained in EF2 
and regularly examined for the appearance of foci of 
transformed cells.
9. TRANSFECTION OF CELLS WITH CLONED DNA FRAGMENTS
Cloned DNA fragments were introduced into cells 
using the calcium phosphate transfection technique. 
There have been a number of modifications made to the 
original calcium phosphate technique described by 
Graham and van der Eb (1973) aimed at increasing the 
efficiency of uptake and subsequent expression of 
exogenous DNA. Two different transfection procedures 
were used in the studies described in this thesis. For 
either procedure, 2x10^ cells were seeded per 50mm 
petri dish and incubated for 16-24 hr at 37°C until the 
monolayers were just subconfluent for transfection.
Transfection procedure 1
The appropriate amount of donor DNA and carrier 
DNA (if required) were dissolved in 210ul of TE buffer, 
pH7.5. 30ul of 2M CaCl2 were added to the DNA solution 
with gentle agitation. After mixing well, the 
DNA-CaCl2 solution was added dropwise to a tube
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containing 240ul of 2xHBS, pH7.1, whilst gently 
vortexing. The calcium phosphate - DNA co-precipitate 
was allowed to form at room temperature for 30 min 
before being added dropwise to monolayers of cells in 
4m1 of growth medium. The calcium phosphate - DNA 
co-precipitate was incubated with the cells for 24hr at 
370c. The medium was then removed, the cell monolayers 
washed and overlaid with 4ml of fresh medium. If RE or 
Helu cells were used for transfection, the cells were 
boosted for 4 min by the addition of l-2ml of 15% 
glucose, 10% glycerol in IxHBS. The monolayers were 
washed three times to remove the glycerol and overlaid 
with fresh medium. 3T3 cells were not boosted as the 
procedure resulted in the cells detaching from the 
plates.
Transfection procedure 2
The second transfection procedure used was that 
described by Spandidos and Wilkie (1984a). 500ul of
solution of donor DNA plus carrier DNA (if required) 
was prepared in 0.ImM EDTA, l.OmM Tris-HCl, pH8.0, to a 
final concentration of 80ug/ml. 400ul of O.lmM EDTA,
l.OmM Tris-HCl pH8.0, and lOOul 2.5M CaCl2 were added 
to the DNA solution and mixed well. The DNA-CaCl2 
solution was slowly added with continuous mixing to 1ml 
of 2xHBS in a second tube. The calcium phosphate-DNA 
co-precipitate was allowed to form at room temperature
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for 30min. After incubation, 500ul of the calcium 
phosphate-DNA suspension were added dropwise to 
monolayers of cells in 5ml of growth medium. The cells 
were incubated at 37°C for 24hr to allow absorption of 
the calcium phosphate-DNA precipitate. If selectable 
markers (eg the aminoglycoside 3' phosphotransferase 
gene) were used in either transfection procedure, the 
appropriate selective medium was added after the 24 hr 
incubation period with the calcium phosphate-DNA 
co-precipitate.
All cultures were trypsinized and passaged 1:4, 24 
hr after being exposed to fresh medium. Cells were 
examined regularly for the appearance of transformed 
foci .
10. ASSAY FOR ANCHORAGE INDEPENDENT GROWTH
To assay for anchorage independent growth, cells 
were plated in soft agar at a density of 2-4x10  ^ cells 
per 50mm petri dish. Petri dishes were prepared with 
4ml of agar underlay as in Methods. Transfected cells 
were trypsinized, pelleted at lOOOrpm for 10 min at 4°C 
and resuspended in EFIO to give a final concentration 
of 1-2x10  ^ cells/ml. 0.2ml of the cell suspension was 
added to 2ml of agar overlay maintained at 42*^ 0 and 
gently pipetted onto the agar underlay. The agar was 
allowed to set at room temperature. The cells were
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then incubated at 37°C and 1ml of EFIO was added every 
3 days. Colonies should appear within 10-30 days.
11. ASSAY FOR TUMOURIGENICITY
Transfected 3T3 cells were assayed for their 
ability to produce tumours in nude mice using a 
modification of the method described by Fasano et al. 
(1984). 3T3 cells were transfected as described
previously. The transfected cells were trypsinized and 
split into four 50mm petri dishes 48 hr after 
transfection. Once the monolayers had just reached 
confluency, the cells from all four plates were 
trypsinized, pooled, pelleted at lOOOrpm for lOmin at 
4°C, and resuspended in 0.2ml of DFIO. Approximately 
10  ^ cells were injected subcutaneously over the right 
shoulders of athymic, 4-8 wk old, female nude mice. 
Tumour growth was monitored weekly. Before death from 
tumour growth, the mice were sacrificed and the tumours 
removed. Some of the tumour tissue was snap frozen in 
liquid nitrogen to obtain DNA at a later time and some 
was further passaged in nude mice.
12. EXTRACTION OF HCMV ADI69 DNA
Monolayers of Helu cells were prepared in sixty 
800ml plastic tissue culture flasks and infected with
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HCMV AD169 at a moi of O.Olpfu/cell. The overlay 
medium was collected daily from day 7 to day 11 post 
infection for the preparation of virion DNA. Cell 
debris was removed from the medium by centrifugation at 
2000rpm for 10 min at 4°C. The virus was then pelleted 
from the supernatant by centrifugation at 13,000rpm for 
90 min, resuspended in TNE buffer and treated with 
50ug/ml DNase for 30 min in the presence of lOmM MgCl2- 
EDTA was then added to a final concentration of 50mM 
and the virus again pelleted, resuspended in TNE plus 
0.2% SDS and digested overnight with 200ug/ml 
proteinase K. Viral nucleic acids were extracted 3 
times with TNE saturated phenol, once with chloroform 
and then dialysed overnight at 4°C against 3 changes of 
O.lxSSC. The nucleic acids were then ethanol 
precipitated, resuspended in lOmM Tris-HCl pH7.5 lOmM 
NaCl and lOOmM EDTA and treated with lOOug/ml RNase for 
2 hr at 37^C. Viral DNA was subsequently re-extracted 
with phenol and chloroform, dialysed, ethanol 
precipitated and finally resuspended in TE pH7.5. DNA 
preparations were aliquoted and stored at -20°c.
13. EXTRACTION OF CELLULAR DNA
Confluent monolayers of cells grown in 80oz roller 
bottles were washed three times in cold PBS and then 
scraped off in a small volume of PBS. The cells were
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pelleted at lOOOrpm for 10 min at 4®C, resuspended in 
cell lysis buffer and digested with 200ug/ml proteinase 
K for 3 hr at 37°C. The viscous DNA preparation was 
then diluted with TE buffer and gently extracted twice 
with TE saturated phenol and once with chloroform. The 
aqueous phase was made 0.2M sodium acetate and the DNA 
precipitated in 2.5 volumes of ethanol at -20°C 
overnight. The nucleic acids were then pelleted at 
2500rpm for 20 min at 4°C and resuspended in TE plus 
lOOug/ml RNase A for 3 hr at 37^0. After RNase 
digestion, the DNA was extracted twice with TE 
saturated phenol and once with chloroform and then 
dialysed extensively against O.lxSSC at 4°C. Stock DNA 
solutions were adjusted to a concentration of Img/ml 
where possible and stored in aliquots at -20°C.
14. EXTRACTION OF DNA FROM CIN TISSUE
CIN tissue was washed in cold PBS, finely minced 
and then digested with 200ug/ml proteinase K in cell 
lysis buffer for 2hr at 37^0 on a rotator. The 
preparation was extracted once with TE saturated phenol 
and chloroform, dialysed overnight at 4°C against 
O.lxSSC and ethanol precipitated in the presence of 
0.2M sodium acetate. To reduce the number of 
manipulations and consequent loss of DNA because the 
yield of nucleic acids was very low (about
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lO-lOOug/sample), the samples were not^RNase:. RNA 
which' migrates ahead of DNA on gel electrophoresis, was 
cut from the gel prior to blotting.
15. PREPARATION OF DENATURED SALMON SPERM DNA 
Salmon sperm DNA was dissolved in sterile
&
distilled water by gently rotating at room temperature 
for several hours. After phenol and chloroform 
extractions, the DNA was ethanol precipitated at -20°C 
overnight in the presence of 0.2M sodium acetate and 
resuspended to give a final concentration of lOmg/ml. 
The DNA was then boiled for 10 min and sonicated using 
a sonic probe. Small aliquots were stored at -20°C.
16. ESTIMATION OF DNA CONCENTRATION
The concentration of high MW DNA was rapidly 
estimated by agarose gel electrophoresis in mini gels. 
Small samples of DNA were electrophoresed with known 
standard concentrations of DNA on 0.6% (w/v) agarose 
gels in TBE electrophoresis buffer containing ethidium 
bromide. The DNA was visualised by UV illumination of 
the gels and the concentration determined by visual 
comparison of the sample fluorescence with that of the 
standards.
The concentration of low MW DNA eg carrier salmon
93
sperm DNA was estimated by optical density (OD) 
measurement at 260nm. The absorption at 260nm of 
various dilutions of the DNA sample was measured using 
quartz microcuvettes in a Perkin Elmer double beam R4 
spectrophotometer. The concentration was estimated 
assuming that 1 optical density unit is equal to 
40ug/ml of single stranded DNA. The purity of the DNA 
could be assessed by calculating the ratio between the 
readings at 260nm and 280nm (OD260/OD280)• For pure 
preparations of DNA this ratio is 1.8.
17. AGAROSE GEL ELECTROPHORESIS
Agarose gel concentrations between 0.4% and 1% 
(w/v) were employed in this study. The agarose was 
dissolved by boiling, cooled to about SO^c and 0.5ug/ml 
ethidium bromide added before pouring. Horizontal gels 
run in E buffer were routinely used. The DNA samples 
were loaded with l/lO volume Dye-Ficoll and 
electrophoresed at room temperature at about 2 V/cm. 
Gels were photographed under either long wave or short 
wave UV irradiation using Polaroid type 665 or 667 
film.
18. RESTRICTION ENDONUCLEASE DIGESTION OF DNA
All restriction endonuclease digestions were
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performed in the buffers recommended by the suppliers 
for each enzyme. Digestion of high MW cellular DNA was 
accomplished with an estimated 4-fold excess of enzyme 
overnight at Most other digests were performed
at 37^C for 3 hr with sufficient enzyme to produce a 
limit digest unless otherwise stated in the text.
Reactions were terminated by the addition of l/lO 
volume of Dye-Ficoll and the products of digestion 
separated by agarose gel electrophoresis and visualised 
by UV illumination.
19. PREPARATION OF COMPETENT E. coli AND 
TRANSFORMATION BY PLASMID DNA
Adapted from the procedure described by Dagert and Ehrlich 1911 
One litre of LB was inoculated with 20ml of an
overnight bacterial culture and grown with vigorous
shaking at 37^0 to an optical density of 0.2 at 650nm.
The culture was then chilled on ice for 10 min and
centrifuged at SOOOrpm for 10 min at 4°C. The pellet
was drained well and resuspended in 400ml of ice-cold
sterile O.IM CaCl2. The cell suspension was left on
ice for 20 min, repelleted, resuspended in 10ml of
ice-cold sterile O.IM CaCl2 and left for a minimum of 6
hr on ice. 20-50ng of DNA in a volume of 1-lOul were
added to lOOul of the CaCl2 treated bacteria, carefully
mixed and left on ice for 10 min. The bacteria were
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then heat shocked for 1 min at 37^0 in a water bath and 
SOOul of prewarmed LB plus lOmM MgCl2 added. The 
preparation was finally incubated at 3 70c on a shaker 
for èo min and lOOul aliquots plated directly onto 
media selective for the appropriate plasmid resistance 
gene.
20. PREPARATION OF PLASMID DNA
Based on the cleared lysate method described by Clewell and
Helinski (1970). ___________________
An overnight culture was prepared from seed stocks
and used to inoculate 2 litres of LB plus lOOug/ml
ampicillin. The bacteria were grown with vigorous
shaking to an OD of 0.8 at 630nm. Chloramphenicol was
then added to a final concentration of lOOug/ml (to
stop the bacteria from multiplying and increase the
number of plasmids per cell) and the cultures
reincubated for 16-24 hr at 37*^ C. The bacterial' cells
were pelleted at 8000 rpm for 15 min at 4°C and
resuspended in 16ml of cold sucrose-tris (25% sucrose
in 50mM Tris-HCl pH8.0). The bacterial suspension was
distributed between 4 tubes chilled to 4*^ C. Each tube
was treated with 2ml of lysozyme (5mg/ml) for 5 min at
4^0, followed by 3ml of 2 50mM EDTA pHS.O for 5 min at
4°C and then 9ml of Triton lysis mix for 20 min at 4°C.
Cell debris was removed by centrifugation at 15,000 rpm
at 40c. The lysate was extracted once with phenol
saturated with TE pHS.O and dialysed against TE buffer
96
at 4°C with at least 2 changes. The nucleic acids were 
precipitated with isopropanol at room temperature and 
the precipitate resuspended in TE. The plasmid DNA was 
purified by centrifugation to equilibrium in caesium 
chloride ethidium bromide gradients. Gradients were 
prepared to give a final density of 1.55g of caesium 
chloride per ml with 500ug/ml of ethidium bromide and 
centrifuged in a Sorvall TV865B rotor on an OTD 50 
ultracentrifuge for a minimum of 16 hr at 15°C. The 
DNA bands were visualised by fluorescence ih long wave 
UV and the plasmid DNA collected by tube puncture. 
Ethidium bromide and caesium chloride were removed by 
extracting three times with isopropanol saturated.with 
caesium chloride solution followed by extensive 
dialysis against TE buffer at 4°C. The DNA was ethanol 
precipitated and resuspended in TE to give a final 
concentration of Img/ml.
21. RECOVERY OF DNA FROM AGAROSE GELS
Cloned HCMV DNA sequences were excised from vector 
sequences and purified twice by agarose gel 
electrophoresis. After the relevant restriction enzyme 
digestion, the fragments were separated on a 1% (w/v) 
agarose slab gel containing 0.5ug/ml ethidium bromide 
and then visualised by long wave UV illumination. The 
required DNA band was cut from the gel and the DNA
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electroeluted using a microelution kit (ISCO Ltd). The 
agarose containing the DNA was cut into small fragments 
and added to the "sample well". The DNA was 
electroeluted in TBE electrophoresis buffer at lOOV 
until all the DNA was concentrated on the dialysis 
membrane over the smaller "collection well". The DNA 
was collected in a small volume, re-electrophoresed 
through a 1% (w/v) agarose gel and electroeluted a 
second time. The ethidium bromide was removed from the 
DNA by passing through a Dowex AG-50W-X8 column 
suspended in TNE and the collected DNA precipitated 
with two volumes of ethanol and resuspended in TE to 
give a final concentration of Img/ml.
22. In vivo LABELLING OF DNA
DNA was labelled in vivo with 32p after Lonsdale 
(1979). Linbro wells (1.5cm diameter) were seeded with 
2x10^ Helu cells in 1ml of Ec2-Pi and incubated at 37°C 
for 24 hr. Medium was removed and the cells infected 
with 2pfu/cell of HCMV. The virus inoculum was removed 
after 90 min, the cells washed twice and then overlaid 
with 1ml of Ec2-Pi. The infected cells were incubated 
at 37®C until the first signs of cpe were apparent.
The medium was then removed and replaced with 0.5ml of 
Ec2-Pi containing 50uCi/ml of 32p orthophosphate 
(carrier free). Incubation was continued until 70-100%
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cpe was observed.
Cells were harvested by the addition of 0.5ml of 
5% (w/v) SDS to each well and mixed with an equal 
volume of phenol saturated with saline EDTA (150mM 
NaCl, lOOmM EDTA, pH8.0) and placed on ice for 10 min. 
The phases were separated by centrifugation at 2000 rpm 
for 10 min. Two volumes of ethanol were added to the 
aqueous phase and the nucleic acids pelleted by 
centifugation at 2000 rpm for 10 min at 4®C. The 
pellet was air dried and resuspended for 2 hr at 37°C 
in 200ul of distilled water containing lOOug/ml of 
RNase-A. 5ul aliquots were TCA precipitated and 
counted in scintillant (see below). Samples were 
stored at -20^C.
23. LABELLING OF DNA PROBES BY NICK TRANSLATION
DNA probes were labelled in vitro by nick 
translation essentially as described by Rigby et al. 
(1977) HCMV and HSV-2 DNA fragments which are G-C rich 
were labelled with
[ot-32p] dGTP and [c<_32p] dCTP. and HPV 11 DNA, which 
is A-T rich, with [^-32p]dATP and [o<.-32p] dTTP.
0.25ug DNA were nick translated in a final volume of 
SOul containing 0.01% BSA, IxNTB, 0.04mM cold dATP and 
0.04mM cold dTTP (cold dGTP and dCTP were used when 
nick translating HPV 11 DNA). 2xlO-5mg/ml of DNase was
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added and the tube incubated for a few minutes at 37^0 
and then placed on ice. 30uCi of each 
[csc-32p] deoxynucleoside triphosphate and 2u of DNase 
polymerase 1 were added and the mixture incubated at 
15°C for about 90 min. Isotope incorporation was 
measured by spotting duplicate filter paper discs with 
lul of the reaction mixture. The DNA was precipitated 
and the unbound counts removed from one filter paper 
disc by three washes of 5 min in 5% (w/v) TCA at 4°C. 
The disc was then rinsed in ethanol and dried. Both 
the washed and unwashed discs were counted for 32p in 
scintillant fluid (5g PPO per litre of toluene) and the 
percentage isotope incorporation calculated. 
Unincorporated deoxynucleoside triphosphates were 
removed by passing the DNA mixture through a 10ml 
Sephadex G50 column. The radiolabelled DNA was 
collected from the first peak in a volume of 
approximately l-2ml. lul of the DNA probe was added to 
SOOul of water and counted for 32p, The probe 
efficiency was calculated. Probes with efficiencies of 
l-SxlO^cpm/ug DNA were used for blot hybridizations.
24. DNA BLOT HYBRIDIZATIONS
The method used for DNA blot hybridization was 
essentially that described by Southern (1975). High MW 
DNA was digested with an excess of restriction
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endonuclease and the products of digestion fractionated 
by electrophoresis through 0.6% agarose gels. The DNA 
fragments were depurinated by gently shaking the gels 
in 0.2M HCl at room temperature for 30 min. The gels 
were then washed three times in deionized water and the 
DNA denatured by gently shaking the gels in Gel Soak 1 
(0.2M NaOH, 0.6M NaCl) for 1 hr. The gels were then 
neutralized in Gel Soak 2 (IM Tris; 0.6M NaCl, pH7.5) 
for 30-45 min. Each gel was then transferred to a 
sheet of Whatman 3MM paper on a glass plate supported 
in a tray of lOxSSC. A sheet of presoaked Biodyne or 
Gene Screen Plus membrane was laid over the gel 
followed by 6 pieces of Whatman 3MM filter paper cut 
2mm smaller than the gel size. A weighted stack of dry 
paper towels was placed on top. The blot was left for 
16-24 hr at room temperature to allow complete transfer 
of the single stranded DNA to the membrane. After 
transfer. Biodyne blots were washed for 30 min in 2xSSC 
and Gene Screen Plus blots immersed in an excess of 
0.4MNaOH for 30-60 seconds to ensure complete 
dénaturation of immobilized DNA and then neutralized in 
0.2M Tris-HCl (pH7.5), 2xSSC. The blots were allowed 
to dry at room temperature. Biodyne blots were baked 
at 80°C in a vacuum oven for 2 hr to permanently fix 
the DNA to the membrane. This procedure was not 
required for Gene Screen Plus blots. The gels were 
stained in a solution of 0.5ug/ml of ethidium bromide
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for 1-2 hr and examined by long wave UV illumination to 
check that complete transfer of DNA had occurred.
The conditions for DNA hybridization were 
determined using the equation of Schildkraut and Lifson 
(1965). Probes were denatured in 0.2M NaOH, boiled for 
20 min, then cooled quickly on dry ice/ethanol at 
-70°C, taking care not to freeze the probe. The probe 
was neutralized by the addition of an appropriate 
volume of HCl to the total hybridization solution 
containing the probe.
Blots probed with HCMV and HSV-2 were hybridized 
in aqueous conditions. The blots were prehybridized at 
72^C for a minimum of 6hr in 3xSSC, lOxDenhardt's 
solution, 0.5% SDS and lOug/ml of denatured salmon 
sperm DNA. Hybridization was carried out in a similar 
solution in which the denatured salmon sperm DNA was 
replaced by the radiolabelled denatured probe. Blots 
were hybridized at 72°C for 16-24hr. Prehybridization 
and hybridization were carried out in a total volume of 
10ml in sealed polythene bags submerged in a plastic 
box placed in a shaking water bath.
Blots probed with HPV 11 DNA were hybridized in 
the presence of formamide. The blots were 
prehybridized in 50%. formamide, 5xSSC, SxDenhardt's 
solution, 0.05M HEPES, 0.5% SDS and 0.5mg/ml of 
denatured salmon sperm DNA for 6 hr at 42°C. 
Hybridization was carried out for 3 days at 42°c in a
102
similar solution, substituting the denatured 
radiolabelled probe for the denatured salmon sperm DNA.
After hybridization. Biodyne blots were washed for 
30 min at room temperature in lOxDenhardt ' s solutiorr, 
3xSSC followed by three 30 min stepwise decreasing 
washes of 3-O.lxSSC, 0.1% SDS plus lOmM sodium 
pyrophosphate at the hybridization temperature. Gene 
Screen Plus blots were washed twice in 2xSSC at room 
temperature for 5 min, then twice in 2xSSC, 1.0% SDS at 
the hybridization temperature for 30 min and finally 
twice in O.lxSSC, at room temperature for 30 min. 
Neither membrane type was allowed to dry out at any 
time to avoid irreversible binding of the DNA probe to 
the blot. The blots were placed between two layers of 
cling film and autoradiographed by exposure at -70°C to 
flashed Kodak X-Oraat H film used in conjunction with a 
Dupont phototungstate intensifier screen.
Before rehybridization, probes were removed by 
washing the membranes according to the procedure 
recommended by the suppliers. Biodyne membranes were 
washed for 1 hr in 50% formamide, lOmM sodium phosphate 
(pH6.5) at 65®C and then in 2xSSC, 0.1% SDS for 15 min 
at room temperature. Gene Screen Plus membranes were 
washed for 30 min in 0.4M NaOH at 42°C and then in 
O.lxSSC, 0.1% SDS, 0.2M Tris-HCl (pH7.5) at 420C for 30 
min with gentle agitation.
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25. CONSTRUCTION OF A CIN DNA LIBRARY IN BACTERIOPHAGE
VECTOR EMBL 3
The cloning strategy used in this study was to 
construct a complete library of CIN DNA and then to 
identify by hybridization those recombinant 
bacteriophage that contained DNA sequences homologous 
to HCMV DNA. Large DNA fragments of 15-20 kb were 
generated by partial digestion of CIN DNA with Sau 3A 
restriction endonuclease and were cloned into the 
lambda vector EMBL 3 (Frischauf et al., 1983). The 
methods employed are described below
Preparation of 15-20 kb fragments of CIN DNA
DNA fragments of 15-20 kb were prepared 
essentially as described by Maniatis et al. (1978). A 
reaction mixture was prepared with lOug of CIN DNA and 
restriction enzyme buffer in a final volume of 250ul. 
50ul of the reaction mixture were dispensed into one 
Eppendorf tube and 25ul into tubes 2-9. Three units of 
Sau 3A enzyme were added to tube 1, mixed, and 25ul 
transferred to tube 2. The 2-fold serial dilution was 
continued through to tube 8 . The reactions were 
incubated for 30 min in a water bath at 37®c. The
tubes were chilled on ice and EDTA added to a final 
concentration of 20mM to stop the reaction. The 
samples were analysed by electrophoresis through a 0.4%
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agarose gel with  ^ DNA size markers in the 2 outside 
lanes. The ^ DNA was digested with Hindlll and Xhol 
enzymes to generate accurate markers in the 15-20 kb 
size region, heated at 68°C for 15 min and chilled * 
quickly on ice before use. Electrophoresis was carried 
out overnight at 30-35V. The gel was photographed and 
the amount of enzyme needed to produce the maximum 
amount of fluorescence in the 15-20 kb region was 
determined. This was accomplished by blocking off all 
regions of the gel on the photograph not containing the 
DNA of the desired size and visually comparing the 
intensity of fluorescence in the various gel tracks.
As the intensity of fluorescence is related to the mass 
distribution of DNA, half the amount of enzyme that 
produced the maximum amount of fluorescence was 
required to obtain the maximum number of molecules of 
15-20 kb. Using these optimized conditions, a large 
scale digest of 15ug of CIN DNA was prepared. The 
enzyme concentration, time, temperature and DNA 
concentration were identical to those used in the pilot 
reactions. The reaction was stopped by chilling on ice 
and the addition of EDTA to a final concentration of 
20mM. The DNA was then extracted twice with 
phenol/chloroform (1:1 v/v), ethanol precipitated and 
resuspended in 50ul of distilled water.
To prevent reannealing, the DNA fragments were -fnooiecl IamÜ 
phosphatase in 50mM Tris-HCl pH8 .0, 0.ImM EDTA pH8.0
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in a final volume of lOOul at 37^0 for 2 hr.
Proteinase K, SDS and EDTA were added to final 
concentrations of lOOug/ml, 0.2% and lOmM respectively, 
in a final volume of lOOul and the reaction mixture 
incubated at 55^C for 1 hr. The DNA was then extracted 
3 times with phenol/chloroform, ethanol precipitated 
and resuspended in 20ul of distilled water.
Ligation and packaging reactions
An equal molar ratio of ligatable CIN DNA and EMBL 
3 arms was required for efficient ligation. Therefore, 
assuming the EMBL 3 arms were JO kb in length and the 
CIN DNA insert 2.0 kb, 0.4ug of CIN DNA were required 
for every lug of arms. Ligation was carried out in the 
buffer recommended by NEB, the suppliers of the T4 DNA 
ligase, at 15°C overnight. The in vitro packaging 
reaction was carried out using the packaging extract 
purchased from Vector Cloning Systems. The ligated CIN 
DNA was mixed with the packaging extract according to 
the instructions provided. The reaction was stopped by 
the addition of 500ul of SM and 20ul of chloroform and 
the packaged DNA stored at 4°C until required.
The cloning efficiency was calculated by titrating 
the X library on host strains Q358 and Q359 (Karn et 
al., 1980). Both recombinant and non recombinant phage
grew on Q358 but only recombinant phage grew on Q359.
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26. PREPARATION OF PLATING BACTERIA
10ml of LB supplemented with lOmM MgSO^ and 0.2% 
(w/v) maltose were inoculated from glycerol stocks of 
host bacteria and incubated overnight at 37*^ 0. The 
overnight culture was used to inoculate 200ml of LB 
plus lOmM MgS04 3;nd 0.2% (w/v) maltose and grown to an 
optical density of 1 at 630nm. The bacteria were 
pelleted at 6000 rpm for 10 min at 4°C and resuspended 
in 20ml of sterile lOmM MgSO^ to give approximately 
1x10^ bacterial cells per ml. The bacteria were stored 
at 4°C and were used up to about 7 days.
27. TITRATION OF BACTERIOPHAGE
Serial ten-fold dilutions of bacteriophage were 
prepared in SM and lOOul of each dilution added to a 
sterile 4x0.5" glass tube containing lOOul of plating 
bacteria. Phage and bacteria were incubated at 37°c 
for 20 min to allow the phage particles to absorb to 
the bacteria. 3ml of melted 0.7% agarose overlay 
medium were then added to each tube and immediately 
poured onto fresh LB plates prewarmed to 37°C. The 
suspension was quickly swirled to ensure even 
distribution of bacteria and agarose. Once the top 
agarose had set the plates were inverted and incubated 
at 370c for 12-16 hr.
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28. IDENTIFICATION OF RECOMBINANT CLONES
Plaque hybridization was carried out as described 
by Benton and Davis (1977). Aliquots of packaging 
mixture containing approximately 10,000 pfu of phage 
were mixed with lOOul of plating bacteria (Q359) and 
incubated at 37^0 for 20 min. 3m1 of molten top 
agarose (0.7%) were added and immediately poured onto 
dried LB plates prewarmed to 37^0. The plates were 
incubated inverted at 37^0 for 12 hr or until the 
plaques were clearly visible but not showing confluent 
lysis. The plates were chilled at 4°C for 2 hr to 
allow the agarose to harden. An asymmetrically marked 
nitrocellulose filter was applied to the surface of 
each plate so there was direct contact between the 
plaques and the filter. The plate was marked according 
to the position of the filter marks and for more - 
accurate alignment each plate was stabbed 3 times with 
an 18 gauge needle through both filter and agar. The 
filter was left in contact with the plaques for 30 sec 
to allow molecules of unpackaged bacteriophage DNA 
present in the plaques to bind to the filter. The 
filter was then carefully peeled off using blunt-ended 
forceps and immersed DNA side up in a shallow tray of 
denaturing solution (1.5M NaCl, 0.5M NaOH) for 30-60 
sec. The filter was transferred to neutralizing
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solution (1.5M NaCl, 0.5M Tris-HCl pH8.0) for 5 min, 
rinsed in 2xSSPE and air dried on Whatman 3MM paper.
A second replica filter was taken from the same 
plate. A small amount of ink was added to the holes 
made in the agar from the needle stabs and the second 
filter placed on the surface of the plate aligning the 
asymmetric marks as closely as possible. The filter 
was stabbed where the ink marks showed through and was 
left for 60 sec. The DNA was denatured and neutralized 
as described above.
Reconstructions were prepared by spotting DNA from 
HCMV AD169 (7.4, 3.7, 0.74ng), EMBL3 (1.7, 0.85,
0.17ng) and pAT (100, 50, lOpg) onto a nitrocellulose 
filter and denaturing and neutralizing the DNA as 
described above.
The filters were baked at 80®C for 2 hr in a 
vacuum oven to permanently fix the DNA to the 
nitrocellulose.
Before hybridization, the filters were soaked for 
5 min in 6xSSC and then transferred to a litre glass 
beaker containing 100ml of prewashing solution (50mM 
Tris-HCl, pHS.O, IM NaCl, ImM EDTA and 0.1% SDS). The 
filters were gently shaken at 42^C for 1-2 hr to remove 
any absorbed medium, agarose or bacterial debris. The 
prewashing solution was removed and 60ml of 
prehybridization solution added (SxSSPE, 5xDenhardt's 
solution, 0.1% (w/v) SDS and lOOug/ml of denatured
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salmon sperm DNA). Prehybridization was carried out at 
65°C for 4-6«hr. The HCMV DNA probe (0.2 5ug) was 
prepared by in vitro nick translation and denatured as 
previously described. Hybridization was carried out in 
25-30 ml (for up to 15 filters per beaker) at 65°C for 
24 hr in a solution identical to the prehybridization 
solution but without denatured salmon sperm DNA.
After hybridization the filters were given 3-4 
washes of 5 min in 500ml of 2xSSC and 0.1% (w/v) SDS at 
room temperature followed by two 90 min washes in 500ml 
of IxSSC, 0.1% (w/v) SDS at 65^0. The filters were air 
dried, placed between 2 sheets of cling film with 
radioactive ink markers and exposed to flashed Kodak 
X-Omat H film with a Dupont phototungstate intensifier 
screen at -VO^C overnight.
After development the films were aligned with the 
filters using the radioactive ink markers. The , 
positions of the asymmetric marks and stab holes were 
marked on the film and aligned with those present on 
the original agar plates. Positive plaques were 
identified by hybridization and picked using a sterile 
pasteur pipette equipped with a rubber bulb. The 
pipette was used to stab through the chosen plaque and 
underlying agar and mild suction applied so that the 
plaque and agar were drawn into the pipette. The 
fragments of agar were flushed out in 1.0ml of SM 
containing a drop of chloroform and left to stand for
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1-2 hr at room temperature. The phage suspension was 
stored at 4°C until required.
29. PREPARATION OF PLATE LYSATE STOCKS
OF BACTERIOPHAGE
8.5x10^ pfu of bacteriophage were mixed with lOOul 
of plating bacteria (approximately 1x10® cells) and 
incubated at 37^0 for 20 min. 8.5x10^ pfu was the 
number of bacteriophage required to obtain confluent 
lysis on a 90mm plate after 12 hr incubation on 0359 
host bacteria. The phage/bacteria suspension was mixed 
with 3ml of top agarose (0.7% w/v) and poured onto 30ml 
of fresh LB agar. The plate was incubated for 8-12 hr 
at 37°C until lysis was confluent. The plate was kept 
as moist as possible and not inverted during 
incubation. After incubation, 5ml of SM were added and 
the plate stored at 4^C for a minimum of 4 hr with 
intermittent gently shaking. The SM was harvested 
using a pasteur pipette and 1ml of fresh SM added to 
the plate which was then stored in a tilted position 
for 15 min to allow the SM to drain into one area. The 
SM was removed and combined with the first harvest. 
lOOul of chloroform were added, the solution vortexed 
and centrifuged at 4000g for 10 min at 4°C. The 
supernatant was recovered, one drop of chloroform added 
and the stock stored at 4^C.
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30. PURIFICATION OF BACTERIOPHAGE
Approximately 2x10? pfu of recombinant 
bacteriophage in a volume of 50ul (made up with SM if 
necessary) were mixed with 50ul of fresh plating 
bacteria (approximately 5x10^ cells) host strain K803. 
The phage were absorbed for 15 min at 37°C, then added 
to 350ml of LB supplemented with lOmM MgSO^ and 0.2% 
maltose and incubated overnight at 37°c with vigorous 
shaking. Concomitant growth of bacteria and phage 
should occur resulting in lysis. If lysis were 
apparent (indicated by the presence of a precipitate of 
bacterial debris) 4ml of chloroform were added and 
incubation continued for a further 30 min.
Bacteriophage particles were purified essentially by 
the method of Yamamoto et al. (1970). The culture was 
chilled to room temperature and pancreatic RNase and 
DNase added, both to a final concentration of lug/ml. 
After 30 min at room temperature, solid sodium chloride 
was added to a final concentration of IM, dissolved by 
gently swirling and the culture left on ice for 1 hr. 
Bacterial debris was pelleted by centrifugation at 8200 
rpm for 10 min at 4^C and solid polyethylene glycol 
(PEG 6000) added to the supernatant to a final 
conentration of 10% (w/v). The PEG was dissolved by 
gently stirring on a mag?.--1 i.c stirrer at room
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temperature. Bacteriophage were precipitated by 
standing the preparation on ice for 2 hr followed by 
centrifugation at 8200 rpm for 10 min at 4°c. The 
pellet was drained well and resuspended in 1.5-2.0ml of 
SM. An equal volume of chloroform was added to the 
bacteriophage suspension, vortexed for 30 secs and then 
centrifuged at 11,500 rpm for 15 min at 4°C. The 
aqueous phase was recovered and 0.5g/ml of solid 
caesium chloride added and dissolved. The 
bacteriophage/caesium chloride solution was then 
layered onto caesium chloride step gradients. Caesium 
chloride solutions with densities of 1.7g/ml, 1.5g/ml 
and 1.45g/ml were prepared in SM and sequentially 
pipetted into cellulose nitrate tubes. The gradients 
were centrifuged at 22,000 rpm for 2 hr at 4°C in a 
Sorvall AH650 rotor on an OTD50 ultracentrifuge. The 
bacteriophage particles formed a bluish-grey band which 
was removed by tube puncture with a 21 gauge needle. 
Sufficient caesium chloride solution (1.5g/ml in SM) 
was added to the bacteriophage to fill a cellulose 
nitrate tube for a Sorvall TST41 rotor. The gradient 
was centrifuged to equilibrium at 35,000 rpm for 48 hr 
at 4^C. The band of bacteriophage particles was 
collected as before and stored in caesium chloride 
solution in a tightly capped tube at 4°C until 
required.
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31. EXTRACTION OF BACTERIOPHAGE DNA
DNA was prepared from purified bacteriophage 
preparations as follows. The caesium chloride was 
removed by dialysis at room temperature against 1 litre 
of lOmM NaCl, 50mM Tris-HCl, pHS.O, and lOmM MgCl2 for 
2 hr with one change of buffer. The bacteriophage were 
then lysed in 20mM EDTA, pHS.O, and 0.5% SDS and 
treated with 50ug/ml of proteinase K at 37®C for 1 hr. 
The DNA was extracted once with phenol equilibrated in 
TE, once with phenol/chloroform (1:1 v/v) and once with 
chloroform. The preparation was then dialysed 
extensively against'TE buffer pHS.O at 4°C overnight 
with 3 changes of buffer and stored at 4°C. The 
concentration of the DNA was determined by agarose gel 
electrophoresis.
ItSSOIiiTS
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SECTION A
TRANSFORMATION STUDIES WITH HCMV API69
The ability of HCMV to transform cells in culture 
has been well documented in the literature. There have 
been several studies describing morphological 
transformation by HCMV of various cell types including 
HEF cells (Albrecht and Rapp, 1973), human.prostatic 
cells (Rapp et al., 1975), Helu cells (Geder et al., 
1976) and guinea pig fibroblasts (Isom et al., 1983).
In addition, RE cells have been successfully transformed 
by UV-inactivated HCMV AD169 in this laboratory. There 
have, however, only been 2 reported studies 
investigating transformation by HCMV at the molecular 
level. Nelson et al. (1982) transfected NIH 3T3 cells 
with restriction endonuclease HCMV AD169 DNA fragments 
in order to identify the transforming region(s). 
Anchorage-independent growth was used as the criterion 
for transformation. They showed that the HindiII E and 
Xbal N DNA fragments of HCMV AD169 could transform NIH 
3T3 cells in culture. Clanton et al. (1983) performed 
similar experiments with the Towne strain in HCMV and 
found that the Xbal E fragment could initiate 
transformation of HEF and NIH 3T3 cells. The aim of the 
experiments in this section was to test the 
repeatability of the transformation assays and to extend
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the work of Nelson et al. (1982) to further investigate 
a molecular basis for cell transformation.
Quality of current virus stocks
Before any experiments were undertaken, it was 
necessary to check the two HCMV AD169 stocks available 
in the laboratory. The Lonsdale method for in vivo 32p 
labelling and extraction of viral DNA was used. This 
method is quick and did not require large scale 
preparation of viral DNA which tends to be difficult due 
to the fact that HCMV only grows to low titre. Aliquots 
of DNA from each of the HCMV virus stocks (labelled 1 
and 2) were digested with Hindlll and Bglll and the 
products of digestion separated by electrophoresis 
through 0.6% agarose gels. The gels were then dried and 
autoradiographed. The restriction profiles of the two 
virus stocks differed both from each other and also from 
those published by Westrate et al. (1980), Oram et al. 
(1982) and Spector et al. (1982) (Figure A.l). The 
reason for this is unclear. Stock one was found to be 
heavily contaminated with mycoplasma. Mycoplasma DNA 
has a molecular weight of approximately 5x10® daltons -
larger than that of HCMV. It is possible that mycoplasma 
contaminating the virus stock incorporated sufficient 
into its DNA during replication to be detected on the 
autoradiograph after digestion with restriction 
endonucleases. A more likely explanation, however, is
I
#
1 2 1 2
FIGURE A.l Restriction enzyme analysis of two 
separate stocks of HCMV AD169
virus from two stocks (1 and 2) available were 
labelled in vivo with 32p, the DNA digested with 
Hindlll and Bglll and separated on a 0.6% agarose gel. 
The letters refer to specific HCMV AD169 DNA fragments, 
the physical map locations of which are given in 
Figure 2.
Symbols: + novel restriction fragments
- missing restriction fragments
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that the novel restriction fragments detected represent 
defective HCMV DNA generated by high serial passage of the 
virus.
To avoid any complications that might have arisen 
in later experiments through the use of these HCMV AD169 
virus stocks, and also because the DNA profiles of these 
viruses were not consistent with the HCMV DNA clones 
that were to be used in this study, it was decided to 
obtain a fresh stock of virus. A plaque-purified stock 
of HCMV AD169 was kindly provided by Dr. J.D. Oram.
When DNA from the new stock was analysed, it was found 
to have restriction enzyme profiles that corresponded to 
those published previously (Oram et al., 1982). This 
virus stock was used throughout this study.
Characterization of cloned HCMV AD169 DNA restriction 
fragments
Cloned restriction fragments of HCMV AD169 DNA were 
obtained from Dr. J.D. Oram. Hindlll fragments of HCMV 
AD159 DNA were cloned into the Hindlll site of vector 
pAT153 and initially propagated in E. coli strain HBlOl 
(Oram et al., 1982). This host strain does not grow 
very quickly so the cloned fragments were transfected 
into C292 cells, a faster growing strain of E. coli by 
tbe procedure described in Methods. It was then
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necessary to check the clones to make sure that the 
cloned DNA inserts had not become rearranged in anyway 
during the transfection procedure. O.Sug of DNA from 
each plasmid clone were digested with Hindlll and 
electrophoresed through 0.7% agarose gels plus 0.5ug/ml 
of ethidium bromide. Hindlll fragments of X DNA were 
chosen as MW markers and were included in the outside 
lanes on the gels. Photographs of the gels are 
presented in Figure A.2. There was no evidence of any 
rearrangements that might have occurred during 
transfection of the majority of the various cloned DNAs 
The DNA insert in clone G appeared to be approximately 
half the molecular weight to that reported by Oram e^ 
al. (1982). The insert should have had a molecular 
weight of about 13.6x10^ daltons. However, this clone 
contained the K and Q Hindlll fragments which contain 
repeat sequences and was not used in these studies as 
explained later. The DNA insert in clone Z appeared to 
be of a slightly higher molecular weight to that 
reported for the Hindlll y fragment by Oram et al. 
(1982). The digestion of clone Z did not proceed to 
completion resulting in additional bands on the gel 
representing partially digested DNA.
Transfection of cells with cloned restriction fragments 
of HCMV ADI69 DNA
Mouse 3T3 cells were used in the initial
Designation of clone.
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FIGURE A.2 Restriction enzyme analysis of cloned 
HCMV AD169 Hindlll fragments after 
transfection into E.coli C292
O.Sug of plasmid DNAs were digested with Hindlll 
and the restriction fragments separated on 0.6% agarose 
gels. Size markers were provided by Hindlll fragments 
of A DNA.
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transfection experiments. They are an established cell 
line frequently used in transfection experiments for the 
efficient uptake of exogenous DNA. Stock 3T3 cells were 
never allowed to reach confluency to prevent the 
formation of spontaneous transformants in the cell line.
Approximately 2x10^ 3T3 cells in 50mm plates were 
transfected with 10-20ug of the cloned Hindlll E 
fragment of HCMV AD169 by procedure one described in 
Methods. In line with other workers (Galloway and 
McDougall, 1981; Nelson et al., 1982) the plasmid was 
cleaved with Hindlll to linearize the DNA prior to 
transfection. Control cells were transfected with 
either lOug of linearized pAT153 plasmid, 500ul of HBS 
or 200ng of plasmid pH06Tl which contains a cloned 
insert of the T24 Ha-rasl gene (Spandidos and Wilkie, 
1984b) plus lOug of carrier RE DNA. 3T3 cells were not 
boosted during the transfection procedure as the cells 
detached from the plates within 30 seconds of the 15% 
glycerol - HBS solution having been added. The cells 
were split 1:4 48 hr post transfection and then 
maintained in DF2 at 37^ C for as long as possible.
Foci of transformed cells appeared 14-17 days post 
transfection with pH06Tl. Approximately 5 foci were 
obtained per 10^ cells. Figure A.3. illustrates the 
type of foci obtained. No foci were obtained after 
transfection of cells with the cloned HCMV AD169 Hindlll 
E fragment, pAT153 or IxHBS.
FIGURE A.3 Transformation of 3T3 cells by the T24 
Ha-rasl oncogene
i
Photograph of transformed foci observed after 
transfection of 3T3 cells with plasmid pH06TI which 
contains the T24 Ha-rasl oncogene. Foci appeared 14-17 
days after transfection at a frequency of about 4-5 
foci per 10^ cells.
Magnification X 320.
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The 3T3 cells used in these experiments were 
obtained from M. Freshney (Beatson Institute, Glasgow) 
and had been in culture for some time. It was therefore 
decided to repeat the transfection experiments using 3T3 
cells from different sources. 3T3 cells were kindly 
provided by G.M. Cooper (Harvard University, Boston,
USA), G . van de Woode (National Cancer Institute, 
Bethesda, USA) and C. Marshall (Chester Beatty 
Institute, London). Again, no morphological 
transformation could be obtained using the cloned HCMV 
AD169 Hindlll E fragment with any of the 3T3 cell 
stocks.
Transfection experiments were also carried out 
using a different transfection procedure (procedure 2, 
see Methods) and a dominant selectable marker, the 
prokaryotic aminoglycoside 3' phosphotransferase gene 
which confers resistance to neomycin. The Hindlll E 
fragment was cotransfected with the pSr-neo hybrid 
plasmid (p. Berg, Standford University Medical Centre, 
California) which contains the pBR322 origin of 
replication and the ampicillin resistance gene, the 
1.4kb bacterial aminoglycoside phosphotransferase gene 
and the the SV40 origin of replication and early 
promoter region. Cells transformed for neomycin 
resistance were selected for by the addition of 
100-500ug/ml of neomycin to the growth medium. Again, 
no transformation was obtained using the HCMV AD169
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Hindlll E fragment. Morphological transformation of 3T3 
c e lls  by the HCMV AD169 Hindlll E fragment also could 
not be demonstrated in experiments undertaken by T. 
Kouzarides and C. Marshall (personal communications).
The Hindlll E fragment was identified as a 
transforming region of HCMV AD169 using anchorage 
independent growth as the criterion for transformation 
(Nelson et al., 1982). It is possible that 
transformation by HCMV requires the coordinated 
expression of more than one transforming gene for 
conversion of cells to the fully transformed phenotype. 
For example, in cells transformed by polyoma virus, 
anchorage independent growth is determined by the 
expression of the small T gene but expression of middle 
T gene is required for morphological transformation. 
Possibly the Hindlll E fragment of AD169 contains,the 
gene responsible for anchorage independence but another, 
as yet unidentified gene is necessary for morphological 
transformation. To test this hypothesis, 3T3 cells were 
transfected as previously described and then plated out 
in soft agar at a concentration of 2x10^ and 4x10^ cells 
per 50mm plate. The cells were maintained in soft agar 
for one month during which time no sign of any colonies 
of transformed cells were observed.
The transfection experiments were also repeated in 
both primary RE cells and Helu cells, but on no occasion 
was morphological transformation or anchorage
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independent growth observed after transfection with the 
HCMV AD169 Hindlll E fragment.
Transformation of RE cells by UV-irradiated HCMV AD169
Since repeated attempts to transform cells with the 
HCMV AD169 Hindlll E fragment were unsuccessful, it was 
decided to follow up the earlier experiments carried out 
in this Institute on the transformation of RE cells by 
UV-irradiated HCMV AD169.
Subconfluent monolayers of primary RE cells were 
infected with 1 and 2pfu/cell of UV-irradiated HCMV 
AD169 as described in Methods. Once the monolayers were 
confluent, the cells from each plate were split 1:3 and 
again grown to confluency. The plates were maintained 
at 370c with regular medium changes in EF2. Transformed 
cells could be discerned approximately three weeks after 
infection and appeared to be of three distinct 
morphological types. These are shown in Figures A.4 and 
5. The most common type of transformed cell (type 1) 
formed large round foci which were very prominent in the 
cell monolayers (Figure A.4). These foci occurred at a 
frequency of about 4-5 foci per 10^ cells - a frequency 
higher than that of transformation by UV-irradiated and 
ts mutants'of HSV. The second type of HCMV transformed 
cell (type 2) also formed foci but at a lower frequency 
than type 1 HCMV transformed cells. The type 2 HCMV 
transformed cells were rounded in appearance and
w.
i,^t^
FIGURE A.4 Transformation o£ RE cells by
UV-irradiated HCMV AD169
Type 1 focus formed by 
HCMV transformed cells
Type 2 focus formed by 
HCMV transformed cells
figure a .5 Transformation of RE cells by
UV-irradiated HCMV AD169
Type 3 HCMV transformed cells
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infiltrated the surrounding normal RE fibroblasts at the 
outer edge of the foci. Unlike the foci formed by type 
1 HCMV transformed cells, the foci formed by type 2 HCMV 
transformed cells had no regular shape (Figure A.4).
The third type of HCMV transformed cell (type 3) did not 
form foci. Type 3 HCMC transformed cells were rounded, 
highly refractile and tended to occur in clusters.
These cells were observed alongside the two other types 
of HCMV transformed cells (Figure A.5).
At first it was thought that the three 
morphological types of HCMV transformed cells might 
represent different stages in the transformation 
process, but close observation of the cells over a 
period of two more weeks revealed no further 
morphological changes. The type 3 HCMV transformed 
cells did not form foci and the foci of types 1 and 2 
only increased in size up to a point. These experiments 
proved that it was possible to repeat the earlier 
transformation experiments using UV-irradiated HCMV 
AD169.
Some of the RE cells infected with UV-irradiated 
HCMV AD169 were plated into soft agar 48 hr after 
infection to assay for anchorage independent growth.
Cells were plated in soft agar at 2x10^ and 4x10^ cells 
per 50mm plate and maintained at 37*^ C for about 2 
months. No colonies of transformed cells were observed 
it this experiment. However, some of the cells appeared
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viable and highly refractile when examined under the 
microscope and were similar to the type 3 HCMV 
transformed cells observed in the cell cultures 
maintained at 37‘^C in EF2.
The transformation studies were continued by 
analysing HCMV transformed and tumour cell lines 
established in the earlier experiments using 
UV-irradiated HCMV AD169. Transformed cell lines Ic and 
0.01c were established by A. Bunce after transformation 
of RE cells with 1 and 0.01 pfu/cell respectively, of 
UV-irradiated HCMV AD169. Tumour cell lines CMT-1 and 
CMT-5 were derived from tumours induced in Hooded Lister 
rats after inoculation with approximately 5x10? cells 
from the Ic transformed cell line.
Southern blot analysis of DNA from HCMV transformed and 
tumour cell lines
Analysis of cells transformed by SV40 and polyoma 
virus has revealed that viral DNA becomes integrated 
into the cellular genome and that continued expression 
of specific viral genes is necessary for maintenance of 
the fully transformed state (Ketner and Kelly, 1976; 
Botchan et al., 1976; Cuzin et al., 1984). The 
integration of viral DNA into the cellular genome has 
also been found to be a crucial event in transformation 
by adenoviruses (Sutter et al., 1978; Sambrook et al., 
1979;) and retroviruses (Duesberg, 1979; Bishop and
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Varmus, 1982). By analogy it would seem reasonable to 
suppose that HCMV DNA is also integrated and retained in 
HCMV transformed and tumour cells. Southern blot 
analysis was used to provide direct evidence for the 
presence of HCMV DNA within the HCMV transformed and 
tumour cell lines established in this Institute.
Southern transfers were prepared of Hindlll 
digested DNA from the HCMV transformed and tumour cell 
lines plus appropriate reconstructions and controls.
The DNAs were hybridized to various cloned Hindlll 
restriction fragments of HCMV AD169. Three probes were 
used in the hybridization reactions
1 ; The HCMV AD169 Hindlll E fragment reported by Nelson e^ 
al. (1982) to initiate transformation of NIH 3T3 cells.
2. EHB3, a Hindi I l/BamHI subclone of the HCMV AD169 
Hindlll E fragment containing the transforming sequence 
(Wilkinson et al., 1984).
3. A composite probe of Hindlll fragments encompassing the 
entire HCMV AD169 genome. The Hindlll fragments were 
nick translated as a mixture in which each fragment was 
present in the correct molar ratio. Fragments 
containing the inverted repeat sequences were omitted 
from the probe because they have been reported to 
contain sequences which share homology with cellular 
DNA (Peden et al., 1982). This probe was used in 
preference to intact total HCMV AD169 DNA as it could 
be nick translated to a higher specific activity.
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The genomic locations of the cloned HCMV AD169 
restriction fragments used as probes are represented 
diagramatically in Figure A.6.
No specific hybridization was obtained between any of 
the HCMV AD169 probes and the DNAs from the HCMV transformed 
and tumour cell lines analysed. Hybridization reactions 
could detect 1 copy/cell or more of viral sequences present 
in cellular DNA. Figure A.7 shows the results of the 
hybridization of the HCMV AD169 Hindlll E probe to the HCMV 
transformed and tumour cell lines. Weak hybridization was 
detected to a fragment of about 3.6kb in the CMT-1 tumour 
cell line. However, this was found to represent 
hybridization of vector sequences to cellular DNA, since the 
fragment could not be detected when the DNA was rehybridized 
with an HCMV AD169 Hindlll E probe from which vector 
sequences had been removed.
There are two possible explanations for the negative 
hybridization results obtained. The first is that the 
technique of Southern blot analysis is not sufficiently 
sensitive to detect very small viral DNA sequences present 
in low copy number. Nelson et al. (1983) have reported that 
the ability of HCMV AD169 to initiate transformation of 
NIH3T3 cells can be attributed to a DNA sequence of only 
500bp. If this sequence was retained in transformed cells 
at low copy number it would escape detection by Southern 
blot analysis. Alternatively, retention of viral DNA in 
HCMV transformed cells may be transient and only necessary
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FIGURE A.7 Southern blot analysis of HCMV transformed 
and tumour cell lines for the presence 
of specific HCMV DNA sequences
High molecular weight DNA (20ug) from control 
rat embryo (RE) and from HCMV transformed and tumour 
cell lines Ic, 0.01c, CMT-1 and CMT-5, was digested 
with a four-fold excess of Hindlll. The products of 
digestion were separated on a 0.6% agarose gel, 
transferred to Biodyne membrane and hybridized at 70^C 
in 6xSSC with a ^2p labelled probe containing the HCMV 
AD169 Hindlll E fragment of specific activity 
2.2xl0^cpm/ug DNA. Reconstruction tracks Rcl, Rc5 and 
RclO contain 20ug of RE DNA plus 1 copy/cell (0.74ng),
5 copies/cell (3.7ng) and 10 copies/cell (7.4ng) of 
HCMV AD169 DNA, respectively, and were treated as 
described above. pAT represents a control 
reconstruction containing 20ug of RE DNA plus 50pg 
(approximately equivalent to 5 copies/cell) of cloned 
vector DNA.
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to initiate the transformation event. If this is the case 
then it would appear that HCMV transforms cells by a 
different mechanism to that described for SV40, polyoma and 
adenoviruses. One possible mechanism by which HCMV could 
initiate cell transformation is by activation of a cellular 
proto-oncogene.
Transfection of 3T3 cells with DNA from a rat tumour induced 
after inoculation with HCMV transformed cells
Experiments were carried out in collaboration with Miss 
L. Clark and Dr. J.C.M. Macnab to see if the DNA from a rat 
tumour induced after inoculation with HCMV transformed cells 
contained a transforming gene capable of inducing tumour 
formation in athymic nude mice.
Tumours were induced in Hooded Lister rats by the 
inoculation of approximately 5x10? cells from the Ic HCMV 
transformed cell line and the DNA extracted as in Methods. 
This tumour DNA is referred to as CMV-T DNA. Approximately 
2x10^ 3T3 cells per 50mm petri dish were transfected with 
lOug of CMV-T DNA plus carrier RE DNA. Control cells were 
transfected with lOug of carrier RE DNA and 200ng of the 
pHOGTl plasmid plus lOug of carrier RE DNA. The transfected 
cells were assayed for tumourigenicity in athymic nude mice 
as described in Methods.
Nude mice inoculated with 3T3 cells transfected with 
the pH06Tl plasmid developed fibrosarcomas within 8-10 days 
post inoculation. Nude mice inoculated with 3T3 cells
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transfected with CMV-T DNA developed tumours 6-8 weeks after 
inoculation. Tumour induction was not observed in nude mice 
inoculated with 3T3 cells transfected with RE DNA. A small 
amount of tumour tissue was taken from a nude mouse 
inoculated with transfected CMV-T DNA and passaged in a 
second nude mouse. The passaged tumour was later removed 
and the DNA extracted for use in later experiments. This 
DNA was designated NMT DNA.
These experiments showed that the CMV-T DNA contained a 
transforming gene which could be transfected and could 
initiate tumour formation in nude mice. As Southern blot 
analysis could not detect HCMV DNA in the HCMV transformed 
and tumour cell lines, it was unlikely that the transfected 
gene in these experiments was a viral transforming gene.
The transfected gene was more likely to have been of 
cellular origin. These experiments thus provide support for 
the hypothesis that HCMV initiates transformation by 
activating a cellular proto-oncogene.
Southern blot analysis of HCMV transformed cell and tumour 
DNAs for the presence of ras genes
The ras genes are the most frequently isolated tumour 
oncogenes so experiments were undertaken to try to determine 
if HCMV had amplifteci a r^ as oncogene in the HCMV transformed 
and tumour cells. A Southern transfer was prepared of 20ug 
of PvuII digested DNA from the Ic transformed cell and CMT-1 
tumour cell lines and of CMV-T and NMT DNAs.
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Reconstructions were prepared from 20ug of PvuII digested 
calf thymus (CT) DNA plus 10 copies/cell (220pg) and 1
copy/cell (22pg) of PvuII digested DNA from the ras
containing plasmid pH06Tl. PvuII digested DNA from a 
transformed cell line established after transfection of 3T3
cells with 200ng of pH60Tl (ras-TC) was also included as a
positive control. The DNAs were hybridized with 0.25ug of 
32p-labelled pH06Tl DNA for 3 days at 42®C in 50% formamide, 
5xSSC, IxHEPES, 5xDenhardt's and 1% SDS.
Hybridization was obtained to Ic and CMT-1 DNA, ras-TC 
and the reconstruction tracks but not to CMV-T or NMT DNAs 
(Figure A.8). If an activated ras gene was involved in 
transformation, the probe would be expected to hybridize to 
all of the HCMV transformed cell and tumour DNAs. The 
pH06Tl plasmid contains rat repetitive sequences so it is 
possible that the probe hybridized to rat cellular sequences 
in the Ic and CMT-1 cell lines. Unfortunately, CT DNA was 
used as the cellular DNA in the reconstructions and RE 
control DNA was not included on the blot. The DNAs need to 
he rehybridized on a blot including control RE DNA and with 
a ras probe from which the rat repetitive DNA sequences have 
been removed. This will determine if the probe has 
hybridized to rat cellular DNA sequences and whether the 
HCMV transformed Ic cells and CMT-1 tumour cells contain 
activated ras genes.
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figure a .8 Southern blot analysis of HCMV transformed
cell and tumour cell DNA for the presence 
of ras oncogenes
An autoradiograph of a Southern transfer 
containing PvuII digested DNA (20ug/track) from HCMV 
transformed cell line Ic, tumour cell line CMTI, ras 
transformed cell line ras-TC (labelled ras) and tumour 
DNAs CMV-T and NMT. Reconstructions Rcl and RclO were 
prepared from 20ug of calf thymus (CT) DNA plus 1 
copy/cell (22pg) and 10 copies/cell (220pg), 
respectively, of pH06Tl DNA digested together with 
PvuII. The DNAs were hybridized for 3 days at 42^C in 
the presence of formamide with pH06Tl DNA labelled to a 
specific activity of 5.3xl0^cpm/ug DNA.
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SECTION B
SOUTHERN BLOT ANALYSIS OF DNA FROM HUMAN CERVICAL 
PRENEOPLASTIC TISSUE FOR THE PRESENCE OF HCMV, HSV-2 AND HPV 
SPECIFIC SEQUENCES
HCMV, HSV-2 and HPV have all been implicated as 
possible oncogenic agents in the development of cervical 
neoplastic disease. Southern blot analysis was used as an 
approach to screen DNA extracted from CIN tissue for the 
presence of HCMV, HSV-2 and HPV specific sequences.
The sensitivity of the Southern blot hybridization technique 
Past attempts to analyse cervical carcinoma biopsy 
specimens for the presence of HSV-2 DNA showed that in cases 
where viral DNA was detected, HSV-2 sequences were present 
in low copy number (Galloway and McDougall, 1983; Park e;t
1983). Since HCMV, HSV-2 and HPV DNA may be present at 
low copy number in CIN tissue, every attempt was made to 
increase the sensitivity of the Southern blot hybridization 
technique, such that it would detect viral fragments present 
at between 0.2 and 1 copy/cell within cellular DNA.
A greater probability of detecting viral DNA present at 
low copy number could be obtained by transferring large 
amounts of DNA to the transfer membranes. 20ug of digested 
cellular DNA were routinely transferred in these 
experiments. To increase the efficiency of transfer of high
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molecular weight (MW) fragments, the DNA was 'acid nicked' 
(depurinated) by gently shaking the gels in 0.25M HCl for 30 
min at room temperature prior to alkaline treatment. This 
procedure partially cleaved the high MW DNA into smaller 
fragments which bind more efficiently to the membrane. 
However, the hydrolysis reaction was not allowed to proceed 
too far and produce fragments of less than 300 bp which are 
too short to bind efficiently to the membrane. The 
sensitivity was also increased by labelling the cloned DNA 
fragments used as probes in the hybridization reactions to 
high specific activities withc<-32p deoxynucleoside 
triphosphates. Probes were only used if they had a minimum 
specific activity of lxlO®cpm/ug DNA and would routinely 
detect 0.2 copies/cell of a viral fragment in 20ug of 
cellular DNA.
Selection of hybridization transfer membranes
A major problem throughout this study was the limited 
amount of CIN DNA available for Southern blot analysis. CIN 
DNA was extracted from punch biopsies. These were no more 
than a few mm in diameter and yielded approximately 50-100ug 
of DNA. Only one biopsy was available from each patient.
If possible, it was hoped to analyse each CIN specimen for 
the presence of HCMV, HPV and HSV-2 specific DNA sequences. 
This was accomplished by using reprobable nylon-based 
transfer membranes for Southern blot analysis. Although 
nitrocellulose membranes are reprobable, they have a
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tendency to become brittle and to break up during the 
washing procedure prior to rehybridization. The nylon-based 
membranes are more durable, remain intact during washing 
procedures even at high temperatures and can be successfully 
reprobed a number of times. Use of these membranes thus 
reduced the amount of CIN DNA required for Southern analysis 
and the number of Southern transfers made. The efficiency 
of the nylon-based membranes was found to be comparable with 
that of nitrocellulose. Initially Biodyne transfer 
membranes were used. However, the same level of sensitivity 
could not be achieved using later batches purchased from the 
same supplier so an alternative transfer membrane was 
sought. Gene screen plus hybridization transfer 
membranes were chosen as the manufacturers claim that these 
membranes have been designed to increase the efficiency of 
transfer of high MW DNA fragments from electrophoresis gels. 
The Gene screen plus transfer membranes were very successful 
for Southern blot analysis although they tended to give a 
higher background compared to the Biodyne membranes. 
Background hybridization was reduced by increasing the 
amount of SDS in the prehybridization and hybridization 
solutions from 0.1% to 0.5% as suggested by the 
manufacturers.
C o n d i t io n s  f o r  S o u th e rn  b l o t  h y b r i d i z a t i o n s
Hybridizations of HCMV DNA probes to Southern transfers 
Were performed in aqueous conditions (6xSSC, lOxDenhardt's
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solution and 0.5% SDS) for 16-24 hr at 70°C. These 
conditions are moderately stringent, being about 35°C below 
the hybrid melting temperature (Tm) and allowing for 35% 
mismatch of base pairs. The Tm was calculated using the 
equation derived by Schildkraut and Lifson (1965) assuming 
the average G+C content of HCMV to be 57%. Moderately 
stringent conditions were chosen to allow for the complexity 
and wide variation in the G+C content of the HCMV genome 
(from 43% to 60%) and also to allow for the possibility that 
HCMV present in CIN may contain some host cell DNA sequences 
of unknown G+C content.
Hybridization of HSV-2 DNA to Southern transfers was 
performed in 3xSSC, lOxDenhardt's solution and 0.5% SDS for 
16 to 24 hr at 72^C. These conditions were slightly more 
stringent than those used for HCMV hybridization reactions, 
being about 30°C below Tm and allowing for 30% mismatch of 
base pairs.
Hybridization of HPV DNA to Southern transfers was 
performed in the presence of 50% formamide and 5xSSC at 42°C 
for 3 days. The presence of every 1% formamide in the 
hybridization solution reduces the Tm by 0.6°C. The 
conditions for the hybridization of HPVll were of a level of 
stringency comparable to those for HSV-2.
Cloned DNA f r a g m e n ts  used i n  h y b r i d i z a t i o n  r e a c t i o n s
The HCMV DNA cloned probes used in the hybridization 
reactions were the same as those previously described in
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Section A. The HCMV HindiII E fragment and the HCMV DNA 
insert in EHB3 were liberated and purified from vector 
sequences. This made the fragments more suitable for nick 
translating to high specific activities and helped to 
alleviate the problem of non specific hybridization of 
vector sequences to human DNAs (discussed later).
The Bam HI t fragment of HSV-2 HG52 was chosen as the 
HSV-2 DNA probe because it contains one of the transforming 
regions identified in HSV-2 that is capable of initiating 
morphological transformation (Galloway and MacDougall,
1983).
The CIN DNAs were also probed with HPVll DNA. The DNA 
was initially cloned into A 47 and then subcloned in pBR322 
(Gissmann et al., 1982, 1983). HPVll was chosen as a probe 
because DNA from CIN tissue was initially found to hybridize 
to HPV6 and HPVll (Gissmann et al., 1983; McCance et al., 
1983) .
Human CIN tissue and controls
CIN tissue was chosen for analysis because CIN is 
thought to represent the precursor stage to cervical 
carcinoma. If HCMV DNA is involved in the initiation of 
transformation and is not required for maintenance of the 
transformed state as previous results have suggested, viral 
DNA would only be detectable during the initial stages of 
malignancy.
Punch biopsies were obtained from patients with CIN in
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the West of Scotland who were referred to a colposcopy clinic 
in the Western Infirmary (Glasgow) with abnormal cervical 
cytology observed on examination of cervical smears. The 
biopsies (taken prior to laser therapy) were kept on ice and 
the DNA extracted within 2 hr of the specimens having been 
taken. The same CIN patients were included in an 
epidemiological study by S. Walkinshaw,(personal communication 
Sera from the patients were examined for the 
presence of antibodies to HSV-2 and HCMV using the 
complement fixation (CF) assay. The patient was considered 
positive for CF antibodies to either virus if the CF titre 
was 8 or greater. The patients were also screened for HPV 
infection by evidence of koilocytes seen on histological 
examination of stained sections from colposcopy specimens.
The serological and histological data plus the ages of the 
patients from whom biopsies were taken are summarized in 
Table B.l. The CIN biopsies have been designated Cl to C43 
for convenience according to the order in which they were 
obtained. High molecular weight DNA was extracted from the 
CIN biopsies as described in Methods.
Two types of control tissue were used:- rat embryo (RE)
DNA which was extracted from approximately 20 day old 
embryos from an inbred Hooded Lister rat colony maintained 
in this Institute, and normal cervix (NC) DNA which was 
prepared from the ectocervix of hysterectomy specimens from 
patients with no evidence or history of malignant disease.
table b .1 Serological and histological data available
for the CIN patients involved in this study
CIN Age of Grade Antibody Antibody HPV
biopsy patient CIN titre to titre to infection
HCMV HSV-1^
Cl 28 II 128 16 +
C2 29 III <8 <8
C3 26 III 32 64
C4 21 II <8 16
C5 48 II 8 16
C6 39 III <8 32 +
C7 30 III <8 <8
C8 26 II ND ND +
C9 35 III <8 ND
CIO 43 III 8 16
Cll 38 III 8 <8 +
C12 30 II 16 16 +
C13 30 III 16 8
C14 30 III <8 <8
CIS 26 II <8 <8
C16 28 II 8 8
C17 25 II 8 8 +
C18 33 III <8 8
C19 35 III <8 16 +
C20 28 II 16 16
C21 37 II 16 8 +
C22 32 II 8 <8 +
C23 29 II <8 8 +
C24 24 III <8 16
C25 32 III <8 <8
C26 33 II 8 16 +
C27 33 I <8 8
C28 28 II <8 8 +
C29 32 II 8 8 +
C30 36 II 16 8 +
C31 35 III <8 16
C32 28 II <8 16 +
C33 30 III 8 8
C34 27 I <8 <8
C35 28 III 32 16
C36 31 III 16 <8
C37 28 II <8 ND
C38 29 II 8 <8 +
C39 28 II <8 <8
C40 31 II 16 16
C41 39 III <8 <8
C42 22 I <8 32
C43 33 III <8 32
ND = Not determined
Antibody titres determ ined by the Diagnost ic Laboratory,
Inst itute of Virology, Glasgow. — ^
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Hybridization of HCMV DNA probes to CIN DNA
The CIN DNAs, RE and NC control DNAs (20ug of each) 
were digested with an excess of Hindlll enzyme. 
Reconstructions were prepared from 20ug of RE DNA plus 0.2,
1, and 5 copies/cell (0.15ng, 0.74ng and 3.7ng, 
respectively) of HCMV AD169 DNA and digested together with 
an excess of HindiII. The digested DNAs were then 
electrophoresed through 0.6% agarose gels and transferred to 
either Biodyne or Gene Screen Plus membranes as described in 
Methods. The Southern transfers were then hybridized at 
different times to the three HCMV probes previously 
described in Section A, namely, the HCMV AD169 Hindlll E 
fragment, EHB3 probe and the HCMV ADI69 composite probe (a 
probe containing Hindlll fragments encompassing most of the 
HCMV AD169 genome). These probes are diagrammatically 
represented in Figure A.6, an unbound copy of which can be 
found at the back of this thesis. Hybridization was 
observed with the HCMV DNA probes to only 2 of the 43 CIN 
DNAs analysed, C2 and C17 (Figures B.l and B.3). All other 
CIN DNAs were negative for hybridization at levels of 
sensitivity which would detect 0.2 copies/cell of an HCMV 
DNA fragment in 20ug of cellular DNA. Figures B.5 and B.6 
show two representative blots (probed with the EHB3 and HCMV 
AD169 composite probes) of Hindlll fragments of CIN DNAs 
that were negative for sequences that hybridize to HCMV. No 
non specific hybridization was observed to either RE or NC 
control DNAs.
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figure B.l Hybridization of HCMV Hindlll E and EHB3
probes to a Southern transfer containing
CIN DNA
Autoradiographs of the same Southern transfer 
containing Hindlll digested DNA (20ug/track) from human 
CiNs Cl and C2 hybridized at different times with HCMV 
Hindlll E and EHB3 probes. Reconstruction tracks Rci 
and Rc5 were prepared from 20ug of rat embryo DNA plus 
1 copy/cell (0.74ng) and 5 copies/cell (3.7ng), 
respectively, of HCMV AD169 DNA and digested together 
with an excess of Hindlll. pAT represents a control 
reconstruction containing 20ug of rat embryo DNA plus 
50pg of cloned vector DNA both digested with Hindlll.
RE and NC represent control tracks of 20ug of Hindlll 
digested rat embryo and normal cervix DNA, 
respectively.
Both probes hybridized to the 20.35kb Hindlll E 
fragment in the virus reconstruction tracks and to a 
similar sized fragment in C2. The Hindlll E probe also 
hybridized to two fragments of C2 DNA of about 3 and 
5kb (labelled with open circles in the photograph).
The DNA insert in the EHB3 probe was purified from 
vector sequences.
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Figure B.l shows an autoradiograph of a Southern 
transfer of Hindlll digested C2 DNA hybridized to the HCMV 
Hindlll E probe. In this particular hybridization, the 
vector sequences had not been removed from the HCMV Hindlll 
E probe. The probe hybridized to 3 fragments of C2 DNA, one 
of which comigrated with the Hindlll E fragment of HCMV 
AD169 present in the reconstruction tracks. The other two 
bands of lower MW did not hybridize to the HCMV Hindlll E 
fragment after it had been purified from vector sequences 
(not shown) . Thus, hybridization of the cloned DNA probe to 
these lower MW bands presumably represents hybridization to 
vector pAT153 sequences. Figure B.l also shows the same 
Southern transfer hybridized to the HCMV EHB3 probe. This 
DNA probe had been purified from vector sequences and also 
hybridized to the fragment of C2 DNA that comigrated with 
the HCMV AD169 Hindlll E fragment.
The nature of the hybridization of C2 DNA sequences to 
vector sequences is unknown. It is possible that the cervix 
of the patient from whom the biopsy was taken may have been 
contaminated with bacteria containing a plasmid population 
with which pAT153 shares homology. Data from a 
bacteriological study of this group of CIN patients at the 
Western Infirmary revealed a higher degree of cervical 
infection with coliform bacteria in CIN patients when 
compared with controls (W. Roberts, personal communication) 
In a separate investigation, cervical swabs 
Were examined for coliform bacteria and the bacterial DNAs
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FIGURE B.2 Hybridization of the HCMV Hindlll E probe
to a Southern transfer containing C2 DNA
Autoradiograph of a Southern transfer containing 
normal cervix (NC), rat embryo (RE) and C2 DNA 
(20ug/track) digested with BamHI and hybridized to the 
purified HCMV AD169 Hindlll E fragment.
Reconstructions Rc.2, Rci and Rc5 were prepared from 
20ug of RE DNA plus 0.2 copies/cell (0.15ng), 1 
copy/cell (0.74ng) and 5 copies/cell (3.7ng), 
respectively, of HCMV AD169 DNA and digested together 
with BamHI.
The HCMV AD169 Hindlll E fragment hybridized to 
5 BamHI fragments, E, P, W, c and e in the 
reconstruction tracks. The same probe hybridized to 
DNA sequences in C2 that comigrated with BamHI 
fragments P, W, c and e and also to two additional 
fragments, one of a higher molecular weight and one of 
a lower molecular weight than the BamHI E fragment of 
AD169.
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analysed by Southern blotting. A significant proportion of 
the bacterial DNAs were found to hybridize to pBR322 
sequences (R. Thompson, personal communication). Several 
plasmids share sequence homology at and adjacent to their 
origins of replication (Selzer et al., 1983) and it is 
probable that the hybridization of pAT153 DNA to human CIN 
DNA is through common sequences within this region, as 
described by Park (1983).
The C2 DNA was further analysed by digestion with BamHI 
and hybridization to the purified Hindlll E fragment (Figure 
B.2). The Hindlll E fragment hybridizes to 5 BamHI 
fragments, E, P, W, c and e of the HCMV AD169 genome. The 
Hindlll E probe hybridized to DNA sequences in C2 that 
comigrated with HCMV AD169 BamHI fragments W, P, c and e.
The probe hybridized to 2 additional fragments, one of a 
higher MW and one of a lower MW than the BamHI E fragment of 
AD169. These bands could represent rearrangement of viral 
DNA sequences within the CIN DNA. An alternative 
explanation could be that the biopsy had been infected in 
vivo with an isolate of HCMV that has a different 
restriction pattern to AD169 in this particular region of 
the genome. However, this possibility was eliminated when 
the Southern transfer containing the BamHI digested C2 DNA 
was rehybridized to the AD169 composite probe. No 
additional sequences within the C2 DNA were found to 
hybridize specifically to HCMV AD169 DNA (data not shown), 
if the biopsy had been infected with HCMV, other regions of
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figure b .3 Hybridization of the HCMV EHB3 probe to
a Southern transfer containing CIN DNAs
Autoradiograph (9 day exposure) of a Southern 
transfer of normal cervix (NC), rat embryo (RE) and CIN 
DNAs 16, 17, 20, 24, 25 and 27 digested with Hindlll 
and hybridized with the HCMV EHB3 probe.
Reconstructions Rc.2, Rci and Rc5 were prepared from 
20ug of RE DNA plus 0.2 copies/cell (0.15ng), 1 
copy/cell (0.74ng) and 5 copies/cell (3.7ng), 
respectively, of HCMV AD169 DNA and digested together 
with Hindlll. pAT represents a control reconstruction 
containing 20ug of Hindlll digested RE DNA plus 50pg of 
vector DNA.
The EHB3 probe hybridized to the 20.35kb Hindlll 
E fragment in the reconstruction tracks and to a DNA 
fragment of about 6kb in C17 (marked with an open 
circle) .
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figure B.4 Hybridization of the HCMV Hindlll E probe
to a Southern, transfer containing C17 DNA
Autoradiograph of a Southern transfer containing 
normal cervix (NC), rat embryo (RE) and C17 DNA 
(20ug/track) digested with BamHI and hybridized to the 
purified HCMV AD169 Hindlll E fragment.
Reconstructions Rc.2, Rci and Rc5 were prepared from 
20ug of RE DNA plus 0.2 copies/cell (O.lSng), 1 
copy/cell (0.74ng) and ^  copies/cell (3.7ng), 
respectively, of HCMV AD169 DNA and digested together 
with BamHI.
The Hindlll E probe hybridized to 5 BamHI 
fragments E, P, W, c and e in the reconstruction tracks 
and very weakly to a DNA fragment in C17 that 
comigrated with the BamHI W fragment of HCMV AD169 
(labelled with a black dot on the photograph).
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the genome would have been represented in equimolar amounts 
in the,sample. Furthermore, antibodies to HCMV could not be 
detected in the sera of the patient from whom the C2 biopsy 
had been taken (Table B.l). It would thus seem unlikely 
that hybridization to the HCMV AD169 Hindlll E fragment 
represented a current infection of the C2 cervical biopsy 
with HCMV.
Figure B.3 shows a 9 day exposure autoradiograph of a 
Southern transfer containing Hindlll digested C17 DNA 
hybridized to the EHB3 probe. The DNA insert in the EHB3 
probe had been purified from vector sequences and hybridized 
to one Hindlll fragment of C17 DNA. The hybridizable DNA 
sequences in C17 were present at less than 0.1 copy/cell by 
comparison with the reconstruction tracks and were only 
visible after a 9 day exposure. The C17 DNA was further 
analysed by BamHI digestion and hybridized to the purified 
Hindlll E fragment. The probe hybridized very weakly to a 
band colinear with the BamHI W fragment of HCMV AD169, 
indicating that the C17 DNA does share restriction sites 
with AD169 (Figure B.4). Either BamHI digestion of C17 DNA 
cleaved the hybridizable DNA into fragments too small and 
present in too low copy number to be detected with the 
Hindlll E probe, or else not all the fragments present in 
virion DNA were equally represented in the viral insert in 
C17. •
The hybridizable DNA in C17 was present in too low copy 
number to permit further analysis of sequence arrangement.
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figure b .5 Hybridization of the HCMV EHB3 probe to
a Southern transfer containing CIN DNAs
Autoradiograph of a Southern transfer containing 
normal cervix (NC), rat embryo (RE) and CIN DNAs 11,
12, 13, 18, 19 and 23 (20ug/track) digested with 
Hindlll and hybridized to the HCMV AD169 EHB3 probe. 
Reconstructions Rc.2, Rci and Rc5 were prepared from 
20ug of RE DNA plus 0.2 copies/cell (O.lSng), 1 
copy/cell (0.74ng) and 5 copies/cell (3.7ng) 
respectively, of HCMV AD169 DNA and digested together 
with Hindlll. pAT represents a control reconstruction 
of 20ug of Hindlll digested RE DNA plus 50pg of vector 
DNA.
This blot is representative of one that did not 
show any hybridization of CIN DNA to HCMV sequences.
figure b .6 Hybridization of the HCMV ADI69 composite
probe to a Southern transfer containing
CIN DNAs
Autoradiograph of a Southern transfer containing 
normal cervix (NC), rat embryo (RE) and CIN DNAs C5 and 
C3 (20ug/track) digested with Hindlll and hybridized to 
the HCMV AD169 composite probe. Reconstructions Rci 
and Rc5 were prepared from 20ug of RE DNA plus 1 
copy/cell (0.74ng) and 5 copies/cell (3.7ng) 
respectively, of HCMV AD169 DNA and digested together 
with Hindlll. pAT represents a control reconstruction 
of 20ug of Hindlll digested RE DNA plus 50pg of vector 
DNA.
This blot is representative of one that did not 
show any hybridization of CIN DNA to HCMV sequences.
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However, it was attempted to clone the hybridizable DNA 
sequences in C2 in lambda vector EMBL3 to eventually 
characterize the viral insert. These experiments are 
described in Section C.
Hybridization of HPVll and HSV-2 DNA probes to CIN DNA
The Southern transfers prepared of the CIN DNAs were 
rehybridized with the HPVll DNA and HSV-2 DNA Bamt probes. 
The blots were washed prior to rehybridization and 
autoradiographed to ensure that the previous probe had been 
completely removed. Reconstructions for the hybridizations 
were prepared from 20ug of RE DNA plus 1 copy/cell (0.5ng) 
and 5 copies/cell (125pg) of HPVll DNA or 1 copy/cell 
(0.5ng) and 5 copies/cell (2.5ng) of HSV-2 HG52 DNA and were 
digested together with Hindlll. The fragments were 
separated on 0.6% agarose gels and transferred to Gene 
screen plus membranes as described in Methods. Small strips 
of membrane containing the appropriate reconstructions were 
hybridized in the same polythene bag as the Southern 
transfer containing the CIN DNA.
Hybridization was obtained with the HPVll DNA probe to 
the following CIN DNAs; C8, C13, C16, Cl7, C18, C19, C20 and 
C40 (Figures B.7 and B.8). When the blots were later 
hybridized to the HSV-2 BamWt probe, hybridization was 
obtained to CIN DNAs C16, C17, C18, C19 and C20, (Figure
B.9). On aligning the autoradiographs obtained from the 
blots concerned, it was noticed that the HPVll and HSV-2 Bam
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figure B .7 Hybridization of the HPVll probe to a
Southern transfer containing GIN DNAs
Autoradiograph of a Southern transfer containing 
normal cervix (NC), rat embryo (RE) and GIN DNAs Cll, 
C12, C13, CIS, C19 and C23 (20ug/track) digested with 
HindiII and hybridized to the HPVll probe. pAT 
represents a control reconstruction of 20ug of Hindlll 
digested RE DNA plus 50pg of vector DNA. Unlabelled 
tracks represent the reconstructions containing HCMV 
AD169 DNA that were transferred along with the GIN 
DNAs, The reconstructions with HPVll DNA were 
transferred separately onto strips of Gene Screen Plus 
membrane and hybridized to the probe together with the 
Southern transfer containing the GIN DNAs. 
Reconstructions Rcl and Rc5 were prepared from 20ug of 
RE DNA plus 1 copy/cell (25pg) and 5 copies/cell 
(125pg) respectively, of the cloned HPVll DNA.
The HPVll probe consisted of HPVll DNA and 69% 
BPV-1 DNA sequences fused to pBR322. A HindiII digest 
of this recombinant plasmid gives rise to two 
fragments, one-of 9.7kb which represents the BPV-1 and 
pBR322 sequences, and the other of 8kb which represents 
HPVll DNA. The HPVll probe hybridized to both the 9.7 
and 8kb fragments in the reconstruction tracks and to 
DNA fragments of about 8, 5 and 3.6kb in GIN DNAs G13, 
CIS and G19. The 5 and 3.6kb fragments in GINs G18 and 
C19 (marked with black dots) were also found to 
Hybridize to the HSV-2 Bamt probe (not shown) and 
probably represent sequences homologous to pBR322 DNA. 
The 8kb fragments in G13 and G19 (marked with open 
circles) represent authentic HPVll DNA of unit length.
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FIGURE B.8 Hybridization of the HPVll DNA probe to
Southern transfers of GIN DNAs C8, C14,
G40 and G41
Autoradiographs of Southern transfers containing 
CIN DNAs G8, G14, C40 and G41 (20ug/track) digested 
with Hindi!I and hybridized to the HPVll DNA probe. 
Reconstructions Rcl and Rc5 were prepared from 20ug of 
RE DNA plus 1 copy/cell (25pg) and 5 copies/cell 
(125pg) respectively, of HPVll DNA and digested 
together with Hindlll.
In the reconstruction tracks, the HPVll probe, 
hybridized to the 9.7kb fragment (representative of the 
BPV-1 and pBR322 DNA sequences) and the 8kb fragment 
(representative of HPVll DNA). The HPVll probe also 
hybridized to two fragments of about 6 and 4kb in GIN 
DNAs G40 and G8, respectively. It is unlikely that 
these fragments represent authentic HPVll DNA sequences 
as where HPVll DNA has been detected in GIN tissue, it 
has been found to be of 8kb unit length. These 
fragments therefore probably hybridized to vector 
sequences in the probe.
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FIGURE B.9 Hybridization of the HSV-2 Bamt probe to
a Southern transfer containing CIN DNAs
Autoradiograph of a Southern transfer containing
normal cervix (NC), rat embryo (RE) DNA and CIN DNAs
C16, C17, 024, C25, and C27(20ug/track) digested with
HI
Hindlll and hybridized to the HSV-2 Bamjt probe. pAT 
represents a control reconstruction of 20ug of Hindlll 
digested RE DNA plus 50pg of vector DNA. Unlabelled 
tracks represent the reconstructions containing HCMV 
AD169 DNA that were transferred along with the CIN 
DNAs. The reconstructions with HSV-2 DNA were 
transferred separately onto strips of oene Screen Plus 
membrane and hybridized to the probe together with the 
Southern transfer of the CIN DNAs. Reconstructions 
Rcl, Rc5 and RclO were prepared from 20ug of RE DNA 
plus 1 copy/cell (O.Sng), 5 copies/cell (2.5ng) and 10 
copies/cell (5ng) respectively, of HSV-2 HG52 DNA
digested together with BamHI.
H\
The HSV-2 Bamt probe hybridized to DNA sequences 
present in C16, C17 and C20 (marked with black dots on 
the photograph) and to a 2.8kb fragment in the 
reconstruction tracks. Since the same sequences in 
C16, C17 and C20 also hybridized to the HPVll DNA probe 
(not shown) and both probes contained pBR322 sequences, 
it was concluded that the hybridizable sequences in 
these CINs were homologous to pBR322 DNA and not to 
HSV-2 DNA.
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t probes had hybridized to identical fragments in CIN DNAs 
C16/ C17, CIS, C20 and to one band of about 3.6kb in C19. 
This was known not to have resulted from residual probe from 
the first hybridization because the blots had been checked 
by autoradiography prior to rehybridization. The only 
explanation for the identical hybridization results was that 
the CIN DNAs had hybridized to vector sequences present in 
the probes. Both probes contained pBR322 sequences. The 
possible nature of this hybridization has already been 
discussed. The HPVll probe hybridized to two 8kb fragments, 
one in C13 and the other in C19, that were not detected 
using the HSV Bamt probe. These probably represent 
authentic HPV sequences. They could represent either HPVll 
or HPV6 DNA, since HPVll DNA shares approximately 82% 
homology with HPV6 DNA (Dartmann et al. submitted for 
publication). An HPVll DNA probe could therefore detect 
HPV6 sequences under hybridization conditions of high 
stringency. There was no evidence from the hybridization 
reactions that the hybridization obtained with the HPVll DNA 
probe to CIN DNAs C8 and C40 could be attributed to pBR322 
sequences. However, HPV sequences detected in CIN and 
carcinoma tissue and in cell lines derived from cervical 
carcinomas have been reported to be of around unit 8 kb 
length, and the sequences detected in C8 and C40 appear to 
be of a much lower MW. This raises the possibility that 
these CINs may after all contain sequences that hybridize to 
pBR322 sequences. The result of these hybridizations
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highlight the problems of plasmid vector sequences 
hybridizing to human cellular DNAs and emphasize the caution 
necessary in interpreting hybridization results and the 
necessity to use multiple digests to verify authentic viral 
sequences within cellular DNAs.
No specific hybridization to HSV-2 DNA was obtained 
with any of the CIN DNAs. There could be two explanations 
for the lack of detection of HSV-2 and very low level of 
detection of HPVll specific DNA sequences in CIN DNAs. 
Firstly, by this stage the membranes had already been probed 
at least three times. The washing procedure prior to each 
rehybridization may have removed some of the CIN DNA. If 
viral sequences were present in the CIN DNAs at very low 
copy numbers there may have been insufficient CIN DNA 
remaining on the blots after washing for the viral sequences 
to be detected. This would not have affected hybridization 
to the reconstructions because they had been transferred on 
separate strips of nylon membrane. Secondly, the results 
may be genuine and HPVll and HSV-2 DNA sequences are not 
present in the majority of CIN samples analysed. This does 
not necessarily mean that the viruses do not play some role 
in the development of cervical neoplastic disease as will be 
discussed later.
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SECTION C
cloning of C2 DNA SEQUENCES IN BACTERIOPHAGE LAMBDA
Southern blot analysis of the DNA from CIN biopsy C2 
revealed the presence of sequences that hybridized to the 
Hindlll E fragment of HCMV AD169. These sequences were 
present at about 20 copies/cell. In addition, C2 DNA also 
contained sequences that hybridized to pAT153. As only a 
small amount of DNA was available from this CIN biopsy, 
further analysis of these hybridizable sequences could only 
be accomplished if the sequences were successfully cloned. 
This section describes the strategy used for cloning the C2 
DNA in bacteriophage lambda.
Choice of cloning vector and preparation of C2 DNA 
for cloning
The fragment of C2 DNA that hybridized to HCMV was 
about 20kb, so a vector capable of accepting a fragment of 
this size was required. EMBL3 was chosen as a suitable 
cloning vector for the C2 DNA. This is a lambda replacement 
vector with a nominal cloning capacity of approximately 9 to 
23kb (77 to 105% of wild type lambda). EMBL3 also carries 
the polylinker sequences Sail, BamHI, EcoRI replacing the 
BamHI sites carried by lambda 1059 (Frischauf et al., 1983). 
Foreign DNA sequences can be cloned into the BamHI site and 
the entire DNA insert excised from the vector by digestion
143
with Sali. The efficiency of cloning is sufficiently high 
to allow the recovery of essentially complete libraries of 
mammalian genomes from microgram amounts of DNA and rapid 
high screening techniques make this lambda replacement 
vector a very convenient system to use.
The C2 DNA was partially digested with Sau3A enzyme to 
generate fragments of 15-20kb for cloning into the BamHI 
site of EMBL3. Sau3A was used to partially digest the high 
MW DNA because it cleaves the DNA more frequently than 
BamHI. Sau3A is an isoschizomer of BamHI and recognises the 
tetranucleotide sequence GATC. BamHI recognises the 
hexanucleotide sequence GGATCC. Assuming that restriction
O ^d tV->aV DNJA has o. G + C cor\h<»A+ o |l 5  0"/o
endonuclease sites are distributed randomly along DNA^ the 
tetranucleotide target for Sau3A will occur on the average 
once every 4^  (ie 256) nucleotides, whereas the 
hexanucleotide target for BamHI will occur once every 4^ (ie 
4096) nucleotides. Since Sau3A is an isoschizomer of BamHI 
the fragments generated by partial digestion of eukaryotic 
DNA with Sau3A can still be cloned into the BamHI site of 
EMBL3. Microgram aliquots of C2 DNA were digested with 
varying amounts of Sau3A and analysed by electrophoresis 
using a series of ^ DNA fragments of known MW as markers.
By comparison of the intensities of fluorescence, it was 
found that 0.094u of Sau3A per ug of C2 DNA were required to 
produce the maximum number of DNA molecules of size 15-20kb 
in 30min at 37°C. , , , -^
Veo+ed loim
The C2 DNA fragments were^phosphatase' as described in
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Methods. This procedure removed the 5' terminal phosphate 
groups so preventing reannealing and the formation of dimers 
which would be too large to be packaged into the lambda 
phage heads.
The lambda library of C2 DNA
After ligation of the C2 DNA fragments to the EMBL3 
arms and packaging of the ligated DNA, the recombinant phage
were titrated on 0358 and Q359 host .bacteria. Approximately
1.4x10? plaques per ug of EMBL3 arms were obtained on 0358 
bacteria and approximately 9x10^ plaques per ug EMBL3 arms 
were obtained on 0359 bacteria. Since only recombinant
phage containing a C2 DNA insert could grow on 0359
bacteria, 9x10^ represents the number of recombinant phage 
in the lambda library. The plaques obtained on 0359 
bacteria were very tiny and quite difficult to see. Plaque 
formation also took longer than 8hr, the majority of plaques 
were not visible in under 16hr. The plaques formed on 0358 
bacteria were much larger.
To detect one copy/cell of a specific fragment of DNA 
it is necessary to screen approximately 1.5x10^ plaques.
Since the C2 DNA fragment that hybridized to HCMV was 
present at 20 copies/cell, it was theoretically possible to 
identify this fragment in a library of only 7.5x10^ plaques. 
The number of recombinant phage for screening could have 
been increased by amplifying the library. However, it was 
decided not to amplify because most of the recombinant phage
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grew poorly and might have been heavily underrepresented in 
the amplified library. Such recombinants, even those that 
form minute plaques, can sometimes be isolated if the 
amplification step is omitted.
Screening recombinant phage
The entire lambda library was plated out on Q359 
bacteria in ten 90mm petri dishes to give approximately 9000 
plaques per dish. Impressions were taken as described in 
Methods and the filters hybridized to the HCMV AD169 Hindlll 
E probe labelled to a specific activity of 1.5xl0®cpm/ug 
DNA. The pAT153 vector sequences had not been removed from 
this probe. It was hoped by using this probe to isolate the 
DNA sequences present in C2 that hybridize to pAT153 as well 
as those that hybridize to the HCMV ADI69 Hindlll E 
fragment. The filters were hybridized under conditions of 
relatively low stringency (5xSSPE, and 0.1% SDS at 65*^ C) to 
increase the probability of detecting positive clones.
After the first screening the autoradiographs showed the 
presence of positive clones on one of the ten plates (Figure
C.l). The positive clones were clustered in one small area 
of the plate. The large number of plaques present made it 
impossible to pick one isolated plaque so three clusters of 
plaques were picked and labelled 1, 2 and 3 as indicated in 
Figure C.l. lOOul aliquots of undiluted, and 1:10 and 1:100 
dilutions of each of these plaque stocks were plated out on 
Q359 bacteria. After overnight incubation suitable numbers
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FIGURE C.l Isolation of positive clones containing C2 
DNA sequences that hybridized to the HCMV 
AD169 Hindlll E probe
Top; An autoradiograph of a reconstruction filter
hybridized to the HCMV AD169 Hindlll E probe 
which contained pAT vector sequences. 
Reconstructions include 10, 50 and lOOpg of 
pAT DNA, 0.74, 3.7 and 7.4ng of HCMV DNA and 
0.17, 0.85 and 1.7ng of EMBL3 DNA. The 
amounts of DNA used in the reconstructions 
correspond to the amounts that would be 
required for 1, 5 and 10 copies/cell of the 
DNA with 20ug of cellular DNA. .
Bottom: An autoradiograph of duplicate filters from a
plate containing plaques which hybridized to 
the HCMV ADI69 Hindlll E probe. Each positive 
plaque was picked and numbered as shown. 
Plaques 1 and 2 were later found to contain C2 
sequences that hybridized to HCMV DNA. Plaque 
3 was later shown to contain C2 sequences that 
hybridized to pAT DNA. Plaque 4 did not 
hybridize to the HCMV DNA probe in subsequent 
experiments and since it was only present on 
one of the filters it must have been a hot 
spot.
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of plaques were obtained on the plates containing the 
undiluted and 1:10 dilutions. Impressions were taken from 
these plates and hybridized to the HCMV AD169 Hindlll E 
probe labelled to a specific activity of 1.9x10® cpm/ug DNA. 
The results are shown in Figure C.2.
Hybridization was obtained to plaques on all of the 
plates indicating that the positive plaques had been 
successfully picked. The hybridization to plaque 3 was 
particularly strong and approximately 80% of the plaques on 
the plate were positives. The hybridization to plaques 1 
and 2 was less marked, still less than 50% of the total 
number of plaques per plate were positive. A selection of 
positive plaques was picked from the plates. In this second 
round of purification, the picked plaques were labelled 
using the number of the original plaque followed by a 
letter. These plaque stocks were plated out onto Q359 
bacteria. However, relatively few plaques were obtained 
(about 1000 plaques per single picked plaque) and 
impressions had to be taken from the plates of undiluted 
stocks. These were hybridized to an HCMV AD169 Hindlll E 
probe from which the pAT153 sequences had been removed to 
determine which, if any, of the positive clones contained 
sequences that hybridized to pAT. The results of the 
hybridization are presented in Figure C.3. No hybridization 
was obtained to any of the plaques picked from stock 3 (not 
shown). Thus, the clones derived from plaque 3 contained C2 
DNA sequences that hybridize to pAT153. Since single picked
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FIGURE C.2 Hybridization of positive clones 1, 2 and
3 to the HCMV AD169 Hindlll E probe
Plaque stocks were prepared from the positive 
clones isolated from the library. Aliquots of 
undiluted (U) and 1:10 diluted (10“ )^ stocks were 
plated out on Q359 bacteria. Duplicate filters were 
prepared from the plates and hybridized to the HCMV 
AD169 Hindlll E probe. The autoradiographs of the 
filters are shown here. All three stocks contained 
clones that hybridized to the HCMV AD169 Hindlll E 
probe.
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FIGURE C.3 Purification of clones 1 and 2 that
contained C2 DNA sequences that hybridized 
to HCMV
Top; An autoradiograph of a reconstruction filter
hybridized to the HCMV AD169 Hindlll E 
fragment (purified from vector sequences). 
Reconstructions include 10, 50, and lOOpg of 
pAT DNA, 0.74, 3.7 and 7.4ng of HCMV DNA and 
0.17, 0.85 and 1.7ng of EMBL3 DNA. The 
amounts of DNA used in the reconstructions 
correspond to the amounts that would be 
required for 1, 5 and 10 copies/cell of the 
DNA with 20ug of cellular DNA.
Bottom Autoradiograph of duplicate filters prepared
Two; from undiluted twice plaque-purifed stocks of
clones 1 and 2 and hybridized to the HCMV 
AD169 Hindlll E fragment. At this stage 
approximately 7 5% of the plaques present on 
the plates were found to be positive.
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FIGURE C.3 Purification of clones 1 and 2 that
contained C2 DNA sequences that hybridized 
to HCMV
Top: An autoradiograph of a reconstruction filter
hybridized to the HCMV AD169 Hindlll E 
fragment (purified from vector sequences). 
Reconstructions include 10, 50, and lOOpg of 
pAT DNA, 0.74, 3.7 and 7.4ng of HCMV DNA and
0.17, 0.85 and 1.7ng of EMBL3 DNA. The 
amounts of DNA used in the reconstructions 
correspond to the amounts that would be 
required for 1, 5 and 10 copies/cell of the 
DNA with 20ug of cellular DNA.
Bottom Autoradiograph of duplicate filters prepared
Two: from undiluted twice plaque-purifed stocks of
clones 1 and 2 and hybridized to the HCMV 
AD169 Hindlll E fragment. At this stage 
approximately 7 5% of the plaques present on 
the plates were found to be positive.
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plaques only gave rise to about 1000 plaques, between 10 and 
20 positive plaques were picked from the plates to give a 
single stock. Undiluted aliquots from these plaque stocks 
were plated out on Q359 bacteria, impressions taken and the 
filters hybridized to the HCMV AD169 Hindlll E fragment. No 
hybridization was obtained to the plaques purified from the 
original plaque 2. More positive plaques were picked and 
impressions taken but again the plaques did not hybridize 
with the HCMV AD169 Hindlll E fragment. Faint hybridization 
was obtained to plaques picked from Ic. However, the 
autoradiographs showed a large number of positive spots 
which could not be aligned with plaques on the plates.
These were definitely not hot spots on the filters because 
they were present in the same place on both the impressions 
taken from the same plate. The positive clones in these 
cases must grow poorly and the plaques formed were too small 
to be seen with the naked eye. This made it very difficult 
to pick isolated positive plaques. About 20 positive 
plaques were picked from the plate and a plate lysate stock 
prepared from these as described in Methods.
Attempts to characterize the DNA sequences in C2 that 
hybridizedto HCMV DNA
The plate lysate stock was used to infect K803 
bacteria. Bacteriophage particles were purified and DNA 
prepared as described in Methods. About lOug of the phage 
DNA was digested with an excess of Sail enzyme to excise the
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C2 DNA insert from the vector. Small aliquots of the Sail 
digested phage DNA were digested separately with Hindlll, 
BamHI, EcoRI and Pstl. Small aliquots of the HCMV AD169 
Hindlll E fragment were also digested with the above enzymes 
(but not Sail) to provide controls. It was hoped that by 
comparing the restriction profiles of the digested phage DNA 
with the corresponding restriction profiles of the HCMV 
AD169 Hindlll E fragment, it would be possible to map the 
hybridizable sequences in C2. The digested DNAs were 
electrophoresed through a 0.7% agarose gel and examined by 
UV-illumination. Hindlll fragments of X were used as 
molecular weight markers. The Sail digest of the phage DNA 
produced 3 bands, an upper and lower band representing the 
EMBL3 arms and a middle band representing the cloned C2 DNA 
insert. The insert appeared to be about lOkb in size. The 
DNA was then transferred to Gene Screen Plus membrane by the 
procedure of Southern and hybridized to the HCMV ADI69 
Hindlll E fragment. No hybridization was obtained to the 
digested phage DNA, although the probe hybridized strongly
to the control digested Hindlll E DNA. The reason why the
isolated recombinant phage did not hybridize is unknown.
The most likely explanation is that the cloned C2 DNA 
sequences that hybridized to HCMV were in some way
detrimental to phage growth. They may be analogous to the
'poison sequences' of pBR322. The positive clones certainly 
grew very poorly as they produced minute plaques and had a 
very low plaquing efficiency. Possibly when the plaques
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were picked to make a plate lysate stock, one or two of the 
clones may not have been positives and outgrew the clones 
containing the HCMV insert during the preparation of the 
phage DNA. The extracted DNA would not then have hybridized 
to the HCMV AD169 Hindlll E fragment.
There is also the possibility that the sequences within 
the C2 DNA that hybridized to HCMV contained an unstable 
gene that was subsequently lost from the phage. This would 
help to explain why the HCMV DNA inserts in both the Ic and 
2b clones were lost from the library. It has also been 
reported that the presence of tandemly repeated sequences in 
eukaryotic DNA can lead to deletions by recombination during 
phage propagation (Arnheim and Kuehn, 1979; Fritsch et al., 
1980; Lauer et al., 1980). Complete sequence data for the 
HCMV AD169 Hindlll E fragment is not yet available but since 
the Hindlll E fragment has been successfully cloned (Oram e^ 
al., 1982) it is unlikely that the fragment contains large 
tandem repeats that would be deleted during phage 
propagation. Thus it seems improbable that the homologous 
C2 sequences could be lost in this manner.
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SECTION D
STUDIES ON THE INFECTION OF CERVICAL CELLS BY HERPESVIRUSES
HCMV and HSV-2 are very common infectious agents of the 
human cervix. HSV-2 produces characteristic cytological 
changes visible in cervical smears whereas HCMV causes 
mostly inapparent infections. Although these herpesviruses 
are important pathogens, there have been very few studies 
investigating the nature of herpesvirus infections in 
cervical cells. The experiments described in this section 
aimed to investigate:
1. the cellular alterations induced by HCMV and HSV-2 
infection of cervical cells
2. the production of infectious virus and antigens in 
cervical cells
3. the ability of the viruses to establish latent 
infections in cervical cells
4. the possible stimuli capable of reactivating latent 
virus.
Histology of the normal cervix
The portio surface of the human cervix is covered by a 
non-keratinizing stratified squamous epithelium known as the 
sctocervix (Figure D.IA). The inner surface of the cervix 
surrounding the os is covered by a single layer of columnar 
epithelial cells known as the endocervix (Figure D.IB). The
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endocervical epithelium forms villi and long ridges with 
intervening clefts that extend several mm deep from the 
surface. Endocervical cells are mucous-producing cells and 
also Line glands present in the underlying stroma. Both the 
ecto- and endocervical cells are exposed to injury and 
infection and form a protective layer around the cervix.
The ectocervix and endocervix are separated by the 
squamo-columnar junction. In a young female, the normal 
squamo-columnar junction is sharp; the columnar epithelium 
ends and native squamous epithelium begins. However, after 
puberty, acid secretions from the vagina initiate the 
process of squamous metaplasia. The endocervical villi fuse 
producing a new flat squamous epithelium punctuated by gland 
openings and bordered by native columnar epithelium in the 
os and native squamous epithelium on the ectocervix. The 
area over which this occurs is often referred to as the 
'transformation zone', and is the area in which CIN usually 
develops.
Culture of human ecto- and endocervical epithelial cells
In order to investigate viral infection of cervical 
cells it was necessary to establish a suitable method for 
the in vitro culture of these epithelial cells. As ecto- 
and endocervical cells may vary in their susceptibility to 
herpesviruses the two different cell types were cultured 
separately. It was necessary to exercise great care during 
the dissection of the cervix to ensure that no tissue was
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FIGURE D.2 In vitro growth properties of 
ectocervical cell
Photographs of a 10 day old explant culture of 
ectocervical cells. Magnification x80 (top) and x320 
(bottom).
Arrows M Outer margin of proliferating cells 
S Sloughing of cells 
E Explant 
V Vacuolated cell
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in Methods. The growth characteristics of the ecto- and 
endocervical cells were found to differ and are described 
below.
Growth properties of ectocervical cells
The attachment of successful explants took place within 
3 to 7 days. Roughly a third of fragments did not attach 
and were removed with a pipette. From the third day onwards 
growing monolayers could be seen to surround the edges of 
the tissue fragments. The proliferating cells appeared to 
be at the outer edges of the monolayers. The ectocervical 
cells grew in a pavement-like mosaic pattern and formed 
organised monolayers with an even margin. Confluent 
monolayers covering the entire surface of a petri dish were 
obtained by seeding several explants in th-e same dish. The 
outer margins of the monolayers from each explant were 
visible even after the monolayers had coalesced. After 
about 2 weeks, the cell process, es began to overlap and 
fragments began to slough into the medium. Confluent 
monolayers could be maintained for no longer than 7-10 days 
before the monolayers started to deteriorate. For this 
reason subconfluent monolayers showing no signs of sloughing 
were preferably used in experiments.
The ectocervical cells were also examined by electron 
microscopy. The presence of desmosomes and tonofilaments 
(Figure D.3) confirmed the epithelial nature of the cells.
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FIGURE D.3 Electron microscopy of ectocervical
cells
Electron micrographs of ectocervical cells 
showing the presence of desmosomes and tonofilaments 
Magnification x45,000 (top) and x90,000 (bottom). 
Arrow indicates the location of the tonofilaments.
I thank J. Aitken for carrying out the electron 
microscopy.
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Growth properties of endocervical cells
Endocervical cells were very difficult to culture. The 
attachment of explants to the plates was often hampered by 
the large amount of muc,us produced by the endocervical 
cells. Few explants grew successfully in culture. The 
endocervical cells did not usually form regular organized 
monolayers like the ectocervical cells. The cells tended to 
grow in an irregularly whorled pattern and were relatively 
loosely attached to each other. They were mainly 
pear-shaped with the narrow end often forming a long curled 
process. Around small epithelium fragments tighter 
epithelial groups were observed (Figure D.4). Satellite 
cells/ single or in clusters were occasiionally noted.
These cells were more rounded in appearance. After about 
10-14 days in culture the endocervical cells ceased 
proliferating and started to detach from the plates.
As the explant technique did not appear to be very 
successful for culturing endocervical cells, a second 
technique employing the use of a fibroblast feeder layer was 
tried. Swiss 3T3 cells (American Type Culture Collection, 
Rockville, Maryland, USA) were Ï -irradiated with 6000 rads 
from a cobalt-60 source and seeded at a density of 2x10^ 
cells per 50mm petri dish. Fragments of endocervical 
epithelium were disaggregated into single cells by two 
trypsinization procedures each of 20 min duration. 
Approximately 10^ cells were plated out onto each feeder 
layer. Using this method small clusters of cells attached
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FIGURE D.4 In vitro growth properties of 
endocervical cells
Photographs of a small explant culture of 
endocervical cells. Magnification x80 (top) and x320 
(bottom).
Arrows E Explant
M Outer margin of proliferating cells
Infection of ectocervical cells by HCMV AD169
It is possible that fresh HCMV isolates may have 
infected ectocervical cells better than the laboratory 
strain AD169. However, in previous studies undertaken 
to characterise HCMV isolates, it was found that fresh 
isolates grew very slowly and cpe was only apparent 3 
weeks or more after infection. It is unlikely that 
ectocervical cells could be maintained for this length 
of time in culture and there was not sufficient time 
during this studentship to test a number of isolates to 
select for faster growing strains.
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to the plates but the cultures still degenerated after 10 
days. Fibroblast contamination became a problem using this 
method, whether this was due to fibroblasts that had escaped 
irradiation or arose from stromal material that had not been 
completely removed from the epithelium is open to 
speculation.
Due to the great difficulty in culturing endocervical 
cells and their limited life time in culture, these cells 
were of limited use in the following experiments.
Infection of ectocervical cells by HCMV AD169
Monolayers of ectocervical cells were infected with 
0.5, 1, 2, and 5pfu/cell of HCMV AD169 when the cell 
monolayers were about 80% confluent. The number of cells 
was estimated assuming that 5x10$ cells gave 100% coverage 
of a 35mm petri dish. The infected cells were observed over 
a period of two weeks during which time no morphological 
alterations of the cells were apparent when compared with 
uninfected cultures. The growth medium from the HCMV 
infected cultures was added to just subconfluent monolayers 
of Helu cells to assay for infectious virus. No viral cpe 
was observed in the Helu cells after 3 weeks. The HCMV 
infected ectocervical cells were scraped off the plates in 
about 400ul of PBS, sonicated and titrated on just 
subconfluent monolayers of Helu cells. Again no viral cpe 
or plaque formation was observed after 3 weeks. In case 
HCMV was present at very low titre, the titrated monolayers
156
were trypsinized and reseeded at a density of 2x10^ cells 
per 50mm petri dish. It was hoped that by reseeding the 
cells, any virus present at low titre would have a better 
chance of replicating and producing cpe. However, no 
evidence of viral infection was observed. These experiments 
suggested that either infectious HCMV is not produced in 
ectocervical cells or that the virus was present at a titre 
too low to be detected by the above methods.
Low titre virus can sometimes be detected by 
cocultivation of the infected cells with different cells 
permissive for virus replication. Infected ectocervical 
cell cultures were incubated for 10 days and then 
approximately 1x10^ Helu cells were added to the cultures. 
The Helu cells eventually overgrew the ectocervical cells 
but showed no signs of viral cpe.
Electron microscopy of HCMV infected ectocervical 
cultures did not reveal any virus particles within the 
cells. However, it should be noted that electron microscopy 
only successfully detects virus particles if a high 
proportion of the cells have been infected. It can be 
concluded from these experiments that either HCMV AD169 
cannot replicate in ectocervical cells in vitro or that the 
virus can only replicate to a very limited degree.
HCMV AD169 infected ectocervical cells were also 
studied by immunofluorescence to determine the presence of 
HCMV specific antigens. Immunofluorescence was carried out 
using both rat antiserum which would detect HCMV IE
y '
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FIGURE D.5 Infection of ectocervical cells by
HCMV ADI69
Immunofluorescence of HCMV infected (A) and mock 
infected (B) ectocervical cells. Ectocervical cells 
were infected with 2 pfu/cell of HCMV AD169 or mock 
infected with growth medium and incubated for 3 days. 
Rat antisera to HCMV AD169 IE polypeptides was used as 
the primary antibody and goat anti-rat conjugated with 
fluoroscein isothiocyanate as the secondary antibody. 
Nuclear fluorescence was observed in about 10% of the 
HCMV infected cells. Only background fluorescence was 
observed in the control mock infected cells.
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polypeptides, and human antiserum which would detect HCMV 
IE, early and late polypeptides. Nuclear fluorescence was 
observed in a small proportion (about 10%) of the cells to 
both antisera (Figure D.5). Thus a small proportion of 
ectocervical cells were presumably abortively infected with 
HCMV.
Infection of ectocervical cells by HSV-2 HG52
Subconfluent monolayers of ectocervical cells were 
infected with 0.5, 1 and 2pfu/cell of HSV-2 HG52. The 
number of cells was estimated assuming that 5x10$ cells gave 
100% coverage of a 35mm petri dish. Cell rounding was 
observed 24hr post infection. After two days the cell 
processes began to retract and the cells began to pull away 
from one another (Figure D.6A). The rounded cells then 
detached from the plate. The infected cells were scraped 
off into the medium, sonicated and lOOul aliquots titrated 
on BHK/C13 cells. The titration results are given in Table 
D,l. The HSV-2 titres obtained in ectocervical cells were 
comparable with those obtained in similarly infected 
cultures of BHK/C13 or Helu cells, indicating that the 
ectocervical cells are equally susceptible to infection by 
HSV-2 HG52. At low moi, HSV-2 produces characteristic 
plaques in ectocervical cells (Figure D.6B).
IE HSV-2 specific antigens could be detected in 
infected ectocervical cells by immunofluorescence. Both 
nuclear and cytoplasmic fluorescence were observed using rat
B’ ' • ■ ■ *
FIGURE D.6 Infection of ectocervical cells 
by HSV-2 HG52
A. Typical cpe observed in an ectocervical
expiant culture infected with 1 pfu/cell of 
HSV-2 HG52, 2 days after infection. 
Magnification x80.
B. A characteristic plaque produced after infection
of ectocervical cells with 0.1 pfu/cell of HSV-2 
HG52. Monolayer has been stained with Gierasa. 
Magnification x320.
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antisera prepared principally against the o< and A IE and 
early polypeptides of HSV-2.
Establishment of latent HSV-2 infections in cell cultures 
Herpesviruses are renowned for their ability to 
establish infections in the natural host. There is the 
possibility that herpesviruses could initiate oncogenesis 
during reactivation of latent virus rather than as a direct 
result of primary infection. HSV remains latent in 
neurological tissue. In relation to genital herpes 
infections, the potential sites of virus latency include 
sacral and lumbar dorsal root ganglia, Frankenhauser's 
sacral nerve plexus and ganglia of the pelvic autonomic 
system. HSV-2 has been reactivated from human sacral dorsal 
root ganglia (Baringer, 1974) and from human uterosacral 
ligaments (Eglin et al., 1982). There have, however, been 
no published attempts to develop an in vitro system for 
studying HSV-2 latent infections in cervical explants.
To establish a state in which infectious HSVr2 could 
not be detected, subconfluent cell monolayers were infected 
with 0.003pfu/cell and the cultures immediately incubated at 
a supraoptimal temperature of 42^C. Cultures were 
maintained at this temperature for 6 days. Experiments were 
set up using both Helu and ectocervical cells. The 
ectocervical monolayers had to be infected when they were 
about 75% confluent so that the experiments could be 
completed before the monolayers started to deteriorate.
Control uninfected Helu and ectocervical cells were maintained at 
42^C for 6 days and the infected with 0.003 pfu/cell of HSV-2 at 
"^7 C. Plaques were produced within 3 days. Virus replication was 
not therefore inhibited by heat shock proteins or other inhibitory 
effects produced in the cells at 42°C.
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Both Helu and ectocervical cells continued to grow at 42^0 
and the cell monolayers usually attained confluency before 
the end of the 42°C incubation period.
After 5-6 days at 42°c, some of the infected Helu and 
ectocervical cell cultures were assayed for the presence of 
infectious virus. The cells were scraped off into the 
growth medium, sonicated and titrated on BHK/C13 cells. No 
viral cpe or plaque formation was observed indicating that 
virus replication had probably been restricted at the 
supraoptimal temperature.
The remaining infected Helu and ectocervical cultures 
were shifted down to 37°C. HSV-2 infected Helu cells could 
be successfully maintained at 37°C for up to 2 weeks and no 
evidence of virus replication was observed during this time. 
Helu cultures infected with 0.003pfu/cell of HSV-2 HG52 but 
not incubated at 42^C, could not be maintained for longer 
than 3-4 days and viral cpe was evident within 2 days post 
infection. HSV-2 infected ectocervical cells could only be 
maintained at 2l^ C for about 7 days following incubation at 
42^0. After this time the monolayers started to deteriorate 
and cells detach from the plate. This was a function of the 
age of the ectocervical cell cultures and not cpe resulting 
from reactivated virus, as uninfected cultures deteriorated 
in a similar fashion after the same period of time. 
Ectocervical cultures infected with 0.003pfu/cell of HSV-2 
HG52 but not incubated at 42°C, showed signs of viral cpe 
within 2 days post infection and could not be maintained for
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more than 3-4 days.
These experiments showed that by incubating infected 
cultures at 42°C, it was possible to establish HSV-2 
infections during which infectious virus could not be 
detected in both Helu and ectocervical cells. Incubation of 
infected cultures at the supraoptimal temperature of 42°C 
must, therefore, result in restriction of the viral 
replicative cycle. Either the production of infectious 
virions is delayed under these conditions or the virus has 
established a latent infection in vitro. This model system 
has great potential for studying the effects of various 
stimuli that could be involved in reactivating latent viral 
infections of the cervix.
Reactivation of latent HSV-2 by HCMV AD169 and HSV 
ts mutants
The cervix is exposed to effects of natural female 
hormones, synthetic hormones such as those used in the 
contraceptive pill, sperm and various sexually transmitted 
organisms. All of these are potential stimuli for the 
reactivation of latent virus in cervical cells. The 
following experiments were carried out to determine if HCMV 
AD169 and mutants of HSV types 1 and 2 could reactivate 
HSV-2 latent in cervical cells in vitro.
Helu and ectocervical cells were infected with 
0.003pfu/cell of HSV-2, maintained at 42°C for 6 days and 
then shifted to 37*^ C as previously described. After
TABLE D.2 Reactivation of HSV—2 from a quiescent
state by HCMV AD169
Helu and ectocervical cells were infected with 
3x10^ pfu of HSV-2, incubated at 42°C for 6 days and then 
shifted to 37^C. After 3 days at 37^C, the cultures were 
infected with varying amounts of HCMV AD169 at 3 7^C and 
then maintained at 37°c for 3 days. The cells were then 
harvested, sonicated and titrated on BHK/C13 cells at 
3 7 0c to assay for the presence of reactivated virus.
M.O.I. Average yield of 
reactivated virus 
from Helu cells (pfu)
Average yield of 
reactivated virus 
from ectocervical 
cells (pfu)
0.1
0.5
1.0
5.0
Mock infected
1.2x105
4.0x105
9.4x105
4.0x104
0
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incubation of the infected cultures at 37^0 for 3 days, the 
monolayers were superinfacted with either HCMV AD169 or HSV 
ts mutants. Monolayers were super inf acted with 0.1, 0.5',
1.0 and 5.0pfu/cell of AD169 at 37^C and then maintained at 
this temperature for 3 days. Control monolayers were mock 
infected with lOOul of growth medium at 370c and maintained 
at this temperature for 3 days. The cells were then 
harvested in the medium, sonicated and titrated on BHK/C13 
cells at 37°C for 3 days to assay for infectious virus. The 
results of the titrations are given in Table D.2. The 
remaining monolayers were superinfected with 5pfu/cell of 
either tsG or ^ 1  mutants of HSV-1 and HSV-2,
respectively) at both 37<^ C and 38.5*^C and maintained at 
these temperatures for 3 days. Control monolayers were mock 
infected with lOOul of growth medium at both 37^C and 38.5°C 
and maintained at these temperatures for 3 days. The cells 
were then harvested, sonicated and titrated on BHK/C13 cells 
at both 31°C and 38.5^C for 3 days. The results of these 
titrations are given in Table D.3.
The results showed that infectious virus could be 
detected in Helu cells that had been superinfected with HCMV 
AD169 but not in ectocervical cells that had been 
superinfected with HCMV AD169. Since BHK/C13 cells are 
nonpermissive for HCMV replication, the infectious virus 
detected must have been HSV-2. No infectious virus was 
detected in either Helu or ectocervical cells that had been 
mock infected with growth medium. This suggests that
All ts mutants were checked for reversion before use.
TABLE D.3 Reactivation of HSV—2 from a quiescent 
state by ts mutants of HSV-1 and HSV-2
Helu and ectocervical cells were infected with 
3xl0^pfu of HSV-2, incubated at 4 2°C for 6 days, and then 
shifted to 37^0. After 3 days at 37^0, the cultures were 
superinfected with 5pfu/cell of either ts G or tsl at 
both 37^C and 38.5°C and maintained at these temperatures 
for 3 days. Control monolayers were mock infected with 
lOOul of growth medium at both 37°C and 38.5°C and 
maintained at these temperatures for 3 days. The cells 
were then harvested, sonicated and titrated on BHK/C13 
cells at both 31°C and 38.5^0 for 3 days.
Titre of yield after titration 
on BHK/C13 cells (pfu)
ts Superinfection
mutant Temperature
Helu cells 
38.5 0c 310C
Ectocervical cells 
38.5 0c 310C
tsG
tsG
M l
tsl
Mock
infected
38.5 0c 
37°C 
38.5 0c
370c
370c
38.5 0c
7.7xl03
1.2x104
2.6x103
1.4x105
0
0
3.2x102
3.0x102
3.0x102
2.0x102
0
0
Cells had detached from the plates during the 3 day 
superinfection period
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incubation at 42°C induced latent infection of HSV-2 and 
that HCMV AD169 is capable of reactivating latent HSV-2 in 
vitro from Relu cells. Reactivation of HSV-2 from a
quiescent state by HCMV has also been demonstrated by
or,d  ^ a n d  ^
Coleberg-Poley et al. (1979). The same researchers later
A
showed that reactivation could be attributed to an early 
HCMV function (Coleberg-Poley, et al., 1981).
Superinfection with Ipfu/cell of HCMV AD169 produced the 
greatest yield of reactivated virus. Superinfection with 
5pfu/cell of HCMV AD169 actually reduced the yield of 
reactivated virus compared with lower multiplicities of 
infection. The Helu cells were initially infected with 
SxlO^pfu of HSV-2. The yields of reactivated HSV-2 were 
10-100 fold higher than the amount of input virus, 
indicating that the virus had not only reactivated but was 
also replicating efficiently. The virus yields obtained 
after superinfection with HCMV AD169 were tenfold higher 
than those obtained after superinfection with HSV ^  
mutants.
Superinfection of HSV-2 latently infected ectocervical 
cells with HCMV AD169 did not reactivate virus. The 
experiments were repeated several times and the 
superinfected cultures maintained at 31^ C for as long as 
possible before deterioration of the monolayers occurred 
through age. No viral cpe was detected during this time. 
Some of the superinfected cultures were titrated on BHK/C13 
cells. On close examination, some parts of these monolayers
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looked as if they may have been developing syncytia. The 
titrated BHK/C13 cells were then trypsinized and reseeded in 
' 260ml tissue culture flasks. It was hoped that by reseeding
the cells thinly, any virus present would have a greater 
chance of replicating and producing cpe. However, no 
plaques developed. Approximately 1x10^ b h k /c 13 cells were 
added to the remaining superinfected ectocervical explants 
and the cultures incubated at 37^0 for as long as possible. 
No evidence of viral cpe or plaque formation was observed.
The reason for the ability of HCMV to reactivate latent 
HSV-2 from Helu cells but not from ectocervical cells may be 
related to the different nature of the cells. Ectocervical 
cells are epithelial cells whereas Helu cells are 
fibroblasts. Virus-cell interactions must be important in 
establishing and/or reactivating latent virus infections and 
will be different in fibroblasts and epithelial cells.
Infectious virus was detected in Helu cells that had 
been infected with HSV-2, incubated at 42°C for 6 days, then 
shifted to 37®C for 3 days and finally superinfected with 
mutants of HSV-1 and 2. The titrations were carried out 
using BHK/C13 cells and at both 31^C and 38.5°C.
The results of these experiments were totally 
unexpected. Higher titres of virus should have been 
detected at 31^C and not at 3B.50C, since both 
mutants and wild type HSV-2 can replicate at 31°C 
whereas only wild type HSV-2 can replicate at 38.5t>c.
Despite these results, the experiments suggest that
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incubation at 42°C induced latent infection of HSV-2 and 
that HSV ^  mutants are capable of reactivating latent 
HSV-2 in vitro from Helu cells.
After superinfection of HSV-2 latently infected 
ectocervical cells, the cells detached from the plates 
within 3 days. Since repeated attempts to detect infectious 
virus in these cultures by titration on BHK/C13 cells 
yielded negative results, it was assumed that the inoculum 
of superinfecting virus was cytotoxic to the ectocervical 
cells. Unfortunately, due to the difficulty in obtaining 
suitable cervical tissue for these experiments at this time, 
it was not possible to repeat the experiments using a lower 
superinfecting inoculum.
Attempts to reactivate latent HSV-2 by hormone treatment
The following experiments were carried out to 
investigate the potential of the female hormones oestrogen 
and progesterone, and the synthetic steroid dexamethasone to 
reactivate latent HSV-2.
Helu cells were infected with 0.003pfu/cell of HSV-2, 
incubated at 42°c for 6 days and then shifted to 31^ C as 
previously described. After the cultures had been incubated
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at 37®C for 3 days, the medium was replaced with fresh 
medium containing hormone-free foetal calf serum. The 
hormones were removed from the foetal calf serum by treating 
the serum with charcoal, pelleting the charcoal and filter 
sterilizing. The cultures were incubated at 37°C for 24hr 
after which time the medium was replaced with fresh medium 
containing lO”"^ and 10~^M concentrations of either 
oestrogen, progesterone or dexamethasone. 10"^M represented 
the normal physiological concentration of hormone in the 
body. The cultures were assayed for reactivated virus after 
3 days at 37^C. No infectious virus was detected in any of 
the hormone treated cultures. Control monolayers were 
either mock infected with lOOul of growth medium or 
superinfected with Ipfu/cell of HCMV AD169. No infectious 
virus was detected in the mock infected cultures. 
Approximately lO^pfu of infectious virus was detected in the 
culture superinfected with HCMV AD169, indicating that HSV-2 
was present in the monolayers in a quiescent state and could 
be reactivated by HCMV. The experiments were repeated and 
the cultures assayed for the presence of infectious virus 
after 7 and 14 days. Again no evidence of viral cpe or of 
plaque formation was observed. Unfortunately, insufficient 
cervical cells were obtained during the period in which 
these studies were undertaken to repeat the experiment to 
determine if hormone treatment can reactivate HSV-2 latent 
in ectocervical cells.
DISCUSSION
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An infectious agent is identified as the causative 
agent of a disease if it fulfils the following criteria;
1. The agent can be regularly isolated from the 
disease.
2. It independently causes the disease.
3. Vaccination against the infectious agent 
prevents the disease.
However, in the case of an oncogenic virus, these 
criteria cannot always be assessed, particularly since 
malignant diseases tend to be of a multifactorial 
nature. Thus, a different set of parameters need to be 
used to define the role of an oncogenic virus in causing 
a malignant disease. Firstly, it is necessary to . 
investigate the epidemiological evidence for an 
association of the virus with the disease. This 
involves both the detection of antibodies to the virus 
in the sera of patients with the disease, and the 
detection of virus-coded information such as DNA, RNA 
and proteins, within the diseased tissue. The ability 
of the virus to induce oncogenic changes within the 
cells needs to be investigated in vitro using a model 
transformation system and also in vivo using an animal 
model. This thesis describes work undertaken to 
investigate the possible role of HCMV in the development 
of CIN, the precursor stage to invasive carcinoma of the 
cervix.
Although some seroepidemiological studies have
167
revealed the presence of antibodies to HCMV in patients 
(os preukoosly dvsc-ossed on.cJ cif&cl cy\ pCfO-c^)^ 
with CIN and cervical carcinoma^ prior to this thesis,
only one molecular epidemiological study had been
carried out. This study, detected HCMV DNA in cervical
carcinoma specimens from some geographical regions but
made no investigation of CIN tissue^. It was therefore
decided to investigate the association of HCMV with CIN
by analysing CIN tissue from patients in the West of
Scotland for HCMV DNA sequences by Southern blot
analysis. Since HPV and HSV-2 have also been implicated
in the development of cervical neoplasia, the same CIN
specimens were analysed for HPV and HSV-2 DNA sequences.
Various in vitro transformation systems have been 
described for HCMV but as yet the mechanism of 
transformation remains unknown. In this thesis two 
different in vitro transformation systems were 
investigated as potential models for studying the 
mechanism of transformation by HCMV. These were, 
transfection of cells with the HCMV AD169 Hindlll-E 
fragment using the calcium phosphate transfection 
technique, and infection of RE cells with UV-inactivated 
HCMV. Cell transformation was not accomplished using 
the Hindlll E fragment but treatment of RE cells with 
UV-inactivated virus proved to be a successful and 
reproducible transformation system. This system was 
then used to try and identify a possible mechanism of 
transformation by HCMV.
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Although the model system described is useful for 
investigating transformation and tumourigenesis by HCMV, 
it does not simulate the environmental conditions to 
which the virus would be exposed within the cervix. The 
rat embryo cells employed in the in vitro transformation 
system aire fibroblasts whereas the cells exposed to 
viral infection in the cervix are epithelial in nature. 
These two different cell types may in their
susceptibility to viral infection and the course of 
infection may be slightly different in cervical cells 
and important in inducing neoplastic change. It was 
therefore considered necessary to investigate the 
interaction of HCMV with the target cervical cells in 
vitro. Cervical cells were grown from explants of 
cervical epithelium obtained from hysterectomy specimens 
and were infected with HCMV or HSV-2. The cellular 
alterations induced by viral infection and the 
production of infectious virus and viral antigens in the 
cells were investigated. The ability of HSV-2 to , 
establish latent infections in the cervical cells was 
also studied and experiments were carried out to 
determine if HCMV or steroid hormones could function as 
reactivating agents.
Unfortunately, time did not permit an 
investigation of the association of HCMV with the 
development of CIN using an animal model. It would have 
been interesting to treat the cervices of experimental
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mice with formalin - inactivated or UV-inactivated HCMV 
to see if prolonged exposure to inactivated virus could 
induce premalignant and malignant lesions, as has 
already been done with HSV-2 (Wentz et al., 1981).
The results of the experiments presented in this 
thesis are summarized and discussed on the following 
pages.
TRANSFORMATION STUDIES
Transformation of RE cells by UV-irradiated HCMV 
proved to be a successful and reproducible model system 
for in vitro transformation. Three types of transformed 
cells were observed in treated cultures. Different 
regions of the HCMV genome may have been responsible for 
initiating the different types of transformed cells.
This transformation system has also been used 
successfully in the past within this Institute. A 
former student, Ann Bunce, established a number of cell 
lines from the foci of cells transformed by 
UV-irradiated HCMV AD169 and from tumours induced in 
rats after inoculation with HCMV transformed cells.
These transformed and tumour cell lines were analysed 
for the presence of HCMV DNA sequences to try to 
elucidate a mechanism of transformation by HCMV. HCMV 
specific DNA sequences could not be detected in any of 
the HCMV transformed or tumour cell lines examined by
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Southern blot analysis at a level of sensitivity that 
could detect 1 copy/cell of viral DNA within cellular 
DNA. Only a very small sequence of viral DNA may have 
been retained in low copy number in the transformed 
cells. The Southern blot technique would not be 
sufficiently sensitive to detect such small amounts of 
DNA. Alternatively the retention of viral DNA in the 
cell may be transient and only necessary to initiate the 
transformation event.
Experiments showed that the DNA from a rat tumour 
induced by the inoculation of HCMV transformed cells 
contained a transforming gene that could be transfected 
and could initiate tumour formation in athymic nude 
mice. Since reasonably low levels of viral DNA could 
not be detected within the original transformed cells, 
the transfected gene was probably of cellular origin. 
Further experiments suggested that the transfected gene 
may be an activated ras gene, although additional 
verification of these experiments is necessary as has 
been previously explained. These experiments raise the 
possibility that HCMV may initiate transformation by 
activating a cellular oncogene. This would seem a 
reasonable proposal since HCMV does influence the 
expression of cellular genes in infected cells causing 
an increase in the synthesis of cellular DNA, RNA 
proteins and enzymes. The possible mechanisms of 
transformation by HCMV will be discussed later.
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Repeated attempts to transform 3T3 cells with the 
Hindlll E fragment of HCMV AD169 were unsuccessful in 
these experiments. This may have been partly due to 
technical difficulties involved with the calcium 
phosphate transfection technique. In the transfection 
experiments, lOug of cloned HCMV DNA were used. Cells 
take up only a small amount of exogenous DNA on 
transfection. On reflection, it may have been better to 
have purified the HCMV Hindlll E fragment from vector 
sequences prior to transfection so that what DNA was 
taken up by the cell contained HCMV and not plasmid 
vector sequences. The Hindlll E fragment is also quite 
large (~' 20kb) and transfection may have been more 
successful using a smaller fragment containing the 
transforming sequence such as the BamHI P fragment.
Other factors affecting transformation may have been 
differences in the cells and growth medium. 
Unfortunately, it was not possible to obtain the 
original NIH 3T3 cells used by Nelson et al. (1982) in 
their pioneering studies. Nelson et al. (1982) used 
Hyclone serum from Utah whereas the foetal calf serum 
used in the growth medium in these experiments was 
purchased from Gibco Laboratories, Paisley, Scotland. 
Differences in foetal calf serum have been found to 
affect the efficiency of transfection (J. Nelson, 
personal communication).
In the original transfection studies by Nelson et
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al. (1982), anchorage independent growth was used as the 
criterion for transformation. It is possible that the 
HCMV AD169 genome contains two transforming regions, one 
responsible for morphological transformation and one for 
inducing anchorage independent growth. The gene coding 
for morphological transformation may not lie within the 
HCMV AD169 Hindlll E fragment. This would explain why 
morphological transformation of different cell types 
could not be obtained using the Hindlll E fragment. 
Transformation of RE cells by UV-irradiated HCMV was 
possible because all regions of the viral DNA were 
present. However, it is difficult to explain why the 
Hindlll E fragment did not induce anchorage independent 
growth of transfected cells. Methylcellulose was used 
by Nelson et al. (1982) to assay for anchorage 
independent growth whereas soft agar was used in these 
experiments. The selective efficiency of these media is 
usually comparable but it may have been worthwhile 
repeating the transfections and assaying for anchorage 
independence by growth in methylcellulose.
POSSIBLE MECHANISMS OF TRANSFORMATION BY HCMV
HCMV may transform cells by a number of 
mechanisms. For example, HCMV may activate a cellular 
proto-oncogene. Activation could be accomplished by 
promoter or enhancer insertion or by the integration of
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an insertion sequence (IS)-like structure into the host 
cell DNA. In some human cancers activation of a 
cellular proto-oncogene has been associated with 
specific chromosomal aberrations and gene 
rearrangements. In addition cellular genes can be 
transactivated by some viral gene products. Other 
possible mechanisms of transformation include 
mutagenesis and changes in the DNA méthylation pattern 
within cells. These mechanisms are discussed on the 
following pages.
Activation of a cellular proto-oncogene by promoter or 
enhancer insertion
Activation of a cellular proto-oncogene by 
promoter insertion was initially proposed to explain the 
induction of B-cell lymphomas by avian leukosis viruses 
(ALV's). These retroviruses induce bursal lymphomas in 
infected birds only after a latent period of 4-12 
months. Integration of an ALV provirus into the host 
DNA results in the viral coding sequence being flanked 
by two long terminal repeats (LTRs). The LTR contains a 
putative promoter sequence (Ju and Skalka, 1980). 
Initiation of normal viral RNA synthesis occurs within 
the left LTR but because this sequence is repeated at 
the right end of the provirus, initiation could also 
occur within the right LTR. The 'promoter insertion' 
theory predicts that the provirus integrates adjacent to
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a cellular proto-oncogene and that transcription is 
initiated from the viral promoter within the LTR 
generating hybrid RNA molecules containing both cellular 
and viral sequences (Neel et al., 1981). Such tumour 
specific RNAs can be detected in ALV-induced lymphomas 
and are expressed at high levels (Neel et al., 1981; 
Payne et al., 1981). Hayward et al. (1981) provided 
strong evidence that in about 85% of lymphomas the c-myc 
gene has been activated. The resultant enhanced 
expression of this cellular gene has presumably le d to 
neoplastic transformation. Integration of the provirus 
at a site which could activate the c-myc gene is 
presumably a rare event, since integration is known to 
occur at multiple sites in the host genome.
In ALV-induced lymphomas in which the provirus has 
been integrated upstream of the c-myc gene in the same 
orientation as c-myc, the upstream 5' LTR has been 
deleted from the provirus. Cullen et al. (1984) have 
presented evidence that viral mRNA transcription from 
the left LTR extending into the downstream LTR of a 
provirus-like construct restricts the ability of this 
LTR to function as an efficient promoter. They suggest 
that spontaneous deletion of the upstream left LTR may 
be necessary to allow c-myc transcription promoted by 
the remaining right LTR to increase to levels sufficient 
to cause malignant transformation.
Oncogenesis by slow transforming retroviruses
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cannot always be explained by the hypothesis that a 
cellular proto-oncogene is activated by promoter 
insertion. For example, in a small number of 
ALV-induced B lymphomas, the provirus has been found to 
be integrated downstream of the c-myc gene but in the 
same orientation or upstream of the c-myc gene in the 
opposite orientation (Payne et al., 1982). These two 
alternative configurations do not allow the direct use 
of the LTR as the promoter for c-myc expression as 
predicted by the promoter insertion model. Similarly, 
in murine T cell lymphomas induced by murine leukaemia 
viruses, the retroviral inserts are not aligned in a 
manner compatible with activation of c-myc by promoter 
insertion (Corcoran et al., 1984). The avian 
retroviruses, Rous sarcoma virus (RSV), Rous associated 
viruses (RAVs) and the endogenous RAV-0 all have 
functional LTR promoter elements but RSV and RAV are 
oncogenic in chickens but RAV-0 is not. RAV-0 does, 
however, lack the LTR enhancer elements (Weber and 
Schaffner, 1985). The above mentioned workers propose 
that oncogenesis by these retroviruses is a function of 
activation of a cellular proto-oncogene by enhancer 
insertion. Because enhancers are able to stimulate a 
nearby gene from a 5' or a 3' position, in either 
orientation and over relatively large distances, they 
have all the properties required to explain the 
activation of a cellular proto-oncogene by LTR enhancer
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sequences.
Very strong promoter and enhancer sequences are 
located upstream from the transcription initiation site 
of the major IE gene of HCMV (Akrigg et al., 1985; 
Boshart et al., 1985; Stinski and Roehr, 1985). The 
HCMV enhancer is of particular interest because it seems 
to have little cell type or species preference and is 
3-5 fold more active than the SV40 enhancer (Boshart et 
al., 1985). It has been shown to enhance transcription 
of the rabbit yg globin gene (Boshart et al., 1985) and 
does, therefore, have the ability to enhance 
transcription of cellular as well as viral genes. Both 
the HCMV promoter and enhancer are contained within the 
Hindlll E fragment of HCMV AD169. The IE promoter is 
about 509 bp and the enhancer about 406 bp (although 
smaller sequences retain enhancer activity). It is 
possible that either of these sequences may become 
inserted into cellular DNA within the transformed cells 
but such small sequences could not be detected by 
Southern blot analysis with the size of probe used in 
this study. In addition, such sequences may only be 
required to initiate some cellular transcription event 
and may not then be continuously required. In such a 
case detection of this sequence would be purely 
fortuitous.
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Activation of a cellular proto-oncogene by an 
IS-like element
The possible involvement of an IS-like element in 
the activation of a cellular proto—oncogene was first 
described in a mouse myeloma (Rechavi et al., 1982) in 
which the 5' end of the cellular c-mos gene had been 
substituted by a segment of DNA from the LTR of the 
intercisternal A particle gene (Kuff et al., 1983). 
Contained within the inserted fragment were sequences 
that could be drawn as a stem-loop structure flanked by 
direct repeats ie an IS-like element. DNA sequence 
analysis of the HCMV transforming fragment of AD169 
identified by Nelson et al. (1982) has shown that the 
sequence can form an IS-like structure (Galloway et al. 
(1984). Whether this HCMV fragment is active in DNA 
transposition and can thus activate a cellular 
proto-oncogene remains to be seen. The mechanism of 
activation of a cellular proto-oncogene by an IS-like 
element is not known. The element could initiate 
transcription of the cellular proto-oncogene by 
introducing a strong promoter. Alternatively, it may 
modify the chromatin structure at the insertion site 
which could create a putative promoter within the 
adjacent cellular proto-oncogene available for 
transcription. The potential for an IS-like element to 
be involved in the initiation of transformation is not 
limited to activating the expression of a cellular
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proto-oncogene. The IS-like element could act as a 
mutagen by integrating into, and perhaps excising 
imprecisely from, cellular genes at random. Further 
investigations are necessary to determine if the IS-like 
element of HCMV can mediate cell transformation and the 
precise mechanism involved.
Activation of a cellular proto-oncogene by gene
rearrangements■
Activation of a cellular proto-oncogene may also
be accomplished by chromosomal rearrangements that bring
the proto-oncogene under the control of a new promoter.
In some Burkitt lymphomas, the c-myc gene has been
translocated from its normal position on chromosome 8 to
the immunoglobulin heavy chain locus on chromosome 14
(Taub et al., 1982). In Burkitt lymphomas carrying the
translocation 2;8, the c-myc gene remains on chromosome
8 but the immunoglobulin light chain locus on chromosome
2 is translocated to a region distal to the c-myc gene
(Erikson et al., 1983). Enhancer elements have been
found within the immunoglobulin genes (Boss, 1983) and
may be responsible for the increased expression of
c-myc. Since many patients with Burkitt lymphomas have
ar>cl egy D N A  Kas b<2en m'ilnese 4"U,YioJrs
high antibody titres to EBV^ EBV has also been
implicated in the development of these tumours.
Possibly EBV is involved in initiating the translocation
event.
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Consistent chromosomal abnormalities, particularly 
translocations, inversions or deletions are frequently 
observed in the malignant cells of a number of human 
cancers and leukaemias. In many cases a cellular 
proto-oncogene has been located at the chromosomal bands 
that are involved in the translocations or deletions 
(reviewed by Rowley, 1983). For example, the 
proto-oncogenes c-mos and c-abl have been located at the 
breakpoint in the 8;21 and 9;22 translocations 
associated with acute myeloblastic leukaemia and chronic 
myelogenous leukaemia, respectively. The 
proto-oncogenes c-ras^ and c-myb have been localised in 
the regions of the chromosomes involved in the deletions 
associated with Wilm's aniridia and acute lymphoblastic 
leukaemia, respectively. However, none of these 
malignancies have been linked to infection by a specific 
virus.
Lüleci et al. (1980) have reported chromosomal 
abnormalities in HCMV infected Helu cells. Chromosomes 
2, 3, 4 and 21 appeared to show more anomalies than the
other chromosomes. The number of anomalies was not 
proportional to the length of the chromosomes. Analysis 
of the rat embryo cell lines transformed by HCMV in this 
laboratory has shown that chromosomal alterations rarely 
involve changes in chromosome number and that 
abnormalities are common in chromosomes 1 and 3 (J.C.M. 
Macnab, personal communication). Changes in chromosomes
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1 and 3 are frequently involved in rat transformed cell 
lines and may be species dependent. It is not known 
whether selective chromosomal damage induced by HCMV is 
.important in the oncogenicity of the virus.
Transactivation
Another possible mechanism involved in 
transformation is transactivation of the cellular genes 
important in growth control by proteins encoded by 
viruses. The adenovirus Ela protein and 180,000 dalton 
IE protein of pseudorabies virus (PRV) can both induce 
transcription of early adenovirus genes (Jones and 
Shenk, 1979; Feldman et al., 1982) and various cellular 
genes including human (Green et al., 1983) and rabbit 
(Svensson and Akusjarvi, 1984) y6-globin and rat 
preproinsulin 1 (Gaynor et al., 1984), when these genes 
are newly introduced into cells by DNA transfection or 
infection in a virus particle. The Ela protein can also 
transactivate the heat shock protein 70 (hsp 70) 
cellular promoter (Nevins, 1982). The function of the 
hsp 70 gene product is unknown, but is presumably 
important in the cell since the protein is highly 
conserved between bacteria and eukaryotic organisms.
This cellular protein may be involved in cellular 
transformation since hsp 70, expression appears to be 
elevated in several transformed cell lines. The IE gene 
products of HSV can also transactivate genes. The
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Vmwl'7 5 protein encoded by the IE gene 3 of HSV-1 is 
capable of transactivating the HSV-1 viral glycoprotein 
D promoter and the rabbit y8-globin promoter (Everett, 
1983; 1984) and is able to complement adenovirus Ela 
mutants. In none of the above cases can the regulation 
of transactivation be attributed to recognition of a 
specific sequence within the promoter regions. The 
mechanism of transactivation remains obscure. It is 
possible that the transactivating proteins recognise DNA 
which is not highly organised into chromatin and either 
modify its structure so that it becomes readily 
accessible for transcription or transport it to 
particular active regions of the nucleus.
Evidence is now accumulating that the IE gene 
proteins of HCMV also have the ability to transactivate 
gene expression. Like the herpesviruses PRV and HSV, 
HCMV AD169 can transactivate transcription of early 
adenovirus genes and complement an Ad5 Ela mutant for 
lytic growth (Tevethia and Spector, 1984). Everett and 
Dunlop (1984) have shown that HCMV AD169 can 
transactivate transcription from both the HSV-1 
glycoprotein D and rabbit^ -globin promoters. Stinski 
and Roehr (1985) and Spaete and Mocarski (1985) have 
also reported the presence of transacting components in 
the promoter regulatory region of the major IE gene of 
HCMV Towne strain. HCMV has, therefore, potential for 
upregulating the expression of cellular genes by
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transactivation and the large increase in host cell DNA 
synthesis on infection could be at least partly due to 
transactivation of cellular genes. Transactivation 
could result in transformation if the upregulated genes 
were important in growth control.
Mutagenesis
Gene mutations are commonly induced by ionizing 
radiations and chemical carcinogens. The primary 
mutagenic effect produced by UV-irradiation is thymidine 
dimerization which causes distortion of the DNA helix 
and therefore interferes with normal replication. 
Acridine dyes appear to cause mutations by inserting 
between two neighbouring purine bases in a single DNA 
strand resulting in insertion or deletion of a single 
nucleotide during replication. Base analogues such as 
bromodeoxyuridine and 2-aminopurine, alkylating agents, 
nitrous acid and hydroxylamine all induce transition 
mutations in which pairing errors arise through the 
transition of the pairing relationship of one purine 
base into the pairing form of another purine or of one 
pyrimidine into that of another pyrimidine. The pairing 
errors are copied during DNA replication, resulting in 
point mutation of a gene. Many investigators believe 
that if viruses are involved in the development of 
certain human malignancies, they initiate tumourigenesis 
by mutagenizing cells in a manner similar to that of
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chemical carcinogens. HSV-1 has been shown to have 
mutagenic activity (Schlehofer and zur Hausen, 1982). 
Possibly a viral replicative product has mutagenic 
properties. Prime candidates include the viral encoded 
alkaline exonuclease, DNA polymerase, ribonucleotide 
reductase or thymidine kinase. Such a mechanism of 
transformation need not involve the retention of viral 
DNA sequences. It has not yet been shown whether HCMV 
can induce mutations within the host cell genome.
Mutagenic agents have been found to induce DNA 
repair mechanisms in treated cells. Such repair 
mechanisms include photoreactivation, excision repair, 
and postreplication repair. Studies have shown that 
mutagens can enhance the survival of UV-irradiated 
viruses in treated cells (Sarasin and Hanawalt, 1978; 
Lytle et al., 1978). HCMV has been found to have a 
similar effect since Nishiyama and Rapp (1980) reported 
that infection of primary rat kidney cells and Vero 
cells with HCMV enhanced survival of UV-irradiated HSV. 
The enhancement process was found to be sensitive to 
caffeine and since caffeine is known to inhibit certain 
repair processes in mammalian cells, it was proposed 
that HCMV may induce a DNA repair pathway in host cells. 
Further investigations showed that HCMV enhanced DNA 
repair capacity in the host cells without producing 
detectable lesions in the cellular DNA and without 
inhibiting DNA synthesis (Nishiyama and Rapp, 1981).
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The results of the study suggested that HCMV induced a 
postreplicative DNA repair mechanism in the cells.
Based on the repair system in bacteria, it has been 
hypothesised that postreplication repair is an 
error-prone process leading to the production of somatic 
mutations and as a result cancer (Lehman, 1974).
However, Nishiyama and Rapp (1981) reported that the 
repair system induced by HCMV appeared to be error proof 
for UV-damaged HSV DNA when tested with HSV thymidine 
kinase-negative mutants. Unless HCMV induces 
error-prone pathways for host cell DNA repair, it would 
seem unlikely that HCMV causes cellular mutations by the 
induction of DNA repair mechanisms in cells.
THE DETECTION OF VIRAL DNA WITHIN CIN TISSUE
Forty three CIN biopsies from patients in the West 
of Scotland were analysed for the presence of HCMV, HPV 
and HSV-2 DNA sequences. Two biopsies, C2 and C17,, were 
found to contain DNA sequences that hybridized to the 
HCMV Hindlll E fragment of AD169. In C17, these 
sequences were present at about 0.1 copies/cell and 
therefore in an amount too low to permit detailed 
analysis of the hybridizable sequences. In C2, the 
hybridizable DNA sequences were present at about 20 
copies/cell. Further analysis showed that the C2 DNA 
contained BamHI fragments that comigrated with the Bam
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HI, W, P, c and e fragments of HCMV AD169. In addition, 
two other Bam HI fragments were detected in C2 that 
hybridized to the HCMV AD169 Hindlll E fragment. One 
was of a higher MW and the other of a lower MW than the 
BamHI E fragment of HCMV AD169. These additional bands 
may consitute rearranged viral sequences or fragments of 
viral DNA present in a chimeric form with cellular DNA. 
The hybridizable DNA sequences probably represent viral 
sequences that have been retained after an HCMV 
infection and have become integrated into the cellular 
DNA and thus may have been responsible for initiating 
the development of CIN in this patient. A  ^ library of 
the C2 DNA was prepared in an attempt to isolate clones 
containing these viral sequences. This would have 
permitted a more detailed analysis of the sequences 
present. The results of the cloning experiments were 
very disappointing. Two clones were isolated that 
contained C2 DNA sequences that hybridized to the HCMV 
AD169 Hindlll E fragment. However, after a few rounds 
of replication, the purified plaques no longer contained 
inserts that hybridized to the HCMV probe. The possible 
explanations for this were discussed previously in 
Section C. It is possible to re-screen the plaque 
stocks prepared when the positive clones were originally 
isolated from the library (ie stocks 1 and 2) and to try 
to purify the positive clones once again. It may be 
beneficial to plate out the clones on a BBL agar base in
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a BBL trypticase-based top agar to increase the plaque 
size. This would facilitate the purification procedure. 
Unfortunately, it was not possible to repeat the 
procedure within the time allocated for this MRC 
studentship.
DNA sequences that hybridized to the HPV 11 and 
H \
HSV-2 Bamt probes were detected in GIN tissue. GIN 
biopsies G13 and G19 were found to contain sequences 
that hybridized specifically to HPV DNA. However, the 
remaining sequences detected represented cellular 
sequences that were homologous to pBR322 or pAT vector 
sequences present in the probe, as has previously been 
explained. This stresses the importance of purifying 
the viral DNA from vector sequences before using it as a 
probe in hybridization reactions involving cellular DNA.
HPV types 6, 11, 16 and 18 have all been 
implicated in the development of cervical carcinoma.
The type of papillomavirus DNA detected in GIN and 
carcinomatous tissue is subject to geographical 
variation. HPV 11 DNA is frequently detected in GIN and 
carcinomatous tissue from patients in Australia (S. 
Gampo, personal communication) whereas HPV 16 is more 
frequently detected in tissue from patients in the USA 
(Prakash et al., 1985; Grum et al., 1984), Germany 
(Dürst et al., 1985) and the West of Scotland and 
Northern England (J. Murdoch and J.G.M. Macnab, 
unpublished results). HPV 11 only shares approximately
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59% homology with HPV 16 (Dartmann et al., submitted for 
publication). Under the conditions of stringency used 
in this thesis, HPV 16 DNA would not have been detected 
in the GIN biopsies analysed using the HPVll DNA probe. 
It would have been interesting to probe the GIN biopsies 
with HPV 16 DNA. Unfortunately, it was not worthwhile 
reprobing the Southern transfers of the GIN DNAs 
prepared in this study because the level of sensitivity 
decreased after each wash and was not high enough to 
detect low copy numbers of viral DNA. Apart from the 
fact that there was insufficient time, there was not 
sufficient DNA to make new transfers of GIN DNA to probe 
with HPV 16 DNA.
HPV sequences have also been detected in normal 
cervical tissue (J. Murdoch and J.G.M. Macnab, personal 
communication). The presence of HGMV, HPV or HSV-2 DNA 
sequences in normal cervical tissue could not be 
investigated because normal cervical biopsy material was 
not available from the patients included in this study.
Past investigators have detected HSV-2 DNA in 
invasive cervical cancer tissue but at a low frequency. 
HSV-2 DNA sequences have been detected by Southern blot 
hybridization in 3 of 9 tumours (Galloway and McDougall, 
1983), 1 of 8 tumours (Park et al., 1983) and 2 of 13 
tumours (Prakash et al., 1985). In the study by Prakash 
et al. (1985) HSV-2 DNA could not be detected in the 9 
GIN biopsy specimens analysed. The absence of HSV-2 DNA
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sequences in the GIN biopsies analysed in this study 
does not therefore come as a surprise.
THE INFEGTION OF GERVIGAL GELLS BY HERPESVIRUSES
The studies described in Section D demonstrated 
that cervical cells differed in their susceptibility to 
herpesvirus infection. Ectocervical cells were found to 
be fully permissive for HSV-2 replication but not for 
HGMV replication. No infectious virus could be detected 
in HGMV infected ectocervical cell cultures and 
HGMV-specific antigens could only be demonstrated in a 
small proportion of the infected cells. Thus, HGMV can 
only replicate to a limited degree within these cells. 
Stinski et al. (1981) have proposed that nonpermissive 
cells may favour latency of the viral genome. As 
ectocervical cells appear to be nonpermissive for HGMV 
replication, they may therefore be potential sites for 
latent HGMV infection. In cases where GIN arises within 
the squamous epithelium of the cervix, latent rather 
than productive HGMV infection may be involved.
Endocervical cells have been reported to be fully 
permissive for HGMV replication (Vesterinen et al.,
1975) but nonpermissive for HSV-2 replication 
(Vesterinen, 1976) . It was not possible to successfully 
investigate herpesvirus infection of endocervical cells 
in these studies due to the difficulties involved in
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establishing cultures of endocervical cells.
These studies have shown that the course of viral 
infection is determined by the nature of the host cell. 
Fibroblasts are usually employed for investigating in 
vitro viral transformation. As the cells involved in 
the development of GIN are epithelial in nature, such 
model systems are not suitable for investigating the 
potential of a virus to induce cervical neoplasia.
These experiments must be done using cervical cells.
REAGTIVATION OF LATENT HSV-2 BY HGMV AND ts 
MUTANTS OF HSV
By incubating infected cultures at 42°G it was 
possible to establish HSV-2 infections during which 
infectious virus could not be detected in Helu
(fibroblast) ar ectocervical (epithelial) cells. 
However, infectious virus could be detected in Helu, but 
not ectocervical cells, if the 42°G treated HSV-2 . 
infected cultures were superinfected with HGMV or 
mutants of HSV. The results from Helu cells suggest 
that HSV-2 established latent infections within the 
cells at 42°G and that HGMV and the HSV ^  mutants 
reactivated the latent virus. Latent infection did not 
appear to permanently affect HSV-2 replicative functions 
since the virus was found to replicate efficiently after 
reactivation. presumably a viral gene product or
190
cellular factor induced on superinfection was 
responsible for reactivating latent HSV-2. Reactivation 
of HSV-2 from a quiescent state by HGMV was previously 
demonstrated by Goleberg-Poley et al. (1981) and was 
attributed to an early HGMV function. Everett and 
Dunlop (1984) have reported that HGMV can transactivate 
transcription from the HSV-1 glycoprotein D promoter. 
During latent infection, the production of infectious 
virus may be prevented by a block on transcription of 
early genes. It is a possibility that an IE or early 
gene product of HGMV can transactivate transcription 
from an early HSV-2 promoter blocked during latent 
infection, resulting in reactivation of latent virus.
The ability of HGMV to reactivate HSV-2
from Helu (fibroblast) but not from ectocervical 
(epithelial) cells may be related to the fact that 
ectocervical cells are not fully permissive for HGMV 
replication. The HGMV gene product responsible for 
reactivation may not be produced in nonpermissive cells 
where HGMV replication is blocked at an early stage. 
Alternatively, HGMV infection of permissive cells may 
induce the production of a host cell factor which is 
responsible for reactivation. This host factor may not 
be induced in cells nonpermissive for HGMV replication. 
Everett and Dunlop (1984) reported that HGMV did not 
appear to induce glycoprotein D transcription in HeLa 
cells which are not fully permissive for HGMV
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replication. This raises the possibility that 
transactivation may be involved in reactivation of 
latent HSV-2 and emphasises again the importance of the 
cell type in determining which viral functions are 
expressed. The processes involved in the reactivation 
of latent HSV-2 from ectocervical cells may be different 
to those involved in virus reactivation from Helu cells 
and different stimuli may be required.
HORMONE - VIRUS INTERACTIONS
Cervical cells are continually exposed to various 
secretions and hormones in vivo and these will probably 
influence viral infection of the cells. Experiments 
were carried out to determine whether various hormones 
could reactivate latent HSV-2 from Helu cells. Neither 
oestrogen, progesterone or the synthetic steroid 
dexamethasone could reactivate latent HSV-2 at the 
physiological concentration of 10“^M or at the higher 
concentration of 10”'^ M. Unfortunately, lack of cervical 
tissue at this time made it impossible to repeat the 
experiments using ectocervical cells. HSV-2 latent in 
ectocervical cells may respond to different stimuli from 
HSV-2 latent in Helu cells. Helu cells have not been 
shown to possess any oestrogen or progesterone receptors 
so the hormones may not have been able to exert their 
effects and produce the physiological changes necessary
192
for virus reactivation. Ectocervical cells on the other 
hand do possess oestrogen and progesterone receptors and 
may therefore respond to the effects of the hormones and 
result in virus reactivation. It would be worthwhile 
repeating the experiments using MCF7 cells (a breast 
cancer epithelial cell line expressing oestrogen 
receptors) or some other cell line that is known to 
possess oestrogen and progesterone receptors. It would 
also be interesting to see if hormones present in the 
growth medium can affect the titre of HSV-2 reactivated 
from latently infected cells by HCMV and mutants of 
HSV.
Some hormones have been shown to enhance virus 
replication. For example, the replication of polyoma 
virus and HCMV in vitro is greatly enhanced by 
dexamethasone and cortisol but not by oestradiol or 
progesterone (Morhenn et al., 1973; Tanaka et al.,
1984a, 1984b; Koment, 1985). A few studies have 
suggested that progesterone increases the incidence of 
HSV-2 genital infections in mice (Munoz, 1973; Nishiura 
and Nii, 1976; Baker and Plotkin, 1978; Baker et al.,
1980). How the hormones increase viral replication is 
unknown. They may facilitate viral infection by 
inducing proliferation of cells permissive for viral 
replication or by suppressing the immune system. 
Alternatively, they may have a direct effect on viral 
transcription or translation. For example.
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transcription from a unique site within the mouse 
mammary tumour virus left hand LTR has been found to be 
regulated by glucocorticoids (Ucker et al., 1983). 
Hormonal enhancement of viral replication may contribute 
to the development of CIN if the virus has oncogenic 
potential in the host. If the virus is capable of 
initiating oncogenesis, hormonal enhancement of viral 
replication would increase the probability of the 
initiation event occurring.
HORMONES AS COFACTORS IN THE DEVELOPMENT OF CIN
Hormones may function as cofactors in the 
development of CIN through their ability to stimulate 
proliferation of cells. Hormones influence the normal 
repair processes of reepithelialization within the 
cervix. Oestrogens specifically stimulate proliferation 
of the stratified squamous epithelium of the ectocervix 
and progestogens stimulate the columnar epithelium and 
underlying reserve cells of the endocervix. When a 
lesion develops in the external surface of the cervix, 
under oestrogenic stimulation it becomes 
reepithelialized mainly by the stratified squamous 
epithelium producing regenerative epithelium. Under 
progestogenic stimulation, the lesion is repaired by 
proliferation of the reserve cells beneath the 
endocervix resulting in reserve cell hyperplasia which
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then undergoes maturation through the process of 
squamous metaplasia. The last stage of the healing 
process is normally signalled by the appearance of a 
so-called third mucosa. In a small p'ercentage of cases, 
however, reepithelialization does not proceed smoothly 
to normal maturation of the overgrowing epithelium and 
is instead followed by the development of precancerous 
lesions of various grades. In these cases, the original 
lesion may have been exposed to the effects of viral 
infections and sperm proteins which could have initiated 
oncogenesis within the cervical cells. During the 
repair processes, these initiated cells may have been 
induced to proliferate by specific hormones resulting in 
the development of cervical dysplasia. From the 
appearance of the various forms of intraepithélial 
neoplasia, it is possible to determine the cells from 
which they originated. For example, dysplasias and CIS 
of the squamous type develop from regenerative 
epithelium derived from the stratified squamous 
epithelium of the ectocervix. On the other hand, mucoid 
dysplasias and CIS of the reserve cell type develop on 
the basis of reserve cell hyperplasia.
THE POSSIBLE ROLE OF HCMV IN THE DEVELOPMENT OF CIN
The development of a fully malignant tumour 
involves complex interactions between several factors.
195
both exogenous (ie. environmental) and endogenous (ie 
genetic, hormonal etc). Tumourigenesis is a multistep 
process but for convenience it is often considered to 
occur in three stages, initiation, promotion and 
progression. Initiation requires only a single exposure 
to a carcinogen and appears to involve genomic changes 
(eg gene mutation, rearrangement and/or amplification). 
Promotion involves multiple exposures to agents that do 
not usually damage DNA directly. Progression involves 
the conversion of tumours from benign to malignant and 
can be considered an open-ended process since tumours 
may continue to increase in their degree of malignancy 
and heterogeneity. CIN probably represents the 
progressive stage in the development of invasive 
carcinoma of the cervix. A number of factors have been 
implicated in the development of cervical neoplastic 
disease including viruses (HPV, HSV-2 and HCMV), sperm 
proteins (Reid, 1964), hormones, (Dallenbach-Hellweg,
1981), the contraceptive pill (Vessey et al., 1980) and 
smoking (Harris et al., 1983). Because of the 
multifactorial nature of tumourigenesis, it is probable 
that all of these factors play a role at some stage in 
the development of this disease.
The role of HCMV in the development of CIN is 
speculative. Although HCMV was only detected in 2 of 43 
CIN biopsies, the work presented in this thesis suggests 
that where the virus is present it may have a role in
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the development of CIN. Analysis of the viral DNA 
retained in the CIN tissue showed that it originated 
from the HindiII E region of HCMV genome and may 
therefore contain the HCMV promoter and/or enhancer 
sequences. It is possible that integration of these 
sequences into the cellular DNA initiated oncogenesis by 
activating a cellular proto-oncogene. This raises the 
problem of how the HCMV DNA became integrated into the 
cellular DNA as integration has not been reported to be 
a normal event during HCMV replication. Gadler and 
Wahren (1983) presented evidence to suggest that HCMV 
DNA integrates or becomes closely associated with a 
subset of cellular DNA during latent infection. Could 
latent HCMV infection of the cervix be involved in the 
development of CIN? Ectocervical cells may be potential 
sites for latent HCMV infection as has already been 
discussed. Initiation of the events leading to 
oncogenesis may occur during virus reactivation when 
part of the viral genome is still integrated in the 
cellular DNA. A number of factors could be responsible 
for reactivating latent HCMV. It is well documented 
that HCMV is reactivated during pregnancy (Montgomery 
et al., 1972). In addition, squamous metaplasia and 
reepithelialization and repair processes occurring 
within the cervix may bring about the physiological 
changes within the cervical cells necessary for virus 
reactivation. All the above mentioned processes are
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influenced by hormones. Possibly other factors such as 
sperm proteins, smoking and the contraceptive pill may 
cause physiological changes in the cervical cells and 
lead to virus reactivation.
Alternatively, HCMV may function as a promoter or 
cofactor in the development of CIN. The consequences of 
an initiation event do not become apparent until the 
initiated cells have replicated. Influences which 
stimulate cell proliferation in tissues containing 
initiated cells often have promoter or cocarcinogenic 
action. HCMV stimulates the synthesis of cellular DNA 
within infected cells and thus has the potential to act 
as a cocarcinogen in tumour development. It has 
recently been shown that the tumour promoter 
12-0-tetradecanoylphorbol-13-acetate (TPA) induces 
transformation of mouse epidermal preneoplastic cells by 
inducing transcription of a gene not normally 
transcribed in these cells (Lerman et al., 1984). HCMV 
could act in a similar fashion to TPA in the development 
of cervical disease.
HCMV may also interact with other viruses. For 
example, the papillomaviruses are known to initiate the 
formation of papillomas but these do not progress to 
malignant tumours unless they are exposed to a promoter. 
In the case of tumours induced by BPV, the promoting 
agent is quercetin (a chemical present in bracken 
leaves). HPV8 causes skin lesions which tend to become
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malignant in the skin areas exposed to sunlight. In 
this case UV is thought to be the promoting agent. 
Similarly, HPV may initiate oncogenesis of cervical 
cells and HCMV act as a promoter in the development of 
cervical neoplasia. HCMV may induce a cellular factor 
that acts as a tumour promoter or an HCMV encoded early 
gene product may itself have potential as a promoting 
agent. HCMV IE gene products have been shown to have 
the ability to transactivate cellular and viral genes as 
previously described. Possibly HCMV early gene products 
can function in trans to stimulate transcription from 
other viral genes involved in tumourigenesis.
Lastly, HCMV may contribute to the development of 
CIN by changing the méthylation pattern of cervical 
cells. Some, but not all, oncogenically transformed 
cells have been found to be hypomethylated relative to 
their normal counterparts. Alterations in DNA 
méthylation of genes have also been reported in some 
human cancers, for example in colon cancers (Feinberg et 
al., 1984). DNA méthylation is thought to be an 
important element in the regulation of gene expression 
(Felsenfield and McGhee, 1982). Changes in the 
méthylation pattern of cells by HCMV may alter 
transcription of cellular genes important in growth 
control and lead to cell transformation and 
tumourigenesis.
FUTURE PROSPECTS
Preliminary investigations with HCMV transformed 
and tumour cells have suggested that HCMV may initiate 
cell transformation by activating a cellular 
proto—oncogene. Identification of the putative cellular 
oncogene activated in HCMV transformed and tumour cells 
would provide strong evidence for this mechanism. The 
activated oncogene could be identified by Southern blot 
analysis of the HCMV transformed and tumour cell DNAs 
using various cloned v-onc probes. The next step would 
then be to try and identify the mechanism of oncogene 
activation. An interesting experiment would be to 
transfect a plasmid containing the HCMV HindiII E 
fragment into Helu cells together with a plasmid 
containing the putative c-onc gene and then assaying for 
transcription of the gene. This would help to determine 
if transactivation was involved in oncogenesis by HCMV. 
It would also be interesting to investigate the 
mutagenic potential of HCMV. For example, the ability 
of UV-irradiated HCMV to induce resistance to 
8-azaguanine of infected cells indicating a mutation in 
the hypoxanthine-guanine-phosphoribosyltransferase gene 
could be investigated in vitro, as previously described 
for HSV-1 by Schlehofer and zur Hausen (1982).
The experiments described in this thesis have 
suggested that HCMV may be involved in the development 
of CIN. However, it must be stressed that
tumourigenesis is a multifactorial, multigenic process 
and HCMV will not be the only factor involved. Further 
investigations are, however, necessary to provide 
stronger evidence for an association of HCMV with CIN. 
It would be useful to determine if HCMV-specific RNA is 
present within CIN tissue and hence determine if HCMV 
DNA has been transcribed in neoplastic cells. It may 
also prove interesting to screen the DNA from other CIN 
biopsies for activated oncogenes. It would be very 
worthwhile to try again to purify the C2 clones that 
hybridized to HCMV DNA sequences. Such clones could 
provide valuable clues as to the possible role of HCMV 
in the development of CIN in this patient. Sequence 
analysis of the HCMV DNA retained in this CIN would 
determine if HCMV promoter, enhancer or IS-like 
sequences may have been involved in initiating 
neoplasia. The cloned C2 viral sequences could also be 
used in transfection experiments with other 
plasmid-borne genes to determine if the retained viral 
sequences have transactivating ability.
There is the possibility that the mechanism 
involved in the transformation of RE cells by 
UV-irradiated HCMV may be different to that involved in 
the development of CIN. It would be ideal if cervical 
cells could be used in in vitro transformation studies 
with HCMV, but unfortunately the limited lifespan of 
these cells precludes their use in long term 
experiments. However, it is important to further
investigate the infection of cervical cells by 
herpesviruses. The in vitro experiments described in 
this thesis for establishing latent HSV-2 infection in 
cervical cells provide a suitable system for 
investigating the interaction between different viruses 
and between hormones and viruses, as well as latency. 
Further experiments could be undertaken to determine the 
state of the viral genome during latency and to compare 
the DNA restriction profiles of reactivated virus with 
those of wild type virus, to see if any rearrangement of 
viral sequences occurred during latency. The 
reactivation of latent HSV-2 by HCMV could be further 
investigated by identifying the region of the HCMV 
genome involved in reactivation. Reactivation studies 
using UV-irradiated HCMV would determine if early 
functions are involved. However, precise identification 
of the viral genes involved would be difficult since 
HCMV mutants are unstable. It would also be 
interesting to investigate reactivation of latent HSV-2 
by HCMV in a variety of cell lines to establish whether 
the infected cell must be permissive for HCMV 
replication before reactivation can occur. It was 
suggested in this study that transactivation may be 
involved in reactivation. This could be further 
investigated by carrying out experiments to see if IE 
HCMV gene products can transactivate the HSV-1 
glycoprotein D promoter in ectocervical cells. It was 
found in this study that hormones could not reactivate
latent HSV-2 from Helu cells. However, the mechanism of 
reactivation may be different in Helu and ectocervical 
cells so it would be useful to see if latent HSV-2 can 
be reactivated by female hormones from ectocervical 
cells or from HeLa or MCF7 cells which contain female 
hormone receptors.
Lastly, it is essential to investigate the 
association of HCMV infection with the development of 
CIN in an animal model. This could be done by treating 
the cervices of experimental mice with 
formalin-inactivated or UV-inactivated HCMV to see if 
prolonged exposure to inactivated virus can induce 
premalignant and malignant cervical lesions. This was 
carried out successfully using HSV-2 by Wentz et al. 
(1981) .
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1ABSTRACT
Punch biopsies were taken from patients with cervical 
intraepithélial neoplasia and the DNA was extracted and examined for 
sequences which hybridized to human cytomegalovirus DNA by Southern 
blotting analysis. Two biopsies out of forty three were found to 
contain DNA which hybridized to human cytomegalovirus DNA. In one 
biopsy, DNA sequences were detected which contained four restriction 
sites colinear with those of the prototype strain AD169. Evidence of 
rearranged viral DNA sequences was also found.
2INTRODUCTION
Several epidemiological studies (Rawls et al., 1968; Nahmias et 
al., 1970) and molecular studies (Eglin et al., 1981; Park et al.,
1983; Macnab et al., 1985; Galloway and MacDougall, 1983) have linked 
cervical neoplastic disease to infection by herpes simplex virus (HSV) 
type 2. Although most studies reveal an association between HSV 
infection and cervical neoplasia, in some geographical areas such an 
association is not observed and not all women with cervical neoplasia 
have serologic evidence of past HSV infection (Vonka et al., 1984). 
These factors indicate a possible multifactorial etiology of cervical 
neoplasia and recently it has been suggested that HSV-2 may interact 
as a cocarcinogen with other agents that infect the cervix (zur 
Hausen, 1982). Human papillomaviruses (HPV) have been strongly 
implicated in cervical neoplasia. HPV DNA has been detected in DNA 
from biopsies of both cervical intraepithélial neoplasia (CIN) and 
invasive carcinomas (Gissmann et al., 1983; McCance et al., 1983;
Dürst et al., 1983, 1985; and Prakash et al., 1985). Human 
cytomegalovirus is another infectious agent with carcinogenic 
potential and epidemiologic features compatible with cervical 
neoplasia as described below.
HCMV frequently infects the cervix, has been demonstrated in the 
uterus, prostate and semen and can be sexually transmitted. The virus 
has been isolated from the genital tract and urine of sexual partners 
(Chandler et al. personal communication; Chretien et al., 1977) and 
has been identified as a common cause of cervicitis and urethritis 
following sexual transmission (Evans, 1976). It has even been 
isolated more frequently than HSV-2 from women attending one venereal 
disease clinic (Jordan et al., 1973). Like HSV-2, HCMV possesses 
oncogenic potential. Primary rat embryo cells have been transformed 
with UV-irradiated HCMV AD169 and these transformed cells are
3lourigenic when inoculated into Hooded Lister rats (our unpublished 
F&ata). These results support the earlier observations by Albrecht and 
Rapp, 1973 Rapp et al., 1975; Geder et al., 1976; and Nelson et al., 
1982. In a study by Melnick et al. (1978) HCMV was isolated from two 
cell cultures derived from cervical biopsies of patients with advanced 
carcinoma. Surprisingly, few studies have investigated the possible 
association between HCMV and cervical neoplasia. The few 
seroepidemiological studies that have been done have yielded 
controversial results. Vestergaard et al. (1972) reported 
significantly higher levels of complement fixing antibodies to HCMV in 
patients with cervical carcinoma compared to matched controls and 
Pacsa et al. (1975) detected complement fixing antibodies to HCMV more 
frequently in the sera of women with atypia than in women with 
cervical disorders other than atypia or healthy controls. Stoian pt 
al. (1982) also reported a higher incidence of complement fixing
antibodies to HCMV in patients with breast, cervical and ovarian 
neoplasms. In contrast to these studies, other groups have been 
unable to correlate elevated antibody levels to HCMV with cervical 
neoplasia (Fucillo et al., 1971; Sprecher-Goldberger et al., 1971; 
Kumar et al., 1980; Hart et al., 1982; Best et al. personal 
communication).
Possibly becuase of the general low correlation between the 
presence of HCMV antibodies and cervical neoplasia, little attention 
has been given to the detection of HCMV-specific nucleic acids in 
cervical preneoplastic tissue. To our knowledge there has only been 
one such study in which HCMV DNA was detected in both normal and 
neoplastic cervical tissue by DNA-DNA reassociation kinetic analysis 
(Huang et al., 1983). The results were, however, subject to 
geographical variation. We report below the presence of sequences 
that hybridize to HCMV DNA in 2 of 43 punch biopsies analysed from 
patients with CIN in the West of Scotland; these patients had all bet
ed to a colposcopy clinic in the Western Infirmary, Glasgow, 
abnormal cervical cytology observed on examination of cervical 
imears.
5MATERIALS AND METHODS
Preparation of virus and viral DNA
Plaque-purified HCMV strain AD169 (supplied by Dr. J.D. Oram, 
PHLS, Porton Down, Salisbury) was propagated in Flow 2002 human foetal 
lung cells infected at a m.o.i. of 0 .Olpfu/cell. The supernatent was 
collected daily from day 7 to day 11 post infection and titrated 
according to the method of Wentworth and French (1970). To extract 
the viral DNA, the cell debris was removed from the medium by 
centrifugation at 2K and the virus pelleted at 13K for 90 min; the 
pellet was resuspended in TNE (0.05M Tris. HCl pH7.4, 0.005M EDTA, 
0.15M NaCl) and treated with DNase (50ug/ml) for 30 min in the 
presence of lOmM MgCl2; EDTA was then added to a final concentration 
of 50mM and the virus repelleted, resuspended in TNE plus 0.2% SDS and 
digested overnight with proteinase K (200ug/ml). The nucleic acids 
were extracted with phenol and chloroform and then digested with 
RNaseA (lOOug/ml) in O.OIM Tris. HCl pH7.5 O.OOIM EDTA and O.OIM NaCl. 
The DNA was subsequently re-extracted with phenol and chlorofom, 
dialysed extensively against O.lxSSC (IxSSC is 0.015M sodium citrate 
plus 0.15M NaCl) ethanol precipitated and finally resuspended in O.OIM 
Tris. HCl pH7.5 and O.OOIM EDTA.
Preparation of cell and CIN DNA
Control DNA was prepared from cervical tissue of routine 
hysterectomy specimens from five women with no evidence or history of 
neoplastic disease. We did not obtain ethical approval to take normal 
cervical samples from the same patients. In a future study this 
control and also more biopsy samples from patients with no evidence of 
cervical disease would be obtained.
CIN DNA was extracted from punch biopsy specimens taken from 
patients attending a colposcopy clinic at the Western Infirmary,
Fsgow. All specimens were kept on ice and the DNA extracted within 
hrs. DNA was prepared as previously described by Varmus et al. 
(1973) and Park et al. (1983).
7>ned restriction DNA fragments used as probes
The cloned restriction fragments used as probes were kindly- 
supplied by Dr. J.D. Oram, PHLS, Porton Down, Salisbury (Figure 1). 
Hindlll restriction framgments of HCMV AD169 DNA has been cloned into 
the Hindlll site of pAT153 and propagated in E .coli strain HBlOl (J.D. 
Oram et al., 1982). HB3 contained a Hindlll/BamHl subfragment of the 
Hindlll E fragment containing the transforming region identified by 
Nelson et al. (1982) cloned into the BamHl site of pAT153. Plasmid 
propagation and purification were carried out as previously described 
by Davison and Wilkie (1983). Before use as probes, all the cloned 
HCMV DNA sequences were excised from vector sequences and purified 
twice by agarose gel electrophoresis; Rigorous purification was 
necessary to eliminate the possibility of vector sequences hybridizing 
to some human CIN DNAs.
Southern blot hybridization
High molecular weight DNA extracted from CIN or control tissue 
was digested with an excess of either Hindlll or BamHI enzyme using 
the buffer conditions recommended by the suppliers. The products of 
digestion were fractionated by electophoresis through 0.6% agarose 
gels and transferred to either Biodyne (Pall) or Gene screen plus (New 
England Nuclear) nylon filters using the procedure of Southern (1975) 
HCMV DNA fragments were labelled in vitro with [ ot.-32p]dCTP and [ (>~ ~ 
32p]dGTP by nick translation (Rigby et al., 1977) to specific 
activities of 1-5x10^ cpm/ug DNA. Probes were denatured by boiling 
for 15 min in 0.2M NaOH and hybridized overnight at 70bc in 6xSSC,
0.5% SDS, 0.02% ficol, 0.02% polyvinylpyrrolidone, 0.02% bovine serum 
albumin and 50ug/ml denatured salmon sperm DNA. Gene screen plus 
filters were washed twice in 2xSSC for 5 min at room temperature, 
twice in 2xSSC, 1% SDS for 30 min at 70oc and then twice in O.lxSSC, 
for 30 min at room temperature. Biodyne filters were washed at 70°c
:hree 30 min stepwise decreasing washes of SSC from 3 x to 0.1. 
fe filters were exposed for autoradiography with Dupont Lighting plus 
intensifier screens to X-Omat (Kodak) film for 2-9 days.
9RESULTS
Tnalysis of CIN DNA for HCMV-related sequences
Hybridization of the HindiIl/BamHI subclone HB3 of HCMV Hindlll 
E AD169 to CIN DNAs digested with Hindlll enzyme revealed that 2 
biopsies, C2 and C17, contain sequences that hybridize to this probe 
(Figure 2a,b). By comparison with the reconstruction tracks, the 
•hybridizable DNA sequences were present at about 20 copies per cell in 
C2 and at less than 0.1 copy per cell in C17. All other CIN biopsies 
were negative for hybridization at levels of sensitivity which would 
detect 0.2 copies per cell of HCMV DNA restriction fragment.
Analysis of the sequence arrangement in C2 and Cl7
C2 and C17 CIN DNAs were analysed further by digestion with 
BamHI and hybridization to the Hindlll E fragment. The Hindlll E 
fragment hybridizes to five Bam HI fragments E, W, P, c and e of the 
AD169 genome. The Hindlll E probe hybridized to DNA sequences in C2 
that comigrated with BamHI fragments W, P, c and e (Figure 3) and also 
to two additional fragments, one of a higher molecular weight and one 
of a lower molecular weight than the BamHI E fragment of AD169. This 
may reflect rearrangement of viral DNA sequences within the CIN DNA
and also loss of restriction sites.
BamHI digestion of C17 CIN DNA and hybridization to Hindlll E 
resulted in very faint hybridization to a band colinear with the BamHI 
W fragment indicating that the C17 DNA does share restriction sites 
with AD169. We conclude that BamHI digestion of C17 DNA either 
cleaved the hybridizable DNA into some fragments too small to be 
successfully detected with the Hindlll E probe or else that not all
the fragments present in virion DNA were equally represented in this
viral insert in CIN17.
As there was the possibility that the C2 CIN biopsy had been
fected in vivo by an isolate of HCMV, we hybridized the BamHI 
.gested C2 DNA to Hindlll fragments encompassing the entire AD169 
genome. No hybridization was obtained to any other regions of the 
HCMV genome (results not shown). Had the biopsy been infected with 
HCMV, other regions of the genome would have been represented in 
equimolar amounts in the sample. Furthermore, antibodies to HCMV 
could not be detected in the sera of the patient from whom the C2 
biopsy had been taken. It would thus seem unlikely that the 
hybridization to the Hindlll E fragment represented a current 
infection of the C2 cervical biopsy with HCMV.
DISCUSSION
We have detected sequences that hybridize specifically to HCMV 
DNA in two out of 43 CIN biopsies analysed. Both positive CIN 
biopsies contained sequences that hybridized to the Hindlll E fragment 
of HCMV AD169. In one CIN biopsy (C2) these hybridizable sequences 
were present at about 20 copies per cell and shared several 
characteristic restriction sites with the prototype AD169. There was 
also evidence of hybridization which we interpret to be rearrangement 
of viral sequences having led to loss of restriction sites. The 
hybridizable DNA in the second CIN biopsy (C17) was not present in 
sufficient copy number to determine the sequence arrangement. The 
detected HCMV DNA sequences are thought to represent viral sequences 
that have been retained after an HCMV infection by integrating into 
the cellular DNA and information in these sequences may be responsible 
for initiating the development of CIN in these two patients.
The role of HCMV in the development of CIN is speculative 
although molecular evidence of the persistence of HCMV DNA sequences 
in some cases of CIN is compelling. Analysis of the viral DNA 
retained in the CIN tissue showed that it originated from the Hindlll 
E region of the HCMV AD169 genome. This very region of the viral 
genome contains a DNA sequence which when transfected into NIH 3T3 
cells, can initiate colony formation in methyl cellulose and 
tumourigenicity in nude mice (Nelson et al., 1982). It is possible 
that integration of this transforming region into the cellular DNA of 
this CIN patient (C2) initiated the development of neoplasia. There 
is no evidence that the transforming region of HCMV codes for a viral 
transforming protein or that it shares homology with any of the known 
retroviral oncogenes (Kouzarides et al., 1983; Nelson et al. , 1984).
The transforming region does, however, contain an insertion sequence 
like structure which could initiate transformation either by
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ivating a cellular proto-oncogene, or through mutagenic action by 
Phonspecifically integrating into, and perhaps excising imprecisely 
from, cellular genes at random (Galloway et al., 1984).
In addition to the transforming region, the Hindlll E fragment 
of the HCMV genome contains both the regulatory promoter and enhancer 
sequences of the major IE gene (Akrigg et al., 1985; Boshart et al., 
1985). The hybridization results have shown that DNA corresponding to 
this region of the AD169 genome appears to be rearranged within the C2 
DNA. This could have occurred when the viral DNA became integrated 
into the cellular DNA in this patient. The rearrangements may not 
have occurred within the promoter or enhancer sequences but in the 
intervening sequences. A A library of the C2 DNA has been constructed 
and clones that hybridize to the HCMV Hindlll E fragment are currently 
being identified. Sequence analysis of these clones will determine 
the nature of the DNA rearrangement observed and whether HCMV promoter 
or enhancer sequences are present.
If the C2 DNA contains the HCMV promoter or enhancer sequences 
then their integration could have activated a cellular proto-oncogene 
and initiated cervical neoplasia. Activation of a proto-oncogene by 
promoter insertion was first proposed by Neel et al. (1981) to explain
the induction of bursal lymphomas by avian leukosis virus. Activation 
by enhancer insertion was proposed to explain the induction of tumours 
by slow tranforming retroviruses in which the integration of 
the retroviral proviruses is not compatible with the promoteer 
insertion model (Payne et al., 1982). Because enhancers are able to 
stimulate the transcription of a gene from a 5' or a 3' position in 
either orientation and over relatively large distances, the enhancer 
sequences can insert into the cell DNA at random and still activate a 
cellular proto-oncogene.
Tumourigenesis is a multifactorial and probably a multigenic 
process. Clearly HCMV is not the only factor involved in the
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relopment of CIN and invasive carcinoma of the cervix. Other 
factors implicated in the development of the disease include HSV-2, 
HPV, sperm proteins (Reid, 1964), the contraceptive pill (Vessey e;t 
al., 1983) and smoking (Harris et al., 1983). Cervical carcinoma or 
CIN may arise by different mechanisms determined by the agents to 
which the patient has previously been exposed. In some pateints HCMV 
may function as a promoter of cocarcinogen rather than as an initiator 
in the development of CIN. For example, HCMV is known to stimulate 
host cell macromolecular synthesis (St Joer et al., 1984; Tanaka et
al., 1985). The virus may therefore induce the proliferation of
already initiated cells and hence contribute to the development of 
neoplasia. Cell proliferation may also facilitate secondary infection 
of cervical cells with HSV-2 or HPV and these viruses could either 
initiate transformation or be involved at certain differentiation 
stages leading to carcinogenesis. We have screened the C2 and Cl7 
biopsies for HSV-2 and HPVll DNA sequences. No HSV-2 or HPVll DNA 
could be detected in either of these biopsies. In other patients 
factors other than HCMV may be involved.
Cervical neoplasia is regarded as the end result of a complex
chain of events probably involving a number of enviornmental agents.
This study provides evidence that HCMV may play a role in the 
development of CIN, the precursor stage to cervical carcinoma.
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FIGURE LEGENDS
Figure 1
Diagram of the HCMV AD169 genome showing the location of the 
cloned restriction fragments used as probes in blot hybridizations. 
Solid boxes represent terminal and internal repeat sequences which 
bind the long (L) and short (S) unique components of the genome. 
Nomenclature taken from J.D. Oram et al. (1982). All cloned HCMV DNA 
sequences were excised from vector sequences and purified twice by 
agarose gel electrophoresis prior to labelling in vitro with [o.- 
-32p[cTP and [ck -32p]GTP to specific activities of l-5xlO®cpm/ug DNA 
by nick translation (Rigby et al., 1977).
\ tirons. A. . lA îlotS
Figure 2
Detection of fragments of HCMV DNA in DNA from CIN biopsies 
(nos. 1,2,16,17,20,24,25,27). From each CIN punch biopsy 20ug of high 
molecular weight DNA were digested with an excess of Hindlll, 
fractionated through 0.6% agarose gels, transferred to either Biodyne 
Pall (a) or Gene screen plus NEN (b) membranes by the procedure of 
Southern (1975) and hybridized to a 32p-labelled HB3 probe excised 
from vector sequences. Blots were exposed for autoradiography with 
Dupont Lighting plus intensifier screens for 2 (a) and 9 (b) days. 
Lanes RE and NC are control tracks containing 20ug of Hindlll digested 
rat embryo and normal cervix DNA respectively. Lanes Rc.2, Rcl and 
Rc5 contain reconstructions of .2 copy (0.148ng) 1 copy (0.74ng) and 5 
copies (3.7ng) respectively of HCMV AD169 DNA plus 20ug of rat embryo 
DNA digested together with Hindlll. pAT represents a control 
reconstruction containing 5 copies per cell of cloned vector DNA plus 
20ug of rat embryo DNA. The HB3 probe hybridized to DNA sequences 
present in C2 and C17 DNA. Size markers are given in kilobase pairs.
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[ure 3
Detection of fragments of DNA containing HCMV DNA sequences 
following cleavage of C2 DNA with BamHI. 20ug of C2 DNA were digested 
with an excess of BamHI, fractionated through a 0.6% agarose gel, 
transferred to Gene screen plus membrane and hybridized to a 
32p-labelled HCMV ADI69 Hindlll E probe. Lanes RE and NC are control 
tracks containing 20ug of BamHI digested rat embyro and normal cervix 
DNA respectively. Reconstruction tracks with 0.2 (Rc.2) 1 (Rcl) and 5 
copies of HCMV AD169 (Rc5) are included on the blot. The Hindlll E 
probe hybridizes to five HCMV AD169 DNA fragments generated after 
BamHI digestion. The probe hybridized to viral DNA sequences in C2 
which are co-linear with the BamHI fragments W, P, c and e and also to 
two additional bands which probably represent viral sequences present 
in a rearranged form and in which some restriction sites are possibly 
deleted.
REFERENCES
AKRIGG, A., G.W.G. WILKINSON, and J.D. QRAM. 1985. The structure 
of the immediate early gene of human cytomegalovirus strain 
AD169. Virus Research 2^107-121.
ALBRECHT, T., AND F . Rapp. 1973. Malignant transformation of 
hamster embyo fibroblasts following exposure to 
ultraviolet-irradiated human cytomegalovirus. Virology 
55:53-61.
BOSHART, M., F. WEBER, G. JAHN, K. DORSCH-HASLER, B.
FLECKENSTEIN, and W. SCHAFFNER. 1985. A very strong enhancer 
is located upstream of an immediate early gene of human 
cytomegalovirus. Cell 41: 521-530.
BOSHART, M., L. GISSMAN, H. IKENBERG, A. KLEIN HEINZ, W.
SCHLEURLEN, and H. ZUR HAUSEN. 1984. A new type of papilloma 
virus DNA, its presence in genital cancer biopsies and in cell 
lines derived from cervical cancer. EMBO Journal ^:1151-1157.
CHRETIEN, J.H., C.G. MCGINNIS, and A. MULLER. 1977. Venereal 
causes of cytomegalovirus mononucleosis. J. Am. Med. Assoc. 
238:1644-1645.
DAVISON, A.J., and N.M. WILKIE. 1981. Nucleotide sequences of the
joint between the L and S segments of herpes simplex virus
types 1 and 2. J. Gen. Virol. 55:315-331.
DURST, M., L. GISSMANN, H. IKENBERG, and H. ZUR HAUSEN. 1983. A
papillomavirus DNA from a cervical carcinoma and its
prevalence in cancer biopsy samples from different geographic 
regions. Proc. Natl. Acad. Sci. U.S.A. 80:3812-3815.
DURST, M., A. KLEINHEINZ, M. HOTZ, and L. GISSMANN. 1985. The 
physical state of human papillomavirus type 16 DNA in benign 
and malignant genital tumours. J. Gen. Virol. 66:1515-1522.
EGLIN, R.P., F. SHARP, A.B. MACLEAN, J.C.M. MACNAB, J.B.
CLEMENTS, and N.M. WILKIE. 1981. Detection of RNA 
complementary to herpes simplex virus DNA in human cervical 
squamous cell neoplasms. Cancer Research 41:3597-3603.
EVANS, T.N. 1976. Sexually transmissable diseases. American J. 
Obstet. Gynecol. 125:116-133.
FUCILLO, D.A., J.L. SEVER, F.L. MODER, T.-C. CHEN, L.W. CATALANO, 
and L.D. JOHNSON. 1971. Cytomegalovirus antibody in patients 
with carcinoma of the uterine cervix. Obstet. Gynecol. 
38:599-601.
GALLOWAY, D.A., and J.K. MCDOUGALL. 1983. The oncogenic potential 
of HSV: evidence for a 'hit and run' mechanism. Nature 
302:21-24.
GEDER, L., R.N. LAUSCH, F.J. O ’NEILL, and F . RAPP. 1976.
Oncogenic transformation of human embryo lung dells by human 
cytomegalovirus. Science 192 :1134-1137.
GISSMANN, L., L. WUOLNICK, H. IKENBERG, U. KOLDOVSKY, H.G.
SCHNURCH, and H. ZUR HAUSEN. 1983. Human papillomavirus types
6 and 11 DNA sequences in genital and laryngeal papillomas and 
in some cervical cancers. Proc. Natl. Acad. Sci. U.S.A. 
80:560-563.
HARRIS, R.W.C., L.A. BRINTON, R.H. COWDELL, D.C.G. SKEGG, P.G. 
SMITH, M.P. VESSEY, and R. DOLL. 1980. Characteristics of 
women with dysplasia and carcinoma in situ of the cervix 
uteri. Br. J. Cancer 42 ; 359-369.
HART, H. , A. SPRINGBETT, and M. NORVAL. 1982. Lack of association 
of cytomegalovirus antibody level with carcinoma of the 
uterine cervix. Gynecol. Obstet. Invest. 14 ; 300-308.
HUANG, E.-S., I. BOLDOGH, and E.C. MAR. 1983. Viruses associated 
with human cancer. L.A. Phillips (Ed) Marcel Dekker Inc. N.Y. 
pp 161-194.
JORDAN, M.C., W.E. ROUSSEAU, G.R. NOBLE, J.A. STEWART, and T.D.Y. 
CHIN. 1973. Association of cervical cytomegalovirus with 
venereal disease. New Engl. J. Med. 288 ; 932-934.
KOUZARIDES, T., BANKIER, A.T. and BARRELL, B.G. (1983).
Nucleotide sequence of the transforming region of human 
cytomegalovirus. Molecular Biology and Medicine ]^, 47-58.
KUMAR, A., M.S. SELIM, D.L. MADDEN, W.C. WALLEN, H.H. VASQUEZ, 
and G.A. NANKERVIS. 1980. Humoral-and cell-mediated immune 
responses to herpesvirus antigens in patients with cervical 
carcinoma. Gynecol. Oncol. 10 :18-25.
MACNAB, J.C.M., M. PARK, I.R. CAMERON, H.C. KITCHENER, S.A.
WALKINSHAW, J. McLAUCHLAN, M.-J. DAVISON, J.W. CORDINER, J.B. 
CLEMENTS, and J.H. SUBAK-SHARPE. 1985. Possibilities and 
consequences of virus detection in patients with CIN and 
Cancer. In Cancer Campaign, Vol. 8, Cancer of the Uterine 
cervix, pp 151-160. E. Grundmann (Ed). Gustav Fischer Verlag, 
Stuttgart, New York.
MCCANCE, D.J., P.G. WALKER, J.L. DYSON, D.V. COLEMAN, and A.
SINGER. 1983. Presence of human papillomavirus DNA sequences 
in cervical intraepithélial neoplasia. Brit. Med. J. 
287:784-788.
MELNICK, J.L., R. LEWIS, I. WIMBERLY, R.H. KAUFMAN, AND E. ADAM. 
1978. Association of cytomegalovirus (CMV) infection with 
cervical cancer; Isolation of CMV from cell cultures derived 
from cervical biopsy. Intervirology 10:115-119.
NAHMIAS, A.J., W.E. JOSEY, L.M. NAIB, C.F. LUCE, and B. GUEST. 
1970. Antibodies to herpesvirus hominis types 1 and 2 in 
humans. II. Women with cervical cancer. Am. J. Epidemiol. 
91:547-552.
NEEL, B.G., HAYWARD, W.S., ROBINSON, H.L., FANG, J. and ASTRIN, 
S.M. (1981). Avian leukosis virus-induced tumours have common 
proviral integration sites and synthesize discrete new RNAs: 
Oncogenesis by promoter insertion. Cell 23 :323-334.
NELSON, J.A., B. FLECKENSTEIN, D.A. GALLOWAY, and J.K. MCDOUGALL. 
1982. Transformation of NIH3T3 cells with cloned fragments of 
human cytomegalovirus strain AD169. J. Virol. 43:83-91.
ijSON, J.A., FLECKENSTEIN, B. , JAHN, G. , GALLOWAY, D.A. and 
McDOUGALL, J.K. (1984). Structure of the transforming region 
of human cytomegalovirus strain AD169. J. Virol. 49, 109-115.
ORAM, J.D., R.G. DOWNING, A. AKRIGG, A.A. DOLLERY, C.J. DUGGLEBY, 
G.W.G. WILKINSON, and P.J. GREENAWAY. 1982. Use of recombinant 
plasmids to investigate the structure of the human 
cytomegalovirus genome. J. Gen. Virol. 59:111-129.
PACSA, A.S., L. KUMMERLANDER, B. PEJTSIK, and K. PALI. 1975.
Herpesvirus antibodies and antigens in patients with cervical 
anaplasia and in controls. J. Natl. Cancer Inst. 55:775-781.
PARK, M., H.K. KITCHENER, and J.C.M. MACNAB. 1983. Detection of 
herpes simplex virus type 2 DNA restriction fragments in human 
cervical carcinoma tissue. EMBO Journal _2:1029-1034.
PAYNE, G., BISHOP, J.M. and VARMUS, H.E. (1982). Multiple
arrangements of viral DNA and an activated host oncogene in 
bursal lymphomas. Nature 295, 209-214.
RAPP, F., L. GEDER, D. MURASKO, R. LAUSCH, R. LADDA, E.-S. HUANG, 
and M. WEBER. 1975. Long term persistence of cytomegalovirus 
genome in cultured human cells of prostatic origin. J. Virol. 
16^982-990.
RAWLS, W.E., W.H.F. TOMPKINS, M.E. FIGUEROA, and J.L. MELNICK. 
1968. Herpes virus type 2 - association with carcinoma of the 
cervix. Science 161:1255-1256.
REID, B.L. 1964. The behaviour of human sperm toward cultured 
fragments of human cervix uteri. Lancet 3^:21-23.
RIGBY, P.W.J., M. DICKMAN, C. RHODES, and P. BERG. 1977.
Labelling deoxyribonucleic acid to high specific activity 
vitro by nick translation with DNA polymerase. J. Mol. Biol. 
113:237-251.
SOUTHERN, E.M. 1975. Detection of specific sequences among DNA 
fragments seperated by gel electrophoresis. J. Mol. Biol. 
98:503-517.
SPRECHER-GOLDBERGER, S., L. THIRY, N. LEFEBVRE, D. DEKEGEL, and 
F . DE-HALLEUX. 1971. Complement-fixation antibodies to 
adenovirus-associated viruses, adenoviruses, cytomegaloviruses 
and herpes simplex viruses in patients with tumours and in 
control individuals. Am. J. Epidemiol. 94:351-358.
ST JEOR, S.C., T.B. ALBRECHT, F.D. FUNK, and F. RAPP. 1974. 
Stimulation of cellular DNA synthesis by human 
cytomegalovirus. J. Virol. 13 :353-362.
STOIAN, M., M. HOZOC, M. lASIPENCO, J. BOLOCAN, and E. NASTAC. 
1982. Presence of antibodies to human cytomegalovirus in 
patients with different forms of cancer and in other 
categories of subjects. Rev. Roum. Med-Viol. 33:153-161.
TANAKA, S., T. FURUKAWA, and S.A. PLOTKIN. 1975. Human
cytomegalovirus stimulates host cell RNA synthesis. J. Virol. 
15^297-304.
VARMUS, H.E., J.M. BISHOP, and P.K. VOGT. 1973. Appearance of
virus—specific DNA in mammalian cells following transformation 
by Rous sarcoma virus. J. Mol. Biol. 74:613-626.
VESSEY, M.P., S.M. LAWLES, K. MCPHERSON, and D. YEATES. 1983. 
Neoplasia of the cervix uteri and contraception: a possible 
adverse effect of the pill. Lancet _2:930-934.
VESTERGAARD, B.F., A. HURNSLETH, and S.N. PEDERSEN. 1972.
Occurrence of herpes and adenovirus antibodies in patients 
with carcinoma of the cervix uteri. Cancer 30:68-74.
VONKA, V., J. KANKA, I. HIRSH, H. ZAVADOVA, M. KRCMAR, A.
SUCHANKOVA, D. REZACOVA, J. BROUCEK, M. PRESS, E. DOMORAZKOVA, 
B. SVOBODA, A. HAVRANKOVA, and J. JELINEK. 1984. Prospective 
study on the relationship between cervical neoplasia and 
herpes simplex type 2 virus. II Herpes simplex type 2 antibody 
presence in sera taken at enrolment. Int. J. Cancer 33:61-66.
WEBER, F . and W. SCHAFFNER. 1985. Enhancer activity correlates 
with the oncogenic potential of avian retroviruses. EMBO 
Journal 4:949-956.
WENTWORTH, B.B., and L. FRENCH. 1970. Plaque assay of
cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. 
Med. 135:253-258.
ZUR HAUSEN, H. 1982. Human genital cancer: Synergism between two 
virus infections or synergism between a virus infection and 
initiating events? Lancet 2^1370-1372.
o - r
I ro r  O
4
H
O
G>0
M
>
CTi
I
CD
m
r o
X
00
ro
o
to XH-
5a
H
H
H
X
00O)
X
00
Ü1
p
o
G
M
>
g
o
w
7^
O'
s /
/
/
/
?
3
X
0
1
ITO
O
b)
&
II od>
8
M3
0
1
<
CD
Hi
H
2:
>a
VX)
(/)
■
Î O' I
I
F IG U R E  2
H m a  Ml
gam HI
K E j T 1 R ! S 1 P |a| U jbd L
1 1 ! ! !
W I e 1 c 1 p C Ihj Q Z 1 Y f 1 R 1 X I
J idie! R
m iw! T I K J V P I b M i l  W jo f
±1 u  I I_
Q W ibid S
N 1 S lUi
20 40
kb
60 80
0-1 0-2
map units
0-3
Hincn\ M Izl
BamHI b| d M
EcoRl A 1 V P M E a cj Q S x | b K
Pst 1 1 G j a A ir jnj Q j y U | | j d L X N j p 1 c j i Y !u| R
Sg/li
Xbal
R ca, ,YiZi M
Q I T ! R 
J I____
80 100 120
kb
140 16(
H / n i l l i  
Sam HI
ccoRi 
Psf !
0-4
Y O
F S a i l l i , ? !
gjh
Si e I S
Sg/'i V  
Xba !
map units
0-6
w  I V i X I , Q
o
b I i l l  i W i t ; !  I l  Q !z' ! Z ! Ü I ivji X ' q
: E
W^X
I__
!6C' 200
kb
0 7
map units
0 9 1 0
